[X] Close
You are about to erase all the values you have customized, search history, page format, etc.
Click here to RESET all values       Click here to GO BACK without resetting any value
Items 1 to 100 of about 160
6. Yomo S, Hayashi M, Chernov M, Tamura N, Izawa M, Okada Y, Hori T, Iseki H: Stereotactic radiosurgery of residual or recurrent craniopharyngioma: new treatment concept using Leksell gamma knife model C with automatic positioning system. Stereotact Funct Neurosurg; 2009;87(6):360-7
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Stereotactic radiosurgery of residual or recurrent craniopharyngioma: new treatment concept using Leksell gamma knife model C with automatic positioning system.
  • BACKGROUND/AIMS: The present study analyzed the initial experience with the application of the original concept of 'robotic microradiosurgery' using Leksell Gamma Knife Model C with automatic positioning system for management of craniopharyngiomas.
  • METHODS: Eighteen patients with residual or recurrent craniopharyngiomas underwent radiosurgery with the use of multiple isocenters, mainly of smaller size, which were positioned compactly within the border of the lesion with resultant improved dose homogeneity, increased average dose within the target, and sharp dose fall outside the treated volume.
  • Mean tumor volume was 1.8 cm(3).
  • RESULTS: Tumor growth was controlled in 17 cases (94%), and its volume reduction was attained in 13 cases (72%).
  • In 3 patients significant shrinkage of the neoplasm after radiosurgery was accompanied by improvement of the visual functions.
  • CONCLUSION: Application of robotic microradiosurgery to the management of residual and recurrent craniopharyngiomas showed promising results during short- to intermediate-term follow-up, providing early tumor shrinkage in the majority of cases as well as sparing of visual and pituitary functions.
  • [MeSH-major] Craniopharyngioma / surgery. Neoplasm Recurrence, Local / surgery. Pituitary Neoplasms / surgery. Radiosurgery / instrumentation. Radiosurgery / methods. Stereotaxic Techniques
  • [MeSH-minor] Adolescent. Adult. Aged. Child. Female. Follow-Up Studies. Humans. Male. Middle Aged. Retrospective Studies. Treatment Outcome. Young Adult

  • Genetic Alliance. consumer health - Craniopharyngioma.
  • MedlinePlus Health Information. consumer health - Pituitary Tumors.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] (c) 2009 S. Karger AG, Basel.
  • (PMID = 19752595.001).
  • [ISSN] 1423-0372
  • [Journal-full-title] Stereotactic and functional neurosurgery
  • [ISO-abbreviation] Stereotact Funct Neurosurg
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't; Review
  • [Publication-country] Switzerland
  • [Number-of-references] 42
  •  go-up   go-down


7. Cavallo LM, Prevedello D, Esposito F, Laws ER Jr, Dusick JR, Messina A, Jane JA Jr, Kelly DF, Cappabianca P: The role of the endoscope in the transsphenoidal management of cystic lesions of the sellar region. Neurosurg Rev; 2008 Jan;31(1):55-64; discussion 64
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Cystic mass lesions within the sella turcica are common, and they include cystic pituitary adenomas, craniopharyngiomas, Rathke's cleft cysts, arachnoid cysts, and other entities.
  • The series consisted of 26 pituitary macroadenomas, 20 Rathke's cleft cysts, 18 craniopharyngiomas, 10 arachnoid cysts, one craniopharyngioma associated with an adrenocorticotropic hormone-secreting adenoma, and one chordoid glioma.
  • Its routine use during transsphenoidal surgery for such lesions is recommended to achieve maximal and safe tumor removal.
  • [MeSH-minor] Adenoma / surgery. Adult. Aged. Arachnoid Cysts / surgery. Central Nervous System Cysts / surgery. Craniopharyngioma / surgery. Female. Humans. Male. Middle Aged. Neurosurgical Procedures / instrumentation. Neurosurgical Procedures / methods. Pituitary Neoplasms / surgery. Sphenoid Sinus

  • MedlinePlus Health Information. consumer health - Endoscopy.
  • COS Scholar Universe. author profiles.
  • ClinicalTrials.gov. clinical trials - ClinicalTrials.gov .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Surg Neurol. 1991 Jun;35(6):446-54 [2053058.001]
  • [Cites] Front Horm Res. 2006;34:105-26 [16474218.001]
  • [Cites] Neurosurgery. 2005;56(1):124-8; discussion 129 [15617594.001]
  • [Cites] Neurosurgery. 1998 Jan;42(1):7-16; discussion 16-7 [9442498.001]
  • [Cites] Diagn Cytopathol. 1999 Mar;20(3):137-47 [10086237.001]
  • [Cites] Acta Neurochir (Wien). 1999;141(2):165-9 [10189498.001]
  • [Cites] J Clin Endocrinol Metab. 1999 Nov;84(11):3972-82 [10566636.001]
  • [Cites] Neurosurgery. 2004 Oct;55(4):933-40; discussion 940-1 [15458602.001]
  • [Cites] Childs Nerv Syst. 2005 Aug;21(8-9):696-700 [16041618.001]
  • [Cites] Surg Neurol. 1981 Apr;15(4):274-82 [7245014.001]
  • [Cites] Minim Invasive Neurosurg. 2002 Mar;45(1):47-51 [11932826.001]
  • [Cites] J Neurosurg. 1984 Jan;60(1):8-13 [6689730.001]
  • [Cites] Skull Base. 2003 Feb;13(1):55-58 [15912160.001]
  • [Cites] Acta Neurochir (Wien). 1999;141(4):389-97; discussion 397-8 [10352749.001]
  • [Cites] Childs Nerv Syst. 2004 Nov;20(11-12):863-7 [15185112.001]
  • [Cites] J Neurosurg. 1999 Feb;90(2):237-50 [9950494.001]
  • [Cites] J Neurosurg. 1970 Jul;33(1):48-53 [5427027.001]
  • [Cites] J Neurosurg. 1980 May;52(5):661-6 [7373393.001]
  • [Cites] J Endocrinol Invest. 2004 Nov;27(10):943-8 [15762042.001]
  • [Cites] Pediatr Neurosurg. 1994;21 Suppl 1:57-63 [7841079.001]
  • [Cites] J Neurosurg. 2002 Jul;97(1):3-11 [12134929.001]
  • [Cites] Laryngoscope. 1996 Jul;106(7):914-8 [8667994.001]
  • [Cites] J Neurosurg. 2003 Feb;98(2):350-8 [12593622.001]
  • [Cites] Neurosurgery. 2001 Jul;49(1):94-100; discussion 100-1 [11440465.001]
  • [Cites] AJNR Am J Neuroradiol. 1994 May;15(5):821-7 [8059648.001]
  • [Cites] J Neurosurg. 1977 Sep;47(3):451-8 [894347.001]
  • (PMID = 17922153.001).
  • [ISSN] 0344-5607
  • [Journal-full-title] Neurosurgical review
  • [ISO-abbreviation] Neurosurg Rev
  • [Language] eng
  • [Publication-type] Journal Article; Multicenter Study
  • [Publication-country] Germany
  •  go-up   go-down


8. Enchev Y, Ferdinandov D, Kounin G, Encheva E, Bussarsky V: Radiation-induced gliomas following radiotherapy for craniopharyngiomas: a case report and review of the literature. Clin Neurol Neurosurg; 2009 Sep;111(7):591-6
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Radiation-induced gliomas following radiotherapy for craniopharyngiomas: a case report and review of the literature.
  • The aim of this study was to collect, describe and analyze the radiation-induced gliomas in craniopharyngioma patients reported in the literature up to date.
  • Although exceptionally rare, the radiation-induced gliomas in craniopharyngioma patients are potentially possible, long-term complications with devastating consequences in typically younger patients with long life-expectancy.
  • [MeSH-major] Brain Neoplasms / complications. Brain Neoplasms / radiotherapy. Craniopharyngioma / complications. Craniopharyngioma / radiotherapy. Neoplasms, Radiation-Induced / pathology. Oligodendroglioma / etiology. Oligodendroglioma / pathology
  • [MeSH-minor] Adult. Female. Humans. Iatrogenic Disease. Magnetic Resonance Imaging. Paresis. Seizures / etiology. Tomography, X-Ray Computed

  • MedlinePlus Health Information. consumer health - Brain Tumors.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19447544.001).
  • [ISSN] 1872-6968
  • [Journal-full-title] Clinical neurology and neurosurgery
  • [ISO-abbreviation] Clin Neurol Neurosurg
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Netherlands
  •  go-up   go-down


9. Minniti G, Saran F, Traish D, Soomal R, Sardell S, Gonsalves A, Ashley S, Warrington J, Burke K, Mosleh-Shirazi A, Brada M: Fractionated stereotactic conformal radiotherapy following conservative surgery in the control of craniopharyngiomas. Radiother Oncol; 2007 Jan;82(1):90-5
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Fractionated stereotactic conformal radiotherapy following conservative surgery in the control of craniopharyngiomas.
  • PURPOSE: To describe the technique and results of stereotactically guided conformal radiotherapy (SCRT) in patients with craniopharyngioma after conservative surgery.
  • METHODS AND MATERIALS: Thirty-nine patients with craniopharyngioma aged 3-68 years (median age 18 years) were treated with SCRT between June 1994 and January 2003.
  • Twelve patients (30%) had acute clinical deterioration due to cystic enlargement of craniopharyngioma following SCRT and required cyst aspiration.
  • CONCLUSION: SCRT as a high-precision technique of localized RT is suitable for the treatment of incompletely excised craniopharyngioma.
  • [MeSH-major] Craniopharyngioma / radiotherapy. Pituitary Neoplasms / radiotherapy. Radiotherapy, Conformal / methods
  • [MeSH-minor] Adolescent. Adult. Aged. Child. Child, Preschool. Disease-Free Survival. Dose Fractionation. Female. Follow-Up Studies. Humans. Hypothalamus / radiation effects. Male. Middle Aged. Pituitary Gland / radiation effects. Radiotherapy Planning, Computer-Assisted. Radiotherapy, Adjuvant. Treatment Outcome. Vision, Ocular / radiation effects

  • MedlinePlus Health Information. consumer health - Pituitary Tumors.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17161483.001).
  • [ISSN] 0167-8140
  • [Journal-full-title] Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology
  • [ISO-abbreviation] Radiother Oncol
  • [Language] eng
  • [Publication-type] Evaluation Studies; Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] Ireland
  •  go-up   go-down


10. Dusick JR, Fatemi N, Mattozo C, McArthur D, Cohan P, Wang C, Swerdloff RS, Kelly DF: Pituitary function after endonasal surgery for nonadenomatous parasellar tumors: Rathke's cleft cysts, craniopharyngiomas, and meningiomas. Surg Neurol; 2008 Nov;70(5):482-90; discussion 490-1
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Pituitary function after endonasal surgery for nonadenomatous parasellar tumors: Rathke's cleft cysts, craniopharyngiomas, and meningiomas.
  • Herein we present the rates and risk factors of new hormonal failure and recovery in patients undergoing surgery for either an RCC, craniopharyngioma, or tuberculum sella meningioma.
  • METHODS: All consecutive patients treated over an 8-year period by endonasal surgery for an RCC, craniopharyngioma, or tuberculum sella meningioma were analyzed.
  • Patient characteristics, tumor size, intraoperative and postoperative events, and extent of tumor resection were correlated with new or resolved hypopituitarism.
  • RESULTS: In total, 50 patients with an RCC, 18 with a craniopharyngioma and 13 with tuberculum sellae meningioma, were analyzed.
  • New anterior pituitary failure and permanent DI occurred as follows: in RCCs, 6% and 2%; in craniopharyngiomas, 31% and 39%; and in meningiomas, 9% and 0%.
  • Overall, improved hormonal function occurred in 57% of patients with an RCC including recovery of one or more anterior axes in 9 (41%) of 22 patients and resolution of hyperprolactinemia in 12 (67%) of 18 patients; no patients with a craniopharyngioma or meningioma had resolution of hypopituitarism.
  • CONCLUSIONS: New hypopituitarism after transsphenoidal surgery occurs in approximately one third of patients with a craniopharyngioma and in less than 10% of patients with an RCC or suprasellar meningioma.
  • Hormonal function improves in the majority of patients undergoing drainage of an RCC but is unlikely to occur after removal of a craniopharyngioma or suprasellar meningioma.
  • [MeSH-major] Central Nervous System Cysts / surgery. Craniopharyngioma / surgery. Meningeal Neoplasms / surgery. Meningioma / surgery. Pituitary Gland / physiopathology. Pituitary Neoplasms / surgery
  • [MeSH-minor] Adolescent. Adult. Aged. Child. Cohort Studies. Female. Humans. Male. Middle Aged. Pituitary Function Tests. Pituitary Hormones, Anterior / metabolism. Pituitary Hormones, Posterior / metabolism. Retrospective Studies. Treatment Outcome

  • MedlinePlus Health Information. consumer health - Pituitary Tumors.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [CommentIn] Surg Neurol. 2009 Dec;72(6):643-4; author reply 644-7 [20082835.001]
  • (PMID = 18482750.001).
  • [ISSN] 0090-3019
  • [Journal-full-title] Surgical neurology
  • [ISO-abbreviation] Surg Neurol
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Pituitary Hormones, Anterior; 0 / Pituitary Hormones, Posterior
  •  go-up   go-down


11. Ierardi DF, Fernandes MJ, Silva IR, Thomazini-Gouveia J, Silva NS, Dastoli P, Toledo SR, Cavalheiro S: Apoptosis in alpha interferon (IFN-alpha) intratumoral chemotherapy for cystic craniopharyngiomas. Childs Nerv Syst; 2007 Sep;23(9):1041-6
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Apoptosis in alpha interferon (IFN-alpha) intratumoral chemotherapy for cystic craniopharyngiomas.
  • OBJECTIVES: The aim of this study was to verify whether intracystic injections of alpha-Interferon (IFN-alpha) in cystic craniopharyngiomas were able to reduce the tumor by activating the Fas apoptotic pathway.
  • MATERIALS AND METHODS: Twenty-one patients with cystic craniopharyngiomas treated at the Pediatric Oncology Institute (IOP/GRAACC) of Federal University of São Paulo were submitted to intracystic chemotherapy with IFN-alpha.
  • The tumor sizes of all patients were monitored and the apoptotic factor soluble FasL (sFasL) concentration was determined by ELISA (enzyme-linked immunosorbent assay) in tumor fluid samples from eight patients.
  • The concentration of sFasL was increased in all the eight patients examined concomitantly with the tumor size reduction.
  • CONCLUSIONS: Our data demonstrated that the IFN-alpha was able to induce Fas-mediated apoptosis together with a reduction in the tumor size; such an observation may suggest the importance to investigate still unexplored mechanisms to be exploited in craniopharyngioma therapy.
  • [MeSH-major] Apoptosis / drug effects. Craniopharyngioma / therapy. Drug Therapy / methods. Immunologic Factors / therapeutic use. Interferon-alpha / therapeutic use. Pituitary Neoplasms / therapy
  • [MeSH-minor] Adolescent. Adult. Child. Child, Preschool. Enzyme-Linked Immunosorbent Assay / methods. Fas Ligand Protein / metabolism. Female. Humans. Infant. Magnetic Resonance Imaging / methods. Male. Retrospective Studies. Tomography Scanners, X-Ray Computed

  • MedlinePlus Health Information. consumer health - Medicines and Children.
  • MedlinePlus Health Information. consumer health - Pituitary Tumors.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Childs Nerv Syst. 2005 Aug;21(8-9):719-24 [16133276.001]
  • [Cites] Pituitary. 2006;9(4):323-6 [17080265.001]
  • [Cites] Acta Oncol. 1998;37(4):331-8 [9743454.001]
  • [Cites] J Neurosurg. 2000 Feb;92 (2):255-60 [10659012.001]
  • [Cites] J Exp Med. 1998 Apr 20;187(8):1205-13 [9547332.001]
  • [Cites] Adv Pediatr. 2006;53:183-209 [17089867.001]
  • [Cites] Neurosurgery. 2000 Jan;46(1):213-6; discussion 216-7 [10626953.001]
  • [Cites] J Neurosurg. 1980 May;52(5):661-6 [7373393.001]
  • [Cites] J Neurosurg. 1996 Jan;84(1):124-6 [8613819.001]
  • [Cites] Expert Rev Mol Med. 2001 Dec 10;2001:1-18 [14987370.001]
  • [Cites] Childs Nerv Syst. 2001 Dec;17 (12 ):724-30 [11862438.001]
  • [Cites] No Shinkei Geka. 1974 Oct;2(10 ):683-8 [4140477.001]
  • [Cites] Clin Neuropathol. 2003 Sep-Oct;22(5):229-34 [14531547.001]
  • [Cites] J Exp Med. 1997 Dec 15;186(12):2045-50 [9396774.001]
  • [Cites] Childs Nerv Syst. 2005 Aug;21(8-9):701-4 [15928963.001]
  • [Cites] Brain Res Brain Res Rev. 2004 Jan;44(1):65-81 [14739003.001]
  • [Cites] J Neurosurg. 2004 Aug;101(1 Suppl):85-90 [16206977.001]
  • (PMID = 17593372.001).
  • [ISSN] 0256-7040
  • [Journal-full-title] Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery
  • [ISO-abbreviation] Childs Nerv Syst
  • [Language] eng
  • [Publication-type] Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] Germany
  • [Chemical-registry-number] 0 / Fas Ligand Protein; 0 / Immunologic Factors; 0 / Interferon-alpha
  •  go-up   go-down


12. Gupta DK, Ojha BK, Sarkar C, Mahapatra AK, Mehta VS: Recurrence in craniopharyngiomas: analysis of clinical and histological features. J Clin Neurosci; 2006 May;13(4):438-42
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Recurrence in craniopharyngiomas: analysis of clinical and histological features.
  • The aim of this study was to investigate the recurrence patterns and significance of various clinical and histological features as predictors of recurrence in craniopharyngiomas.
  • A series of 234 craniopharyngiomas (156 males, 78 females; age range 1.6-65 years) was reviewed.
  • Peri-operative mortality was 7.4% and tumor recurrence was observed in 26 patients (20.3%).
  • Of the patients with recurrence, one had total tumor excision (recurrence-free survival (RFS) 14 months), four had near-total excision (mean RFS 18.2 months) and 21 had subtotal tumor excision (RFS for symptomatic recurrence 7.1 months).
  • Brain tissue was included in 67 cases and brain invasion was noted in 44 (all were of adamantinous histology).
  • No correlation was noted between histopathological subtyping or brain invasion and recurrence.
  • The significant clinical factors predictive of recurrence included the extent of resection, tumor size greater than 4 cm and cystic tumors.
  • [MeSH-major] Brain Neoplasms / pathology. Craniopharyngioma / pathology. Neoplasm Recurrence, Local / pathology
  • [MeSH-minor] Adolescent. Adult. Aged. Child. Child, Preschool. Female. Follow-Up Studies. Humans. Infant. Magnetic Resonance Imaging / methods. Male. Middle Aged. Retrospective Studies

  • MedlinePlus Health Information. consumer health - Brain Tumors.
  • MedlinePlus Health Information. consumer health - Childhood Brain Tumors.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16678722.001).
  • [ISSN] 0967-5868
  • [Journal-full-title] Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia
  • [ISO-abbreviation] J Clin Neurosci
  • [Language] eng
  • [Publication-type] Comparative Study; Journal Article
  • [Publication-country] Scotland
  •  go-up   go-down


13. Bommakanti K, Panigrahi M, Yarlagadda R, Sundaram C, Uppin MS, Purohit AK: Optic chiasmatic-hypothalamic gliomas: is tissue diagnosis essential? Neurol India; 2010 Nov-Dec;58(6):833-40
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • RESULTS: The three radiological groups were: Group-1 solid tumors with or without microcysts in 9 patients (histology: 8 pilocystic astrocytomas and 1 tuberculoma); Group-2 mixed tumors with solid and cystic components in 9 patients (histology: 7 pilocytic astrocytomas and 2 craniopharyngiomas); Group-3 ring enhancing lesions in 6 patients (all the 6 patients initially received antituberculous treatment, in 3 patients the lesion resolved and in the remaining 3 patients the lesion was subjected to biopsy as it did not resolve, the biopsy was suggestive of pilocytic astrocytoma).
  • CONCLUSIONS: Various lesions like craniopharyngiomas, tuberculomas can mimic optic chiasmatic-hypothalamic gliomas radiologically, and it is not possible to diagnose them with certainty on the basis of radiological findings alone.
  • [MeSH-minor] Adolescent. Biopsy / methods. Child. Child, Preschool. Contrast Media. Female. Humans. Magnetic Resonance Imaging / methods. Male. Young Adult

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [CommentIn] Neurol India. 2011 Jan-Feb;59(1):144 [21339694.001]
  • (PMID = 21150045.001).
  • [ISSN] 0028-3886
  • [Journal-full-title] Neurology India
  • [ISO-abbreviation] Neurol India
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] India
  • [Chemical-registry-number] 0 / Contrast Media
  •  go-up   go-down


1
Advertisement
4. Müller HL, Gebhardt U, Wessel V, Schröder S, Kolb R, Sörensen N, Maroske J, Hanisch E: First experiences with laparoscopic adjustable gastric banding (LAGB) in the treatment of patients with childhood craniopharyngioma and morbid obesity. Klin Padiatr; 2007 Nov-Dec;219(6):323-5
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] First experiences with laparoscopic adjustable gastric banding (LAGB) in the treatment of patients with childhood craniopharyngioma and morbid obesity.
  • Craniopharyngiomas are embryogenic malformations which lead to eating disorders and morbid obesity due to hypothalamic involvement in about 50% of all patients with pediatric craniopharyngioma.
  • The experience with laparoscopic adjustable gastric banding (LAGB) in obese craniopharyngioma patients is limited.
  • We are reporting on four patients with childhood craniopharyngioma diagnosed at age 2, 11, 12, and 21 years.
  • We conclude that LAGB could be effective in weight reduction of obese craniopharyngioma patients with hypothalamic syndrome.
  • Close follow-up is necessary in order to analyze long-term effects and complications of LAGB in patients with childhood craniopharyngioma and morbid obesity.
  • [MeSH-major] Craniopharyngioma / complications. Gastroplasty. Laparoscopy. Obesity, Morbid / etiology. Obesity, Morbid / surgery. Pituitary Neoplasms / complications
  • [MeSH-minor] Adolescent. Adult. Body Mass Index. Child. Female. Follow-Up Studies. Humans. Male. Time Factors. Treatment Outcome


15. Jung TY, Jung S, Choi JE, Moon KS, Kim IY, Kang SS: Adult craniopharyngiomas: surgical results with a special focus on endocrinological outcomes and recurrence according to pituitary stalk preservation. J Neurosurg; 2009 Sep;111(3):572-7
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Adult craniopharyngiomas: surgical results with a special focus on endocrinological outcomes and recurrence according to pituitary stalk preservation.
  • OBJECT: The aim of this study was to evaluate the results of surgical treatment of adult craniopharyngioma with a special focus on the endocrinological outcomes and tumor recurrence in cases of pituitary preservation.
  • METHODS: Between 1993 and February 2008, 41 patients underwent 47 surgical procedures for craniopharyngioma.
  • The tumor was totally removed in 36 procedures (76.6%), subtotally in 10 (21.3%), and partially in 1 (2.1%).
  • The rate of tumor recurrence was 24.4%.
  • The recurrence-free survival rate was significantly different between patients in whom complete tumor resection was accomplished and those in whom tumor resection was incomplete.
  • CONCLUSIONS: The pituitary stalk must be preserved with maximal tumor resection whenever possible to increase the chance of intact anterior pituitary function being maintained.
  • [MeSH-major] Craniopharyngioma / surgery. Pituitary Gland. Pituitary Neoplasms / surgery
  • [MeSH-minor] Adolescent. Adult. Aged. Disease-Free Survival. Female. Follow-Up Studies. Humans. Male. Middle Aged. Neoplasm Recurrence, Local. Neurosurgical Procedures / methods. Postoperative Complications. Vision Disorders / etiology

  • MedlinePlus Health Information. consumer health - Pituitary Tumors.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19361259.001).
  • [ISSN] 0022-3085
  • [Journal-full-title] Journal of neurosurgery
  • [ISO-abbreviation] J. Neurosurg.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  •  go-up   go-down


16. Schittenhelm J, Psaras T, Meyermann R, Honegger J, Beschorner R: Pituitary adenomas and craniopharyngiomas are CDX2 negative neoplasms. Folia Neuropathol; 2010;48(2):75-80
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Pituitary adenomas and craniopharyngiomas are CDX2 negative neoplasms.
  • While many neoplasms have been studied, to date, no data is available on CDX2 expression in craniopharyngiomas.
  • MATERIAL AND METHODS: We investigated CDX2 expression in 28 normal pituitary glands, 75 pituitary adenomas of varying hormonal activity (including 7 invasive adenomas and 7 atypical adenomas) and 23 craniopharyngiomas (17 adamantinous and 6 papillary) in tissue microarrays.
  • RESULTS: None of the pituitary adenomas, craniopharyngiomas and normal pituitary glands showed expression of CDX2.
  • CONCLUSIONS: There is no evidence for that CDX2 might play a role in tumourigenesis, invasive growth or tumour recurrence of pituitary adenomas or in tumourigenesis of craniopharyngiomas.

  • MedlinePlus Health Information. consumer health - Pituitary Tumors.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20602288.001).
  • [ISSN] 1509-572X
  • [Journal-full-title] Folia neuropathologica
  • [ISO-abbreviation] Folia Neuropathol
  • [Language] ENG
  • [Publication-type] Journal Article
  • [Publication-country] Poland
  • [Chemical-registry-number] 0 / Biomarkers, Tumor; 0 / CDX2 protein, human; 0 / Homeodomain Proteins
  •  go-up   go-down


17. Jane JA Jr, Kiehna E, Payne SC, Early SV, Laws ER Jr: Early outcomes of endoscopic transsphenoidal surgery for adult craniopharyngiomas. Neurosurg Focus; 2010 Apr;28(4):E9
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Early outcomes of endoscopic transsphenoidal surgery for adult craniopharyngiomas.
  • OBJECT: Although the transsphenoidal approach for subdiaphragmatic craniopharyngiomas has been performed for many years, there are few reports describing the role of the endoscopic transsphenoidal technique for suprasellar craniopharyngiomas.
  • The purpose of this study was to report the outcomes of the endoscopic transsphenoidal approach for adults with craniopharyngiomas in whom the goal was gross-total resection.
  • CONCLUSIONS: The authors have achieved a high rate of radical resection and symptomatic improvement with the endoscopic transsphenoidal technique for both subdiaphragmatic (sellar/suprasellar) and supradiaphragmatic (suprasellar) craniopharyngiomas.
  • Endoscopic assessment of tumor resection may be more sensitive for residual tumor than the first postoperative MR imaging study.
  • [MeSH-major] Craniopharyngioma / surgery. Neuroendoscopy / methods. Neurosurgical Procedures / methods. Pituitary Neoplasms / surgery
  • [MeSH-minor] Adult. Aged. Diabetes Insipidus / etiology. Female. Humans. Hypopituitarism / etiology. Magnetic Resonance Imaging. Male. Microsurgery / methods. Middle Aged. Postoperative Complications / etiology. Sella Turcica / pathology. Sella Turcica / surgery. Sphenoid Sinus. Treatment Outcome. Tumor Burden. Vision Disorders / etiology

  • MedlinePlus Health Information. consumer health - Pituitary Tumors.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20367523.001).
  • [ISSN] 1092-0684
  • [Journal-full-title] Neurosurgical focus
  • [ISO-abbreviation] Neurosurg Focus
  • [Language] eng
  • [Publication-type] Comparative Study; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


18. Daousi C, Dunn AJ, Foy PM, MacFarlane IA, Pinkney JH: Endocrine and neuroanatomic features associated with weight gain and obesity in adult patients with hypothalamic damage. Am J Med; 2005 Jan;118(1):45-50
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Endocrine and neuroanatomic features associated with weight gain and obesity in adult patients with hypothalamic damage.
  • Much less information is available on adult patients and long-term survivors.
  • The aims of this study were to estimate the prevalence of obesity in adult patients with acquired structural hypothalamic damage and to define the characteristics of patients at greatest risk of obesity.
  • These included 22 craniopharyngiomas, 24 pituitary adenomas, and six other hypothalamic tumors.
  • Changes in body mass index were determined, magnetic resonance imaging scans were scored by a radiologist for tumor size and the extent of involvement of the hypothalamus, and current hormone replacement therapy was recorded, to identify possible features associated with new or worsened obesity (defined as a body mass index > or =30 kg/m(2) at the latest follow-up, which had increased by at least 2 kg/m(2) since diagnosis of the tumor).
  • No correlation was found between the initial size or location of the tumor and subsequent weight gain.
  • CONCLUSION: Obesity is highly prevalent in adult survivors of hypothalamic tumors.
  • Use of desmopressin and growth hormone therapy, but not size or location of the tumor, were associated with weight gain and obesity following diagnosis.
  • [MeSH-minor] Adolescent. Adult. Aged. Body Mass Index. Confidence Intervals. Deamino Arginine Vasopressin / administration & dosage. Deamino Arginine Vasopressin / adverse effects. Female. Growth Hormone / administration & dosage. Growth Hormone / adverse effects. Humans. Male. Middle Aged. Multivariate Analysis. Odds Ratio. Prevalence. Renal Agents / administration & dosage. Renal Agents / adverse effects. Retrospective Studies

  • Genetic Alliance. consumer health - Obesity.
  • MedlinePlus Health Information. consumer health - Obesity.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15639209.001).
  • [ISSN] 0002-9343
  • [Journal-full-title] The American journal of medicine
  • [ISO-abbreviation] Am. J. Med.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Renal Agents; 9002-72-6 / Growth Hormone; ENR1LLB0FP / Deamino Arginine Vasopressin
  •  go-up   go-down


19. Bikmaz K, Guerrero CA, Dammers R, Krisht AF, Husain MM: Ectopic recurrence of craniopharyngiomas: case report. Neurosurgery; 2009 Feb;64(2):E382-3; discussion E383
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Ectopic recurrence of craniopharyngiomas: case report.
  • OBJECTIVE: Craniopharyngiomas are benign tumors that originate from squamous cell rests of the embryonal hypophyseal-pharyngeal duct located along the pituitary stalk.
  • After their surgical resection, recurrence usually occurs in the region of the original tumor bed.
  • Ectopic recurrence of craniopharyngiomas is extremely rare.
  • We present 3 examples of ectopic recurrences of craniopharyngiomas.
  • CLINICAL PRESENTATION: The first patient was a 52-year-old woman with a history of resected suprasellar craniopharyngioma presenting 15 years later with a history of balance problems and new onset of double vision.
  • Her magnetic resonance imaging scan revealed a tumor in the prepontine cistern.
  • The second patient was a 41-year-old man with a history of a resected suprasellar craniopharyngioma presenting 9 years later with headache, dizziness, and disequilibrium.
  • The third patient was a 24-year-old man with a history of suprasellar craniopharyngioma resection, followed by conventional radiotherapy 12 years before his recent presentation with headache, numbness of the right side of his face, and increased drowsiness.
  • INTERVENTION: The first patient underwent operation via a petrosal approach with subtotal resection of the tumor and decompression of the brainstem; this patient had an uneventful postoperative course.
  • The tumor in the second patient was surgically resected through a pterional craniotomy, with an uneventful postoperative course.
  • The third patient's right-sided cerebellopontine angle lesion was microsurgically resected, and the patient was given a single-dose gamma knife for the left-side and residual small right-side tumor.
  • The histological diagnosis of all 3 lesions was craniopharyngioma.
  • CONCLUSION: Although ectopic recurrence of a craniopharyngioma is very rare, it should always be considered in the differential diagnosis of what appears to be a new tumor in a patient with a history of previously resected craniopharyngiomas.
  • Long-term follow-up of patients with resected craniopharyngioma is very important.
  • [MeSH-major] Craniopharyngioma / diagnosis. Craniopharyngioma / surgery. Neoplasm Recurrence, Local / diagnosis. Neoplasm Recurrence, Local / surgery. Neoplasms, Second Primary / diagnosis. Neoplasms, Second Primary / surgery. Pituitary Neoplasms / diagnosis. Pituitary Neoplasms / surgery
  • [MeSH-minor] Adult. Female. Humans. Male. Middle Aged. Treatment Outcome

  • MedlinePlus Health Information. consumer health - Pituitary Tumors.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19190442.001).
  • [ISSN] 1524-4040
  • [Journal-full-title] Neurosurgery
  • [ISO-abbreviation] Neurosurgery
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


20. Kawamata T, Kubo O, Hori T: Histological findings at the boundary of craniopharyngiomas. Brain Tumor Pathol; 2005;22(2):75-8
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Histological findings at the boundary of craniopharyngiomas.
  • Although a craniopharyngioma is grossly well circumscribed, microscopically the borders are frequently irregular and may be associated with gliosis in the adjacent brain tissue.
  • In the current study, we investigated the histology of the interface between craniopharyngiomas and surrounding normal structures such as the hypothalamus and pituitary gland.
  • Histologically, we classified the findings at the boundary of craniopharyngiomas into three types.
  • In type 1, a relatively thick capsule-like tissue was identified at the boundary between the craniopharyngioma and surrounding normal structure composed of tumor cells and inflammatory changes.
  • In type 2, a craniopharyngioma had a relatively clear cleavage between the surrounding gliosis.
  • In type 3, the boundary had some interdigitation of the tumor in the surrounding gliotic layer adjacent to the craniopharyngioma.
  • In types 1 and 3, surgeons may fail to accomplish complete resection of the tumor.
  • These histological features may result in recurrence of craniopharyngioma even after gross total resection.
  • [MeSH-major] Craniopharyngioma / ultrastructure. Hypothalamus / ultrastructure. Pituitary Gland / ultrastructure. Pituitary Neoplasms / ultrastructure
  • [MeSH-minor] Adolescent. Adult. Aged. Brain Stem / ultrastructure. Child. Child, Preschool. Female. Gliosis / etiology. Gliosis / pathology. Humans. Infant. Male. Middle Aged. Neoplasm Invasiveness. Retrospective Studies. Visual Pathways / ultrastructure. Young Adult

  • MedlinePlus Health Information. consumer health - Pituitary Tumors.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18095108.001).
  • [ISSN] 1861-387X
  • [Journal-full-title] Brain tumor pathology
  • [ISO-abbreviation] Brain Tumor Pathol
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Japan
  •  go-up   go-down


21. Holmer H, Ekman B, Björk J, Nordstöm CH, Popovic V, Siversson A, Erfurth EM: Hypothalamic involvement predicts cardiovascular risk in adults with childhood onset craniopharyngioma on long-term GH therapy. Eur J Endocrinol; 2009 Nov;161(5):671-9
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Hypothalamic involvement predicts cardiovascular risk in adults with childhood onset craniopharyngioma on long-term GH therapy.
  • CONTEXT: Craniopharyngioma patients without GH therapy are at an increased cardiovascular disease (CVD) risk and particularly concerning women.
  • No previous study on long-term GH therapy in adults with childhood onset (CO) craniopharyngioma was identified.
  • OBJECTIVE: To investigate CVD risk in adults with CO craniopharyngioma on complete hormone replacement, including long-term GH therapy, and to investigate the impact of disease-related factors on CVD risk.
  • DESIGN AND PARTICIPANTS: In a cross-sectional study of operated CO craniopharyngiomas (1958-2000) from a defined area of Sweden (2.5 million), we enrolled 42 patients (20 women) with a median age of 28 years (range 17-57) and assessed CVD risk of 20 (4-40) years after first operation.
  • Comparisons were made with matched controls and between patients with tumor growth into the third ventricle (TGTV) versus non-TGTV.
  • CONCLUSIONS: Adult patients with CO craniopharyngioma, especially those with TGTV, have persistently increased CVD risk.

  • Genetic Alliance. consumer health - Craniopharyngioma.
  • MedlinePlus Health Information. consumer health - Hormone Replacement Therapy.
  • MedlinePlus Health Information. consumer health - Pituitary Tumors.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19667040.001).
  • [ISSN] 1479-683X
  • [Journal-full-title] European journal of endocrinology
  • [ISO-abbreviation] Eur. J. Endocrinol.
  • [Language] ENG
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Insulin; 0 / Leptin; 12629-01-5 / Human Growth Hormone
  •  go-up   go-down


22. Elliott RE, Moshel YA, Wisoff JH: Minimal residual calcification and recurrence after gross-total resection of craniopharyngioma in children. J Neurosurg Pediatr; 2009 Apr;3(4):276-83
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Minimal residual calcification and recurrence after gross-total resection of craniopharyngioma in children.
  • OBJECT: The purpose of this study was to assess the impact of minimal residual calcification without enhancing tumor on the rate of recurrence after gross-total resection (GTR) of craniopharyngioma in children.
  • METHODS: Data were retrospectively collected in 86 patients younger than 21 years of age in whom 103 craniopharyngioma resections were performed by the senior author between 1986 and 2008.
  • Forty-nine patients (27 boys and 22 girls, with a mean age of 8.6 years) fulfilled the criteria for inclusion in this study by having tumor calcification on the preoperative CT scan, undergoing GTR, and having complete postoperative CT and MR imaging and clinical follow-up.
  • At a mean follow-up of 9.4 years (median 10 years), 2 (15%) of 13 patients with and 10 (28%) of 36 patients without residual calcification experienced tumor recurrence.
  • CONCLUSIONS: The absence or presence of minimal residual calcification does not have an impact on the risk of recurrence after GTR in pediatric craniopharyngiomas.
  • The authors recommend withholding irradiation or other adjuvant therapy in the setting of minimal residual calcification without enhancing tumor.
  • [MeSH-major] Calcinosis / complications. Craniopharyngioma / pathology. Craniopharyngioma / surgery. Neoplasm Recurrence, Local / epidemiology. Pituitary Neoplasms / pathology. Pituitary Neoplasms / surgery
  • [MeSH-minor] Adolescent. Child. Child, Preschool. Cohort Studies. Disease-Free Survival. Female. Humans. Infant. Male. Neoplasm, Residual. Retrospective Studies. Risk Factors. Young Adult

  • Genetic Alliance. consumer health - Craniopharyngioma.
  • MedlinePlus Health Information. consumer health - Pituitary Tumors.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19338405.001).
  • [ISSN] 1933-0707
  • [Journal-full-title] Journal of neurosurgery. Pediatrics
  • [ISO-abbreviation] J Neurosurg Pediatr
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


23. de Divitiis E, Cavallo LM, Cappabianca P, Esposito F: Extended endoscopic endonasal transsphenoidal approach for the removal of suprasellar tumors: Part 2. Neurosurgery; 2007 Jan;60(1):46-58; discussion 58-9
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • The series consisted of seven pituitary adenomas, seven craniopharyngiomas, three suprasellar Rathke's cleft cysts, two tuberculum sellae meningiomas, and one pilocytic astrocytoma of the chiasm.
  • RESULTS: Tumor removal, as assessed by postoperative magnetic resonance imaging, revealed complete removal of the lesion in four out of seven pituitary adenomas, five out of seven craniopharyngiomas, three out of three Rathke's cleft cysts, and two out of two tuberculum sellae meningiomas.
  • One patient (5%) with craniopharyngioma had a postoperative cerebrospinal fluid leak that required reoperation.
  • [MeSH-major] Brain Neoplasms / surgery. Nasal Cavity / surgery. Neuroendoscopy / methods. Sphenoid Sinus / surgery
  • [MeSH-minor] Adult. Aged. Central Nervous System Neoplasms / diagnosis. Central Nervous System Neoplasms / radiography. Central Nervous System Neoplasms / surgery. Female. Humans. Male. Middle Aged. Sphenoid Bone / radiography. Sphenoid Bone / surgery

  • MedlinePlus Health Information. consumer health - Brain Tumors.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17228252.001).
  • [ISSN] 1524-4040
  • [Journal-full-title] Neurosurgery
  • [ISO-abbreviation] Neurosurgery
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  •  go-up   go-down


24. Cavallo LM, Prevedello DM, Solari D, Gardner PA, Esposito F, Snyderman CH, Carrau RL, Kassam AB, Cappabianca P: Extended endoscopic endonasal transsphenoidal approach for residual or recurrent craniopharyngiomas. J Neurosurg; 2009 Sep;111(3):578-89
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Extended endoscopic endonasal transsphenoidal approach for residual or recurrent craniopharyngiomas.
  • OBJECT: The management of recurrent or residual craniopharyngiomas remains controversial.
  • The extended (also called expanded) endoscopic endonasal transsphenoidal approach through the planum sphenoidale has been proposed over the past decade as an alternative surgical route for removal of various suprasellar tumors including craniopharyngiomas.
  • In this study, the authors describe the feasibility and advantages of this technique in recurrent or symptomatic residual craniopharyngiomas.
  • METHODS: Between January 2004 and June 2008, 22 patients underwent surgery via the extended endoscopic transsphenoidal approach for the treatment of recurrent or residual symptomatic craniopharyngiomas at either the University of Pittsburgh or the Universita degli Studi di Napoli.
  • The lesions included 12 purely suprasellar craniopharyngiomas, 9 with both intra- and suprasellar extensions, and 1 arising from a remnant in the Meckel cave.
  • To better evaluate the features of the extended endonasal approach for recurrent or residual craniopharyngiomas, each patient was assigned to 1 of 3 subgroups depending on the original surgical treatment: transcranial pterional route (13 patients), transphenoidal approach (3 patients; 2 microsurgically and 1 with the standard endoscopic technique), or extended endonasal endoscopic approach (6 patients).
  • Subtotal removal (>70%) was attained in 4 patients (18.2%), and tumor removal was partial (<50%) in only 1 case (4.5%).
  • CONCLUSIONS: Most of the advantages of the endoscopic endonasal technique were noted during tumor dissection from the inferior aspect of the chiasm, the infundibulum, the third ventricle, and/or the retro- and parasellar areas.
  • The endoscopic endonasal technique should be considered as a therapeutic option in selected cases of recurrent or symptomatic residual craniopharyngiomas.
  • [MeSH-major] Craniopharyngioma / surgery. Neuroendoscopy / methods. Pituitary Neoplasms / surgery
  • [MeSH-minor] Adolescent. Adult. Aged. Aged, 80 and over. Female. Humans. Male. Middle Aged. Neoplasm Recurrence, Local / surgery. Neoplasm, Residual / surgery. Neurosurgical Procedures / methods. Postoperative Complications. Reoperation. Treatment Outcome


25. Julow J, Backlund EO, Lányi F, Hajda M, Bálint K, Nyáry I, Szeifert GT: Long-term results and late complications after intracavitary yttrium-90 colloid irradiation of recurrent cystic craniopharyngiomas. Neurosurgery; 2007 Aug;61(2):288-95; discussion 295-6
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Long-term results and late complications after intracavitary yttrium-90 colloid irradiation of recurrent cystic craniopharyngiomas.
  • OBJECTIVE: Data were analyzed to assess the value of stereotactically applied intracystic colloidal yttrium-90 (YTx) for the treatment of recurrent cystic craniopharyngiomas during a 30-year period.
  • CONCLUSION: Despite sporadic complications, intracavitary YTx irradiation is a valuable treatment alternative for craniopharyngioma cysts, sometimes as part of a multimodality management in these tumors, especially in precarious surgical cases.
  • [MeSH-major] Brachytherapy / methods. Craniopharyngioma / radiotherapy. Cysts / radiotherapy. Pituitary Neoplasms / radiotherapy. Yttrium Radioisotopes / administration & dosage
  • [MeSH-minor] Adolescent. Adult. Aged. Child. Child, Preschool. Colloids. Combined Modality Therapy. Female. Humans. Kaplan-Meier Estimate. Male. Middle Aged. Radiosurgery. Radiotherapy Dosage. Recurrence. Tomography, X-Ray Computed

  • MedlinePlus Health Information. consumer health - Pituitary Tumors.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17762741.001).
  • [ISSN] 1524-4040
  • [Journal-full-title] Neurosurgery
  • [ISO-abbreviation] Neurosurgery
  • [Language] eng
  • [Publication-type] Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Colloids; 0 / Yttrium Radioisotopes
  •  go-up   go-down


31. Schmalisch K, Beschorner R, Psaras T, Honegger J: Postoperative intracranial seeding of craniopharyngiomas--report of three cases and review of the literature. Acta Neurochir (Wien); 2010 Feb;152(2):313-9; discussion 319
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Postoperative intracranial seeding of craniopharyngiomas--report of three cases and review of the literature.
  • PURPOSE: Seeding of craniopharyngioma has been rarely reported.
  • METHODS: The first patient was a 13-year-old boy who had initially undergone radical excision of a suprasellar and retrosellar craniopharyngioma by a right pterional approach.
  • Postoperative MRI showed no evidence of residual tumor.
  • Two years later, MRI revealed a local recurrence and in addition a separated cystic tumor on the right side adjacent to the middle cerebral artery consistent with seeding along the surgical route.
  • On histopathological examination, both, the local recurrent tumor and the distant deposit turned out to be adamantinomatous craniopharyngiomas.
  • The second patient was a 27-year-old woman who was operated on for the first time via a right pterional and 1 year later for a recurrent craniopharyngioma via a transsphenoidal approach.
  • This deposit in the operative pathway was found to be an adamantinomatous craniopharyngioma, as was the initial tumor.
  • The recent control MRT revealed a right parietal intracranial tumor with peripheral contrast enhancement, which was located distant to the former craniotomy.
  • The tumor was removed and histopathological examination revealed an adamantinomatous craniopharyngioma in accordance with the initial tumor.
  • CONCLUSION: Although craniopharyngiomas exhibit a benign histopathological pattern, cerebrospinal fluid seeding along the surgical route or along the CSF pathways has been observed.
  • Ectopic recurrence of craniopharyngioma suggests that meticulous protection of the whole surgical field and careful handling of the tumor during the operation are required.
  • [MeSH-major] Brain Neoplasms / secondary. Craniopharyngioma / secondary. Neoplasm Metastasis / pathology. Neoplasm Seeding. Pituitary Neoplasms / pathology
  • [MeSH-minor] Adolescent. Adult. Craniotomy. Female. Frontal Bone / pathology. Frontal Bone / surgery. Humans. Magnetic Resonance Imaging. Male. Neoplasm Recurrence, Local / pathology. Neoplasm Recurrence, Local / surgery. Parietal Bone / pathology. Parietal Bone / surgery. Reoperation. Treatment Outcome

  • MedlinePlus Health Information. consumer health - Brain Tumors.
  • MedlinePlus Health Information. consumer health - Pituitary Tumors.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19859655.001).
  • [ISSN] 0942-0940
  • [Journal-full-title] Acta neurochirurgica
  • [ISO-abbreviation] Acta Neurochir (Wien)
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article; Review
  • [Publication-country] Austria
  • [Number-of-references] 31
  •  go-up   go-down


32. Hori T, Kawamata T, Amano K, Aihara Y, Ono M, Miki N: Anterior interhemispheric approach for 100 tumors in and around the anterior third ventricle. Neurosurgery; 2010 Mar;66(3 Suppl Operative):65-74
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • METHODS: One hundred patients with 46 craniopharyngiomas, 12 hypothalamic gliomas, 12 meningiomas, 6 hypothalamic hamartomas, and 24 other lesions were operated on using an anterior interhemispheric approach with or without opening of the lamina terminalis.
  • This surgical approach involves no frontal sinus opening; a narrow (approximately 15-20 mm in width) access between the bridging veins, which is sufficient to remove the tumor totally; and sparing of the anterior communicating artery.
  • RESULTS: Total removal of the neoplasm was accomplished in 37 of 46 patients with craniopharyngiomas (80.4%), whereas subtotal resection was performed in hypothalamic gliomas.
  • No significant differences in pre- and postoperative hormonal disturbances were observed in 37 craniopharyngiomas and 10 hypothalamic gliomas.
  • CONCLUSION: The minimally invasive anterior interhemispheric approach, with or without opening of the lamina terminalis, is useful for removal of tumors in and around the anterior third ventricle, such as craniopharyngiomas and hypothalamic gliomas.
  • [MeSH-major] Brain Neoplasms / surgery. Hypothalamus / surgery. Neurosurgical Procedures / methods. Third Ventricle / surgery. Ventriculostomy / methods
  • [MeSH-minor] Adolescent. Adult. Aged. Cerebrum / anatomy & histology. Cerebrum / surgery. Child. Child, Preschool. Craniopharyngioma / pathology. Craniopharyngioma / surgery. Female. Glioma / pathology. Glioma / surgery. Hamartoma / pathology. Hamartoma / surgery. Humans. Infant. Male. Meningioma / pathology. Meningioma / surgery. Middle Aged. Minimally Invasive Surgical Procedures / instrumentation. Minimally Invasive Surgical Procedures / methods. Postoperative Complications / etiology. Postoperative Complications / prevention & control. Surgical Instruments / standards. Treatment Outcome. Young Adult

  • MedlinePlus Health Information. consumer health - Brain Tumors.
  • MedlinePlus Health Information. consumer health - Childhood Brain Tumors.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20173574.001).
  • [ISSN] 1524-4040
  • [Journal-full-title] Neurosurgery
  • [ISO-abbreviation] Neurosurgery
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


33. Kitano M, Taneda M: Extended transsphenoidal surgery for suprasellar craniopharyngiomas: infrachiasmatic radical resection combined with or without a suprachiasmatic trans-lamina terminalis approach. Surg Neurol; 2009 Mar;71(3):290-8, discussion 298
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Extended transsphenoidal surgery for suprasellar craniopharyngiomas: infrachiasmatic radical resection combined with or without a suprachiasmatic trans-lamina terminalis approach.
  • To evaluate the capability of this approach for removal of suprasellar craniopharyngiomas, surgical outcomes were retrospectively analyzed.
  • METHODS: During a 9-year period, 20 consecutive patients with suprasellar craniopharyngioma underwent transsphenoidal tumor resection.
  • No patient had a purely intrasellar tumor, 9 had prechiasmatic tumors, 9 had retrochiasmatic tumors, and 2 had purely intraventricular tumors.
  • CONCLUSIONS: Reasonable surgical results in this study suggest that the extended transsphenoidal approach is safe and effective for removal of craniopharyngiomas.
  • Although preservation of the pituitary stalk can be achieved in a high percentage of patients, postoperative endocrinopathy still remains as a significant problem after radical removal of the craniopharyngioma.
  • [MeSH-major] Craniopharyngioma / surgery. Neurosurgical Procedures / methods. Optic Chiasm. Pituitary Neoplasms / surgery. Sella Turcica
  • [MeSH-minor] Adolescent. Adult. Aged. Child. Female. Follow-Up Studies. Humans. Male. Middle Aged. Pituitary Gland / surgery. Postoperative Complications. Retrospective Studies. Sphenoid Bone / surgery. Young Adult

  • MedlinePlus Health Information. consumer health - Pituitary Tumors.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18291485.001).
  • [ISSN] 0090-3019
  • [Journal-full-title] Surgical neurology
  • [ISO-abbreviation] Surg Neurol
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


34. Pereira AM, Schmid EM, Schutte PJ, Voormolen JH, Biermasz NR, van Thiel SW, Corssmit EP, Smit JW, Roelfsema F, Romijn JA: High prevalence of long-term cardiovascular, neurological and psychosocial morbidity after treatment for craniopharyngioma. Clin Endocrinol (Oxf); 2005 Feb;62(2):197-204
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] High prevalence of long-term cardiovascular, neurological and psychosocial morbidity after treatment for craniopharyngioma.
  • INTRODUCTION: The treatment of craniopharyngiomas is associated with long-term morbidity.
  • AIM OF THE STUDY: To assess the long-term functional outcome and mortality rates after treatment for craniopharyngiomas, we audited our data with special focus on cardiovascular, neurological and psychosocial morbidity.
  • PATIENTS AND METHODS: Between 1965 and 2002, 54 consecutive patients underwent surgery for craniopharyngiomas at the Leiden University Medical Centre (LUMC).
  • CONCLUSION: Craniopharyngioma is associated with excessive long-term multisystem morbidity and mortality, especially in female patients, despite a high cure rate.
  • [MeSH-major] Craniopharyngioma / therapy. Pituitary Neoplasms / therapy
  • [MeSH-minor] Adolescent. Adult. Aged. Cardiovascular Diseases / etiology. Child. Child, Preschool. Disease-Free Survival. Female. Follow-Up Studies. Humans. Male. Middle Aged. Morbidity. Neoplasm Recurrence, Local. Nervous System Diseases / etiology. Prevalence. Risk. Sex Factors. Survival Rate. Time Factors. Visual Acuity. Visual Fields

  • Genetic Alliance. consumer health - Craniopharyngioma.
  • MedlinePlus Health Information. consumer health - Pituitary Tumors.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15670196.001).
  • [ISSN] 0300-0664
  • [Journal-full-title] Clinical endocrinology
  • [ISO-abbreviation] Clin. Endocrinol. (Oxf)
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] England
  • [Number-of-references] 30
  •  go-up   go-down


35. Ishii K, Zaitsu M, Yonemitsu N, Kan Y, Hamasaki Y, Matsuo M: 5-lipoxygenase pathway promotes cell proliferation in human glioma cell lines. Clin Neuropathol; 2009 Nov-Dec;28(6):445-52
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • We investigated 5-LO expression and examined whether the 5-LO pathway is associated with the proliferation of human brain tumors.
  • METHODS: We immunohistochemically evaluated the profile of 5-LO expression in various types of brain tumors obtained from 42 patients, and examined the proliferative effects of the 5-LO pathway in human glioma cell lines using a proliferation assay.
  • RESULTS: Immunohistochemistry of glioblastomas, astrocytomas, meningiomas, medulloblastomas, craniopharyngiomas, ependymomas, neurinomas, oligodendrogliomas, malignant lymphomas, dysembryoplastic neuroepithelial and metastatic brain tumors revealed 5-LO expression in the cytoplasm and nuclei or nuclear envelopes of tumor cells.
  • CONCLUSIONS: We confirmed the expression of 5-LO in various human brain tumors and demonstrated the partial suppression of tumor growth by inhibitors of the 5-LO-LTA4 hydrolase pathway in human glioma cell lines.
  • [MeSH-major] Arachidonate 5-Lipoxygenase / physiology. Brain Neoplasms / pathology. Cell Proliferation. Glioma / pathology. Signal Transduction / physiology
  • [MeSH-minor] Adolescent. Adult. Aged. Astrocytoma / pathology. Astrocytoma / physiopathology. Child. Child, Preschool. Dose-Response Relationship, Drug. Female. Glioblastoma / pathology. Glioblastoma / physiopathology. Humans. Leucine / analogs & derivatives. Leucine / pharmacology. Leukotriene A4 / antagonists & inhibitors. Leukotriene A4 / physiology. Lipoxygenase Inhibitors. Male. Meningioma / pathology. Meningioma / physiopathology. Middle Aged. Protease Inhibitors / pharmacology. Tumor Cells, Cultured. Young Adult

  • Genetic Alliance. consumer health - Glioma.
  • MedlinePlus Health Information. consumer health - Brain Tumors.
  • MedlinePlus Health Information. consumer health - Childhood Brain Tumors.
  • Hazardous Substances Data Bank. L-Leucine .
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • The Lens. Cited by Patents in .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19919819.001).
  • [ISSN] 0722-5091
  • [Journal-full-title] Clinical neuropathology
  • [ISO-abbreviation] Clin. Neuropathol.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] Germany
  • [Chemical-registry-number] 0 / Leukotriene A4; 0 / Lipoxygenase Inhibitors; 0 / Protease Inhibitors; EC 1.13.11.34 / Arachidonate 5-Lipoxygenase; GMW67QNF9C / Leucine; I0J33N5627 / ubenimex
  •  go-up   go-down


36. Ulfarsson E, Karström A, Yin S, Girnita A, Vasilcanu D, Thoren M, Kratz G, Hillman J, Axelson M, Larsson O, Girnita L: Expression and growth dependency of the insulin-like growth factor I receptor in craniopharyngioma cells: a novel therapeutic approach. Clin Cancer Res; 2005 Jul 1;11(13):4674-80
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Expression and growth dependency of the insulin-like growth factor I receptor in craniopharyngioma cells: a novel therapeutic approach.
  • Craniopharyngioma is a rare benign intracranial epithelial tumor that, however, often recurs and sometimes kills the affected patients, one-third of which are children.
  • Together, these circumstances raise the question whether IGF-IR may be involved in craniopharyngioma growth.
  • To address this issue, we analyzed phenotypically well-characterized primary low-passage craniopharyngioma cell lines from nine different patients for IGF-IR expression and IGF-I dependency.
  • Taken together, our data suggest that IGF-IR may be involved in the growth of a subset of craniopharyngiomas and points to the possibility of the involvement of IGF-IR inhibitors as a treatment modality to obtain complete tumor-free conditions before growth hormone substitution.
  • [MeSH-major] Craniopharyngioma / pathology. Pituitary Neoplasms / pathology. Receptor, IGF Type 1 / biosynthesis
  • [MeSH-minor] Adolescent. Adult. Cell Proliferation / drug effects. Child. Dose-Response Relationship, Drug. Humans. Immunohistochemistry. Inhibitory Concentration 50. Insulin-Like Growth Factor I / pharmacology. Middle Aged. Phosphorylation / drug effects. Podophyllotoxin / analogs & derivatives. Podophyllotoxin / pharmacology. Tumor Cells, Cultured

  • Genetic Alliance. consumer health - Craniopharyngioma.
  • MedlinePlus Health Information. consumer health - Pituitary Tumors.
  • Hazardous Substances Data Bank. PODOFILOX .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16000560.001).
  • [ISSN] 1078-0432
  • [Journal-full-title] Clinical cancer research : an official journal of the American Association for Cancer Research
  • [ISO-abbreviation] Clin. Cancer Res.
  • [Language] eng
  • [Publication-type] Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0F35AOI227 / picropodophyllin; 67763-96-6 / Insulin-Like Growth Factor I; EC 2.7.10.1 / Receptor, IGF Type 1; L36H50F353 / Podophyllotoxin
  •  go-up   go-down


37. Baldé NM, Diallo MM, Poirier JY, Sow MS, Brassier G, Lorcy Y: [Long-term outcome of the adult onset craniopharyngiomas]. Ann Endocrinol (Paris); 2007 Jun;68(2-3):186-90
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Long-term outcome of the adult onset craniopharyngiomas].
  • [Transliterated title] Devenir à long-terme des craniopharyngiomes de l'adulte.
  • There is few published series dealing on the long-term outcome of the adult-onset craniopharyngiomas.
  • We report the long term clinical, tomodensitometric and MRI data outcome of 35 (23 woman and 12 men) consecutive adult-onset cured for craniopharyngiomas between 1983 and 2002, and followed-up in Rennes University Hospital.
  • Recurrence of tumour occurred in 8 patients (25.8%) and a tumor progression in 1 case.
  • Two patients had 5 and 6 years treatment by growth hormone (GH), without tumor recurrence.
  • The observed increase of weight after the surgical cure of craniopharyngiomas concerned 22 patients (63%).
  • In conclusion the craniopharyngiomas recurrence is frequent and can appear in very prolonged deadlines after the initial surgery.
  • [MeSH-major] Craniopharyngioma / therapy. Pituitary Neoplasms / therapy
  • [MeSH-minor] Adult. Aged. Female. Follow-Up Studies. Growth Hormone / therapeutic use. Humans. Magnetic Resonance Imaging. Male. Mental Disorders / etiology. Middle Aged. Neoplasm Recurrence, Local. Survival Analysis. Tomography, X-Ray Computed. Treatment Outcome

  • MedlinePlus Health Information. consumer health - Pituitary Tumors.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17531946.001).
  • [ISSN] 0003-4266
  • [Journal-full-title] Annales d'endocrinologie
  • [ISO-abbreviation] Ann. Endocrinol. (Paris)
  • [Language] fre
  • [Publication-type] English Abstract; Journal Article
  • [Publication-country] France
  • [Chemical-registry-number] 9002-72-6 / Growth Hormone
  •  go-up   go-down


38. Agozzino L, Ferraraccio F, Accardo M, Esposito S, Agozzino M, Cuccurullo L: Morphological and ultrastructural findings of prognostic impact in craniopharyngiomas. Ultrastruct Pathol; 2006 May-Jun;30(3):143-50
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Morphological and ultrastructural findings of prognostic impact in craniopharyngiomas.
  • Craniopharyngioma is a slow-growing epithelial tumor with an unpredictable tendency to recur.
  • The MIB-1 Labelling Index was: 22.12% in primary tumors, 27.5% in recurrences, 31.3% in adult nonrecurrent tumors, and 4.1% in the pediatric tumor.
  • Lack of clear correlations between morphological or immuno-staining patterns and behavior suggests that these features have no prognostic value in adult as well as in pediatric craniopharyngiomas.
  • In this study, the only results that may be related to the aggressiveness of tumor is the major vascularization in the recurrent tumors in which the vessels show also ultrastructural changes.
  • [MeSH-major] Craniopharyngioma / pathology. Pituitary Neoplasms / pathology
  • [MeSH-minor] Adolescent. Adult. Biomarkers, Tumor / analysis. Child. Child, Preschool. Cytoplasm / ultrastructure. Endothelium, Vascular / ultrastructure. Epithelial Cells / ultrastructure. Female. Humans. Ki-67 Antigen / analysis. Male. Microscopy, Electron, Transmission. Middle Aged. Neoplasm Recurrence, Local. Proliferating Cell Nuclear Antigen / analysis. Vascular Endothelial Growth Factor A / analysis

  • MedlinePlus Health Information. consumer health - Pituitary Tumors.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16825115.001).
  • [ISSN] 1521-0758
  • [Journal-full-title] Ultrastructural pathology
  • [ISO-abbreviation] Ultrastruct Pathol
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Biomarkers, Tumor; 0 / Ki-67 Antigen; 0 / Proliferating Cell Nuclear Antigen; 0 / VEGFA protein, human; 0 / Vascular Endothelial Growth Factor A
  •  go-up   go-down


39. Gapstur R, Gross CR, Ness K: Factors associated with sleep-wake disturbances in child and adult survivors of pediatric brain tumors: a review. Oncol Nurs Forum; 2009 Nov;36(6):723-31
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Factors associated with sleep-wake disturbances in child and adult survivors of pediatric brain tumors: a review.
  • PURPOSE/OBJECTIVES: To identify factors associated with sleep-wake disturbances in pediatric and adult survivors (aged older than 18 years) of pediatric brain tumors.
  • The search and a personal communication with one author discovered 25 English-language research articles and case reports describing sleep-wake patterns in brain tumor survivors from 1966-2008.
  • This contributes to decreased daytime alertness, which remains the most reported sleep-wake disturbance in brain tumor survivors.
  • Patients with craniopharyngiomas, radiation dose more than 3,500 cGy, and younger age at time of treatment experienced more severe sleep dysfunction.
  • CONCLUSIONS: Patients with brain tumors experience a disruption of sleep-wake patterns associated with major dysfunction in the hypothalamic-pituitary axis, affecting both Process S (homeostasis) and Process C (circadian) from the Two-Process Model of Sleep Regulation.
  • IMPLICATIONS FOR NURSING: Current sleep literature has identified patterns of sleep disturbances in cross-sectional studies of brain tumor survivors.
  • [MeSH-major] Brain Neoplasms / nursing. Oncology Nursing. Pediatric Nursing. Sleep Disorders, Circadian Rhythm / nursing
  • [MeSH-minor] Adult. Child. Humans. Survivors

  • MedlinePlus Health Information. consumer health - Brain Tumors.
  • MedlinePlus Health Information. consumer health - Childhood Brain Tumors.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19887361.001).
  • [ISSN] 1538-0688
  • [Journal-full-title] Oncology nursing forum
  • [ISO-abbreviation] Oncol Nurs Forum
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] United States
  • [Number-of-references] 50
  •  go-up   go-down


40. Lin LL, El Naqa I, Leonard JR, Park TS, Hollander AS, Michalski JM, Mansur DB: Long-term outcome in children treated for craniopharyngioma with and without radiotherapy. J Neurosurg Pediatr; 2008 Feb;1(2):126-30
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Long-term outcome in children treated for craniopharyngioma with and without radiotherapy.
  • OBJECT: The authors report the results of surgery alone or in combination with radiotherapy in the management of craniopharyngiomas in children.
  • METHODS: The authors retrospectively reviewed the outcomes in 31 patients treated for craniopharyngiomas at the Department of Radiation Oncology at Washington University in St. Louis and the St. Louis Children's Hospital.
  • CONCLUSIONS: Radiotherapy delivered as part of the initial management of craniopharyngiomas in children or at the time of recurrence provides effective local control.
  • [MeSH-major] Craniopharyngioma / surgery. Pituitary Neoplasms / surgery
  • [MeSH-minor] Adolescent. Adult. Brachytherapy. Child. Child, Preschool. Disease Progression. Disease-Free Survival. Female. Follow-Up Studies. Humans. Infant. Longitudinal Studies. Male. Neoplasm Recurrence, Local / pathology. Phosphorus Radioisotopes / therapeutic use. Postoperative Complications. Radiopharmaceuticals / therapeutic use. Radiotherapy, Adjuvant. Radiotherapy, Conformal. Radiotherapy, High-Energy. Retrospective Studies. Survival Rate. Treatment Outcome

  • Genetic Alliance. consumer health - Craniopharyngioma.
  • MedlinePlus Health Information. consumer health - Pituitary Tumors.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [CommentIn] J Neurosurg Pediatr. 2008 Feb;1(2):124-5; discussion 125 [18352780.001]
  • (PMID = 18352781.001).
  • [ISSN] 1933-0707
  • [Journal-full-title] Journal of neurosurgery. Pediatrics
  • [ISO-abbreviation] J Neurosurg Pediatr
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Phosphorus Radioisotopes; 0 / Radiopharmaceuticals
  •  go-up   go-down


41. Zhou L, Luo L, Xu J, Li Q, Chen J, Jiang S, Cai B, You C: Craniopharyngiomas in the posterior fossa: a rare subgroup, diagnosis, management and outcomes. J Neurol Neurosurg Psychiatry; 2009 Oct;80(10):1150-4
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Craniopharyngiomas in the posterior fossa: a rare subgroup, diagnosis, management and outcomes.
  • OBJECTIVE: Craniopharyngiomas with predominant pars in the posterior fossa are very rare and extremely overlooked.
  • The purpose of this study was to explore the differing characteristics of posterior fossa craniopharyngiomas.
  • METHODS: Seven patients with pathologically proven craniopharyngiomas located in the posterior fossa were retrospectively investigated.
  • CONCLUSIONS: Posterior fossa craniopharyngiomas are rare and may be considered an independent subgroup of classifications.
  • [MeSH-major] Craniopharyngioma / diagnosis. Craniopharyngioma / surgery. Infratentorial Neoplasms / diagnosis. Infratentorial Neoplasms / surgery. Pituitary Neoplasms / diagnosis. Pituitary Neoplasms / surgery
  • [MeSH-minor] Adolescent. Adult. Child. Cohort Studies. Female. Humans. Male. Retrospective Studies. Treatment Outcome

  • MedlinePlus Health Information. consumer health - Pituitary Tumors.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [RetractionIn] J Neurol Neurosurg Psychiatry. 2010 Aug;81(8):942 [20682723.001]
  • (PMID = 19762904.001).
  • [ISSN] 1468-330X
  • [Journal-full-title] Journal of neurology, neurosurgery, and psychiatry
  • [ISO-abbreviation] J. Neurol. Neurosurg. Psychiatry
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't; Retracted Publication
  • [Publication-country] England
  •  go-up   go-down


42. Derrey S, Blond S, Reyns N, Touzet G, Carpentier P, Gauthier H, Dhellemmes P: Management of cystic craniopharyngiomas with stereotactic endocavitary irradiation using colloidal 186Re: a retrospective study of 48 consecutive patients. Neurosurgery; 2008 Dec;63(6):1045-52; discussion 1052-3
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Management of cystic craniopharyngiomas with stereotactic endocavitary irradiation using colloidal 186Re: a retrospective study of 48 consecutive patients.
  • OBJECTIVE: We retrospectively reviewed the results of stereotactic endocavitary irradiation with colloidal 186Re in the treatment of cystic craniopharyngiomas.
  • Concerning visual functions, 12 (44.5%) patients improved and 2 worsened, despite tumor control.
  • CONCLUSION: 186Re stereotactic endocavitary irradiation for the treatment of cystic craniopharyngiomas is a safe and effective procedure with a tumor control rate greater than 70%.
  • This treatment can be used for first-intention treatment of pure cystic craniopharyngiomas or for second-intention treatment of cystic recurrences.
  • [MeSH-major] Craniopharyngioma / radiotherapy. Cysts / radiotherapy. Pituitary Neoplasms / radiotherapy. Radioisotopes / therapeutic use. Rhenium / therapeutic use
  • [MeSH-minor] Adolescent. Adult. Aged. Aged, 80 and over. Child. Child, Preschool. Colloids / therapeutic use. Female. Humans. Male. Middle Aged. Radiopharmaceuticals / therapeutic use. Radiosurgery / methods. Retrospective Studies. Treatment Outcome. Young Adult

  • MedlinePlus Health Information. consumer health - Pituitary Tumors.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19057317.001).
  • [ISSN] 1524-4040
  • [Journal-full-title] Neurosurgery
  • [ISO-abbreviation] Neurosurgery
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Colloids; 0 / Radioisotopes; 0 / Radiopharmaceuticals; 7440-15-5 / Rhenium
  •  go-up   go-down


43. Karavitaki N, Warner JT, Marland A, Shine B, Ryan F, Arnold J, Turner HE, Wass JA: GH replacement does not increase the risk of recurrence in patients with craniopharyngioma. Clin Endocrinol (Oxf); 2006 May;64(5):556-60
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] GH replacement does not increase the risk of recurrence in patients with craniopharyngioma.
  • BACKGROUND: A significant number of patients with craniopharyngioma are GH deficient.
  • OBJECTIVE: To assess the effect of GH replacement upon recurrence in patients with craniopharyngioma.
  • PATIENTS AND METHODS: All the patients with craniopharyngioma followed-up at the Departments of Endocrinology or Paediatrics in Oxford and treated or not with GH were studied retrospectively.
  • The remaining 32 (22 males/10 females) received GH for a mean period of 6.3 +/- 4.6 years (median 5.1, range 0.8-22); 21 started during childhood (13 of them continued after the achievement of final height with an adult dose) and 11 during adult life.
  • None of the nine patients with insufficient imaging data for inclusion in the statistical analyses [5 men/4 women, 3 treated with GH during childhood/6 during adult life, mean duration of GH therapy 2.9 +/- 2.4 years (median 1.8, range 0.4-7)] showed clinical features suggestive of recurrence during the period of GH replacement.
  • CONCLUSION Based on the data of the craniopharyngiomas database in Oxford, there is no evidence that GH replacement is associated with an increased risk of tumour recurrence.
  • [MeSH-major] Brain Neoplasms / pathology. Craniopharyngioma / pathology. Growth Hormone / therapeutic use. Hormone Replacement Therapy. Neoplasm Recurrence, Local / pathology
  • [MeSH-minor] Adolescent. Adult. Child. Child, Preschool. Female. Follow-Up Studies. Humans. Infant. Male. Middle Aged. Proportional Hazards Models. Retrospective Studies. Risk Factors


44. Burghaus S, Hölsken A, Buchfelder M, Fahlbusch R, Riederer BM, Hans V, Blümcke I, Buslei R: A tumor-specific cellular environment at the brain invasion border of adamantinomatous craniopharyngiomas. Virchows Arch; 2010 Mar;456(3):287-300
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] A tumor-specific cellular environment at the brain invasion border of adamantinomatous craniopharyngiomas.
  • Craniopharyngiomas (CP) are benign epithelial tumors of the sellar region and can be clinicopathologically distinguished into adamantinomatous (adaCP) and papillary (papCP) variants.
  • Both subtypes are classified according to the World Health Organization grade I, but their irregular digitate brain infiltration makes any complete surgical resection difficult to obtain.
  • Herein, we characterized the cellular interface between the tumor and the surrounding brain tissue in 48 CP (41 adaCP and seven papCP) compared to non-neuroepithelial tumors, i.e., 12 cavernous hemangiomas, 10 meningiomas, and 14 metastases using antibodies directed against glial fibrillary acid protein (GFAP), vimentin, nestin, microtubule-associated protein 2 (MAP2) splice variants, and tenascin-C.
  • Furthermore, the outer tumor cell layer of adaCP showed a distinct expression of MAP2, a novel finding helpful in the differential diagnosis of epithelial tumors in the sellar region.
  • Our data support the hypothesis that adaCP, unlike other non-neuroepithelial tumors of the central nervous system, create a tumor-specific cellular environment at the tumor-brain junction.
  • [MeSH-major] Craniopharyngioma / pathology. Pituitary Neoplasms / pathology
  • [MeSH-minor] Adolescent. Adult. Aged. Biomarkers, Tumor / metabolism. Brain / metabolism. Child. Child, Preschool. Female. Gene Expression Regulation, Neoplastic. Glial Fibrillary Acidic Protein / metabolism. Humans. Intermediate Filament Proteins / metabolism. Male. Microtubule-Associated Proteins / metabolism. Middle Aged. Neoplasm Invasiveness / pathology. Neoplasm Invasiveness / physiopathology. Neoplasm Metastasis / pathology. Neoplasm Metastasis / physiopathology. Nerve Tissue Proteins / metabolism. Nestin. Tenascin / metabolism. Vimentin / metabolism

  • MedlinePlus Health Information. consumer health - Pituitary Tumors.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Am J Surg Pathol. 2006 Dec;30(12):1595-603 [17122517.001]
  • [Cites] Am J Pathol. 2002 Dec;161(6):1997-2001 [12466115.001]
  • [Cites] Neuropathol Appl Neurobiol. 2002 Dec;28(6):480-8 [12445164.001]
  • [Cites] Endocr Rev. 2006 Jun;27(4):371-97 [16543382.001]
  • [Cites] J Pathol. 2004 Jul;203(3):814-21 [15221941.001]
  • [Cites] Expert Rev Anticancer Ther. 2007 May;7(5):675-87 [17492931.001]
  • [Cites] Nat Cell Biol. 2001 Sep;3(9):778-84 [11533656.001]
  • [Cites] Brain Res. 2002 Jul 12;943(2):174-80 [12101039.001]
  • [Cites] Acta Neurochir (Wien). 2008 Dec;150(12):1213-26 [19002375.001]
  • [Cites] Oncogene. 2005 Dec 8;24(55):8200-4 [16091738.001]
  • [Cites] Glia. 2000 Feb 1;29(3):233-45 [10642750.001]
  • [Cites] Cancer Res. 1994 Jul 15;54(14):3897-904 [8033113.001]
  • [Cites] Acta Neuropathol. 2004 Aug;108(2):89-96 [15146346.001]
  • [Cites] Acta Neuropathol. 2005 Jun;109(6):589-97 [15891929.001]
  • [Cites] Brain Res Dev Brain Res. 2002 Nov 15;139(1):9-17 [12414089.001]
  • [Cites] J Neurochem. 1999 Dec;73(6):2531-7 [10582615.001]
  • [Cites] Glia. 1997 Jan;19(1):35-46 [8989566.001]
  • [Cites] J Biol Chem. 1990 Nov 15;265(32):19679-84 [2174050.001]
  • [Cites] Neurosurgery. 2005 Apr;56(4):763-76 [15792515.001]
  • [Cites] Brain Res Dev Brain Res. 1992 Feb 21;65(2):259-67 [1373996.001]
  • [Cites] Acta Neuropathol. 1978 Sep 15;43(3):191-203 [696237.001]
  • [Cites] Brain Pathol. 2009 Jul;19(3):357-64 [18540944.001]
  • [Cites] Pediatr Neurosurg. 1996 Nov;25(5):240-6; discussion 247 [9309787.001]
  • [Cites] Brain Res Dev Brain Res. 1992 Jul 24;68(1):111-23 [1521317.001]
  • [Cites] Proc Natl Acad Sci U S A. 1995 Nov 21;92(24):10894-8 [7479905.001]
  • [Cites] J Cell Sci. 1994 Nov;107 ( Pt 11):3115-25 [7699010.001]
  • [Cites] Cell Tissue Res. 2003 Dec;314(3):315-24 [14523640.001]
  • [Cites] Acta Neuropathol. 2007 Aug;114(2):97-109 [17618441.001]
  • [Cites] J Neurosurg. 2007 Jan;106(1 Suppl):3-12 [17233305.001]
  • [Cites] Matrix Biol. 2001 Feb;20(1):13-22 [11246000.001]
  • [Cites] J Neurosurg. 1999 Feb;90(2):237-50 [9950494.001]
  • [Cites] J Neurosurg. 1988 Aug;69(2):155-70 [3292716.001]
  • [Cites] Eur J Endocrinol. 2005 Apr;152(4):557-67 [15817911.001]
  • [Cites] J Neurosurg. 1990 Jul;73(1):12-7 [2352012.001]
  • [Cites] Horm Res. 2008;69(4):193-202 [18204266.001]
  • [Cites] Curr Drug Targets CNS Neurol Disord. 2005 Feb;4(1):85-92 [15723616.001]
  • [Cites] Lab Invest. 2002 Mar;82(3):345-51 [11896213.001]
  • [Cites] Clin Endocrinol (Oxf). 2005 Apr;62(4):397-409 [15807869.001]
  • [Cites] J Neuropathol Exp Neurol. 2001 Oct;60(10):984-93 [11589429.001]
  • [Cites] Annu Rev Cell Biol. 1989;5:71-92 [2480799.001]
  • [Cites] Curr Opin Pediatr. 2007 Aug;19(4):471-9 [17630614.001]
  • [Cites] Proc Natl Acad Sci U S A. 1985 Sep;82(17):6006-9 [3898077.001]
  • [Cites] Cancer Res. 2006 Dec 15;66(24):11771-80 [17178873.001]
  • [Cites] Glia. 1995 Apr;13(4):233-54 [7615335.001]
  • [Cites] Dev Dyn. 2004 May;230(1):1-11 [15108304.001]
  • [Cites] Brain Tumor Pathol. 2005;22(2):75-8 [18095108.001]
  • [Cites] J Neurosurg. 1998 Oct;89(4):547-51 [9761047.001]
  • [Cites] Eur J Neurosci. 2005 Oct;22(8):1863-72 [16262626.001]
  • [Cites] Pituitary. 2005;8(2):75-9 [16195780.001]
  • [Cites] Neurosurgery. 1994 Dec;35(6):1001-10; discussion 1010-1 [7885544.001]
  • [Cites] Acta Neuropathol. 2007 May;113(5):585-90 [17221204.001]
  • [Cites] Brain Res Dev Brain Res. 2002 Mar 31;134(1-2):87-92 [11947939.001]
  • [Cites] Cell. 1990 Feb 23;60(4):585-95 [1689217.001]
  • [Cites] Exp Neurol. 1999 Dec;160(2):348-60 [10619552.001]
  • [Cites] Eur J Endocrinol. 2008 Dec;159 Suppl 1:S95-9 [18775978.001]
  • [Cites] J Pediatr Endocrinol Metab. 2006 Apr;19 Suppl 1:453-4 [16700324.001]
  • [Cites] Cancer. 2003 Dec 1;98(11):2430-9 [14635078.001]
  • [Cites] J Neurosurg. 1995 Aug;83(2):206-14 [7616262.001]
  • [Cites] Neuropathology. 2007 Feb;27(1):1-9 [17319278.001]
  • (PMID = 20069432.001).
  • [ISSN] 1432-2307
  • [Journal-full-title] Virchows Archiv : an international journal of pathology
  • [ISO-abbreviation] Virchows Arch.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] Germany
  • [Chemical-registry-number] 0 / Biomarkers, Tumor; 0 / Glial Fibrillary Acidic Protein; 0 / Intermediate Filament Proteins; 0 / Microtubule-Associated Proteins; 0 / NES protein, human; 0 / Nerve Tissue Proteins; 0 / Nestin; 0 / Tenascin; 0 / Vimentin
  •  go-up   go-down


45. Baldelli R, Bianchi A, Diacono F, Passeri M, Fusco A, Valle D, Poggi M, Terlini M, Toscano V, Tamburrano G, Pontecorvi A, Maira G, De Marinis L: Characteristics of adult patients with growth hormone deficiency who underwent neurosurgery for functioning and non-functioning pituitary adenomas and craniopharyngiomas. J Endocrinol Invest; 2005 Feb;28(2):157-61
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Characteristics of adult patients with growth hormone deficiency who underwent neurosurgery for functioning and non-functioning pituitary adenomas and craniopharyngiomas.
  • The aim of the present study was to evaluate the characteristics of GH deficiency (GHD) in adult patients after neurosurgery for pituitary adenomas and craniopharingiomas.
  • One hundred and one GHD patients, (42 F/59 M), aged 47.58+/-14.4 yr (mean+/-SD; range 21-78), body mass index (BMI) 28.6+/-0.6, with a history of adult-onset hypothalamic-pituitary disease, were recruited for the study.
  • The whole group included: 45 non-functioning pituitary adenomas, 23 craniopharyngiomas, 16 PRLomas, 8 GHomas, 7 ACTHomas and 2 FSHomas; in particular 51 were macroadenomas and 27 microadenomas.
  • [MeSH-major] Adenoma / surgery. Craniopharyngioma / surgery. Human Growth Hormone / deficiency. Neurosurgical Procedures. Pituitary Neoplasms / surgery
  • [MeSH-minor] Adult. Aged. Arginine. Cushing Syndrome / blood. Cushing Syndrome / metabolism. Cushing Syndrome / surgery. Drug Combinations. Female. Growth Hormone-Releasing Hormone. Humans. Insulin-Like Growth Factor I / metabolism. Male. Middle Aged. Postoperative Period

  • Genetic Alliance. consumer health - Adult Growth Hormone Deficiency.
  • Genetic Alliance. consumer health - Growth Hormone Deficiency.
  • MedlinePlus Health Information. consumer health - Pituitary Tumors.
  • Hazardous Substances Data Bank. (L)-ARGININE .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Pediatr Endocrinol Metab. 2004 May;17(5):749-57 [15237710.001]
  • [Cites] J Endocrinol. 2002 Feb;172(2):363-73 [11834454.001]
  • [Cites] Lancet. 1998 Jul 11;352(9122):127-34 [9672293.001]
  • [Cites] Endocrine. 2001 Jun;15(1):29-38 [11572322.001]
  • [Cites] World J Gastroenterol. 2004 Jan 15;10(2):255-9 [14716834.001]
  • [Cites] J Clin Endocrinol Metab. 1998 May;83(5):1615-8 [9589665.001]
  • [Cites] Endocr Rev. 1998 Apr;19(2):203-23 [9570037.001]
  • [Cites] Endocr Rev. 1995 Feb;16(1):63-86 [7758433.001]
  • [Cites] J Pediatr Endocrinol Metab. 2001;14 Suppl 5:1233-42; discussion 1261-2 [11964018.001]
  • [Cites] Clin Endocrinol (Oxf). 1994 Oct;41(4):511-6 [7955461.001]
  • [Cites] J Nephrol. 2002 Mar-Apr;15(2):136-43 [12018629.001]
  • [Cites] J Clin Endocrinol Metab. 1996 Jun;81(6):2250-6 [8964860.001]
  • [Cites] Clin Endocrinol (Oxf). 2002 Sep;57(3):391-9 [12201833.001]
  • [Cites] Growth Horm IGF Res. 2004 Apr;14(2):91-6 [15123168.001]
  • [Cites] World J Gastroenterol. 2004 Sep 15;10(18):2740-3 [15309731.001]
  • [Cites] J Clin Endocrinol Metab. 1998 Feb;83(2):382-95 [9467546.001]
  • [Cites] Clin Endocrinol (Oxf). 2003 Jul;59(1):56-61 [12807504.001]
  • [Cites] Pediatr Diabetes. 2001 Sep;2(3):123-30 [15016195.001]
  • [Cites] Growth Horm IGF Res. 2003 Apr-Jun;13(2-3):104-8 [12735932.001]
  • [Cites] Lancet. 2004 Apr 24;363(9418):1346-53 [15110491.001]
  • [Cites] J Clin Endocrinol Metab. 2002 May;87(5):2067-79 [11994342.001]
  • [Cites] Growth Horm IGF Res. 2004 Aug;14(4):301-8 [15231299.001]
  • [Cites] J Intern Med. 2003 Apr;253(4):454-62 [12653875.001]
  • [Cites] Eur J Clin Invest. 2004 Apr;34(4):249-55 [15086355.001]
  • [Cites] J Clin Endocrinol Metab. 1991 Feb;72(2):374-81 [1991807.001]
  • [Cites] J Clin Endocrinol Metab. 2004 Jul;89(7):3397-401 [15240621.001]
  • [Cites] Thyroid. 2001 Nov;11(11):1043-8 [11762714.001]
  • [Cites] J Clin Endocrinol Metab. 1998 Feb;83(2):379-81 [9467545.001]
  • [Cites] Eur J Endocrinol. 2002 Sep;147(3):417-24 [12213680.001]
  • [Cites] J Clin Endocrinol Metab. 2002 Feb;87(2):477-85 [11836272.001]
  • [Cites] Lancet. 1994 Apr 30;343(8905):1064-8 [7512681.001]
  • [Cites] J Pediatr Endocrinol Metab. 2003 Jan;16(1):35-42 [12585338.001]
  • [Cites] Eur J Endocrinol. 1996 Mar;134(3):352-6 [8616534.001]
  • [Cites] Endocrine. 2001 Feb;14 (1):95-9 [11322508.001]
  • (PMID = 15887862.001).
  • [ISSN] 0391-4097
  • [Journal-full-title] Journal of endocrinological investigation
  • [ISO-abbreviation] J. Endocrinol. Invest.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Italy
  • [Chemical-registry-number] 0 / Drug Combinations; 12629-01-5 / Human Growth Hormone; 67763-96-6 / Insulin-Like Growth Factor I; 9034-39-3 / Growth Hormone-Releasing Hormone; 94ZLA3W45F / Arginine
  •  go-up   go-down


46. Kabil MS, Shahinian HK: Application of the supraorbital endoscopic approach to tumors of the anterior cranial base. J Craniofac Surg; 2005 Nov;16(6):1070-4; discussion 1075
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Pathologies treated were meningiomas, craniopharyngiomas, pituitary adenomas with extrasellarextensions, and other variable supratentorial pathologies.
  • The use of endoscopy allowed thorough visualization of all critical structures at the paramedian skull base without the need for a bicoronal scalp flap, bifrontal osteotomies, or brain retraction.
  • [MeSH-minor] Adenoma / surgery. Adult. Aged. Arachnoid Cysts / surgery. Craniopharyngioma / surgery. Electrocoagulation. Female. Follow-Up Studies. Frontal Sinus / surgery. Humans. Male. Meningeal Neoplasms / surgery. Meningioma / surgery. Middle Aged. Minimally Invasive Surgical Procedures. Mucocele / surgery. Paranasal Sinus Diseases / surgery. Pituitary Neoplasms / surgery. Postoperative Complications. Retrospective Studies. Treatment Outcome

  • MedlinePlus Health Information. consumer health - Endoscopy.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16327556.001).
  • [ISSN] 1049-2275
  • [Journal-full-title] The Journal of craniofacial surgery
  • [ISO-abbreviation] J Craniofac Surg
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


47. Dehdashti AR, Ganna A, Witterick I, Gentili F: Expanded endoscopic endonasal approach for anterior cranial base and suprasellar lesions: indications and limitations. Neurosurgery; 2009 Apr;64(4):677-87; discussion 687-9
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • METHODS: From June 2005 to June 2007, the expanded endoscopic endonasal approach was used in 22 patients with the following pathologies: 6 craniopharyngiomas; 4 esthesioneuroblastomas; 3 giant pituitary macroadenomas; 2 suprasellar Rathke's pouch cysts; 2 angiofibromas; and 1 each of suprasellar meningioma, germinoma, ethmoidal carcinoma, adenoid cystic carcinoma, and large suprasellar arachnoid cyst.
  • RESULTS: Gross total tumor removal, as assessed by postoperative magnetic resonance imaging, was possible in the majority of patients (73%), with the exception of the craniopharyngioma group, in which only 1 lesion was completely removed.
  • Large lesions, significant lateral extension, encasement of neurovascular structures, and brain invasion in malignant lesions are considered some of the contraindications for this technique.
  • The avoidance of craniotomy and brain retraction and reduced neurovascular manipulation with less morbidity are potential advantages.
  • [MeSH-major] Brain Neoplasms / surgery. Nasal Cavity / surgery. Neuroendoscopy / methods. Neurosurgical Procedures / methods. Sella Turcica / surgery. Skull Base / surgery
  • [MeSH-minor] Adult. Aged. Craniopharyngioma / surgery. Esthesioneuroblastoma, Olfactory / surgery. Female. Humans. Magnetic Resonance Imaging / methods. Male. Middle Aged. Neurofibroma / surgery. Retrospective Studies. Young Adult

  • MedlinePlus Health Information. consumer health - Brain Tumors.
  • The Lens. Cited by Patents in .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19349826.001).
  • [ISSN] 1524-4040
  • [Journal-full-title] Neurosurgery
  • [ISO-abbreviation] Neurosurgery
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


48. Zhou L, Li Q, Luo L, Xu J, Zhang Y, Chen T, Wei Y, You C: Radiological features of craniopharyngiomas located in the posterior fossa. J Neurol Sci; 2009 Dec 15;287(1-2):119-25
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Radiological features of craniopharyngiomas located in the posterior fossa.
  • BACKGROUND AND PURPOSE: Posterior fossa craniopharyngiomas (PFCP) constitute 1.6-4% of all craniopharyngiomas and have long been neglected.
  • Seven tumors were of retrochiasmatic origin and 5 of 7 were of retrostalk growth pattern with location in the ventral area of brain stem.
  • Total tumor removal was accomplished in 5 cases, subtotal removal and partial removal in 1 case respectively.
  • Tumor with cystic component arises from sellar region and then extends to posterior fossa, which should be strongly suspected as a PFCP.
  • [MeSH-major] Cranial Fossa, Posterior / pathology. Craniopharyngioma / pathology. Infratentorial Neoplasms / pathology. Pituitary Neoplasms / pathology
  • [MeSH-minor] Adolescent. Adult. Central Nervous System Cysts / etiology. Central Nervous System Cysts / pathology. Central Nervous System Cysts / radiography. Child. Cohort Studies. Craniotomy / methods. Diagnosis, Differential. Female. Humans. Magnetic Resonance Imaging. Male. Neurosurgical Procedures. Pituitary Gland / pathology. Pituitary Gland / radiography. Pituitary Gland / surgery. Sella Turcica / pathology. Sella Turcica / radiography. Sella Turcica / surgery. Tomography, X-Ray Computed. Treatment Outcome

  • MedlinePlus Health Information. consumer health - Pituitary Tumors.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19758604.001).
  • [ISSN] 1878-5883
  • [Journal-full-title] Journal of the neurological sciences
  • [ISO-abbreviation] J. Neurol. Sci.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] Netherlands
  •  go-up   go-down


49. Fahlbusch R, Hofmann BM: Surgical management of giant craniopharyngiomas. Acta Neurochir (Wien); 2008 Dec;150(12):1213-26
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Surgical management of giant craniopharyngiomas.
  • INTRODUCTION: Multimodal treatment in the management of giant craniopharyngiomas (>4 cm in diameter) is necessary to obtain optimal results, and includes conservative or palliative treatment and "aggressive" removal.
  • MATERIALS AND METHODS: Between January 1996 and January 2005 16 patients were diagnosed with giant craniopharyngiomas.
  • If hypothalamic disturbances are absent or improving due to pre-treatment (medical therapy, symptomatic surgery), giant craniopharyngiomas can be surgically removed in more than two of three patients with low morbidity and only moderate deterioration of endocrine function.
  • [MeSH-major] Craniopharyngioma / surgery. Microsurgery / methods. Neurosurgical Procedures / methods. Pituitary Gland / surgery. Pituitary Neoplasms / surgery
  • [MeSH-minor] Adolescent. Adult. Aged. Central Nervous System Cysts / etiology. Central Nervous System Cysts / pathology. Central Nervous System Cysts / surgery. Child. Clinical Protocols. Female. Hormone Replacement Therapy / methods. Humans. Hypothalamo-Hypophyseal System / physiopathology. Hypothalamo-Hypophyseal System / secretion. Hypothalamo-Hypophyseal System / surgery. Male. Middle Aged. Pituitary Hormones / blood. Pituitary Hormones / secretion. Preoperative Care / methods. Prospective Studies. Stereotaxic Techniques. Treatment Outcome

  • MedlinePlus Health Information. consumer health - Pituitary Tumors.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19002375.001).
  • [ISSN] 0942-0940
  • [Journal-full-title] Acta neurochirurgica
  • [ISO-abbreviation] Acta Neurochir (Wien)
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Austria
  • [Chemical-registry-number] 0 / Pituitary Hormones
  •  go-up   go-down


50. Shi XE, Wu B, Zhou ZQ, Fan T, Zhang YL: Microsurgical treatment of craniopharyngiomas: report of 284 patients. Chin Med J (Engl); 2006 Oct 5;119(19):1653-63
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Microsurgical treatment of craniopharyngiomas: report of 284 patients.
  • BACKGROUND: Generally, total surgical removal of craniopharyngioma results in satisfactory outcome with a low recurrence rate, however, the location of the tumor and its adherence to the hypothalamic structures can make the operation difficult.
  • The goal of the present study was to assess the outcome of craniopharyngiomas in 284 patients treated surgically.
  • METHODS: A total of 284 patients (151 men and 133 women) with craniopharyngioma were treated surgically by our neurosurgeons from January 1996 to March 2006.
  • The tumors were classified into the superior (23 patients) and inferior ventricular (261) types according to the location of the tumor relative to the third ventricular floor.
  • For the patients with craniopharyngioma of inferior ventricular type, pterional approach was used in 191 (67.3%) patients, subfrontal approach in 17 (6.0%), and translamina terminalis through frontobasal interhemispheric approach in 53 (18.7%).
  • Of the 284 patients, 204 (71.8%) were followed up for 0.5 to 8 years (mean, 2.1 +/- 1.8), including 162 patients received total tumor removal, and 37 underwent subtotal or partial removal.
  • During the follow-up, 23 (14.1%) patients experienced tumor recurrence 1.0 - 3.5 years (mean, 1.8 +/- 1.6) after total tumor removal, and 24 (64.9%) had recurrent tumor 0.25 - 1.5 years (mean, 0.5 +/- 0.4) after subtotal or partial resection.
  • In addition, preservation of the pituitary stalk is critical when total tumor resection is feasible.
  • [MeSH-major] Craniopharyngioma / surgery. Microsurgery / methods. Neurosurgical Procedures / methods. Pituitary Neoplasms / surgery
  • [MeSH-minor] Adolescent. Adult. Aged. Child. Child, Preschool. Female. Humans. Infant. Male. Middle Aged

  • MedlinePlus Health Information. consumer health - Pituitary Tumors.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17042979.001).
  • [ISSN] 0366-6999
  • [Journal-full-title] Chinese medical journal
  • [ISO-abbreviation] Chin. Med. J.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] China
  •  go-up   go-down


51. Albright AL, Hadjipanayis CG, Lunsford LD, Kondziolka D, Pollack IF, Adelson PD: Individualized treatment of pediatric craniopharyngiomas. Childs Nerv Syst; 2005 Aug;21(8-9):649-54
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Individualized treatment of pediatric craniopharyngiomas.
  • OBJECTIVE: The treatment of children with craniopharyngiomas should be individualized because of their heterogeneous clinical and radiographic characteristics.
  • METHODS: Medical records were reviewed for children with craniopharyngiomas who presented to the Children's Hospital of Pittsburgh for their initial management between 1983 and 2004.
  • Children were treated with microsurgical tumor resections (27), intracavitary irradiation with phosphorus 32 (32P) (12), and with gamma knife stereotactic radiosurgery (GKSR) (5).
  • There was no morbidity or mortality from GKSR, which achieved tumor stabilization or shrinkage in 4 of 5 cases.
  • Resections, 32P, and GKSR are complimentary treatment modalities for children with craniopharyngiomas.
  • [MeSH-major] Craniopharyngioma / therapy. Pituitary Neoplasms / therapy
  • [MeSH-minor] Adolescent. Adult. Child. Child, Preschool. Combined Modality Therapy / methods. Female. Follow-Up Studies. Humans. Infant. Male. Medical Records / statistics & numerical data. Microsurgery / methods. Radiography. Radiosurgery / methods. Retrospective Studies. Stereotaxic Techniques. Treatment Outcome

  • MedlinePlus Health Information. consumer health - Pituitary Tumors.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Neurosurgery. 1997 Feb;40(2):263-9; discussion 269-70 [9007857.001]
  • [Cites] Childs Nerv Syst. 1999 Nov;15(11-12):764-9 [10603020.001]
  • [Cites] J Neurosurg. 1990 Jul;73(1):3-11 [2352020.001]
  • [Cites] Pediatr Neurosurg. 1994;21 Suppl 1:39-43 [7841077.001]
  • [Cites] Neurosurgery. 2000 Jan;46(1):213-6; discussion 216-7 [10626953.001]
  • [Cites] J Neurosurg. 2000 Dec;93 Suppl 3:47-56 [11143262.001]
  • [Cites] Pediatr Neurosurg. 2000 Oct;33(4):211-8 [11124639.001]
  • [Cites] Appl Neurophysiol. 1985;48(1-6):146-50 [3915643.001]
  • [Cites] Radiology. 1995 Oct;197(1):195-8 [7568823.001]
  • [Cites] Childs Nerv Syst. 2001 Dec;17 (12 ):724-30 [11862438.001]
  • [Cites] Pediatr Neurosurg. 1994;21 Suppl 1:90-7 [7841084.001]
  • [Cites] Neurosurgery. 2000 Feb;46(2):291-302; discussion 302-5 [10690718.001]
  • (PMID = 15931512.001).
  • [ISSN] 0256-7040
  • [Journal-full-title] Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery
  • [ISO-abbreviation] Childs Nerv Syst
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] Germany
  • [Number-of-references] 16
  •  go-up   go-down


52. [Craniopharyngiomas in the adults]. Arkh Patol; 2005 Jul-Aug;67(4):41-5
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Craniopharyngiomas in the adults].
  • Craniopharyngiomas (CP) were studied morphologically (52 cases), immunohistochemically (6 cases) and molecular-genetically (5 cases) in patients aged 18-65 years.
  • [MeSH-major] Biomarkers, Tumor / analysis. Craniopharyngioma / diagnosis. Craniopharyngioma / mortality. Pituitary Neoplasms / diagnosis. Pituitary Neoplasms / mortality
  • [MeSH-minor] Adolescent. Adult. Female. Humans. Male. Middle Aged. Mutation


53. Yin J, Su CB, Xu ZQ, Xia XW, Song F: Reconstruction of the sellar floor following transsphenoidal surgery using gelatin foam and fibrin glue. Chin Med Sci J; 2005 Sep;20(3):198-201
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • METHODS: A total of 176 consecutive patients who underwent surgery for pituitary adenomas, cysts, chordomas, or subdiaphragmatic craniopharyngiomas in the sella turcica between January 2001 and April 2003 at Peking Union Medical College Hospital were enrolled.

  • MedlinePlus Health Information. consumer health - Pituitary Tumors.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16261893.001).
  • [ISSN] 1001-9294
  • [Journal-full-title] Chinese medical sciences journal = Chung-kuo i hsueh k'o hsueh tsa chih
  • [ISO-abbreviation] Chin. Med. Sci. J.
  • [Language] ENG
  • [Publication-type] Journal Article
  • [Publication-country] China
  • [Chemical-registry-number] 0 / Fibrin Tissue Adhesive; 0 / Tissue Adhesives
  •  go-up   go-down


54. Cappabianca P, Cavallo LM, Esposito F, De Divitiis E: Craniopharyngiomas. J Neurosurg; 2008 Jul;109(1):1-3; reply 3-5
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Craniopharyngiomas.
  • [MeSH-major] Craniopharyngioma / pathology. Craniopharyngioma / surgery. Endoscopy. Pituitary Neoplasms / pathology. Pituitary Neoplasms / surgery
  • [MeSH-minor] Adult. Child. Humans. Nasal Cavity. Patient Selection

  • MedlinePlus Health Information. consumer health - Endoscopy.
  • MedlinePlus Health Information. consumer health - Pituitary Tumors.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [CommentOn] J Neurosurg. 2008 Jul;109(1):6-16 [18590427.001]
  • (PMID = 18590426.001).
  • [ISSN] 0022-3085
  • [Journal-full-title] Journal of neurosurgery
  • [ISO-abbreviation] J. Neurosurg.
  • [Language] eng
  • [Publication-type] Comment; Editorial
  • [Publication-country] United States
  •  go-up   go-down


55. Hasegawa T, Kobayashi T, Kida Y: Tolerance of the optic apparatus in single-fraction irradiation using stereotactic radiosurgery: evaluation in 100 patients with craniopharyngioma. Neurosurgery; 2010 Apr;66(4):688-94; discussion 694-5
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Tolerance of the optic apparatus in single-fraction irradiation using stereotactic radiosurgery: evaluation in 100 patients with craniopharyngioma.
  • OBJECTIVE: To determine the limiting dose to the optic apparatus in single-fraction irradiation in patients with craniopharyngioma treated with gamma knife radiosurgery (GKRS).
  • METHODS: One hundred patients with 109 craniopharyngiomas treated with GKRS were evaluated with a median follow-up period of 68 months.
  • Tumor volume varied from 0.1 to 36.0 (median, 3.3) cm.
  • RESULTS: The actuarial 5- and 10-year overall rates of survival of tumor progression after GKRS were 93% and 88%, respectively.
  • [MeSH-major] Craniopharyngioma / surgery. Pituitary Neoplasms / surgery. Radiosurgery / methods. Vision, Ocular / physiology
  • [MeSH-minor] Adolescent. Adult. Disease-Free Survival. Dose-Response Relationship, Radiation. Female. Follow-Up Studies. Humans. Magnetic Resonance Imaging. Male. Optic Chiasm / radiation effects. Optic Nerve Diseases / etiology. Radiotherapy Dosage. Retrospective Studies. Time Factors

  • Genetic Alliance. consumer health - Craniopharyngioma.
  • MedlinePlus Health Information. consumer health - Pituitary Tumors.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20190668.001).
  • [ISSN] 1524-4040
  • [Journal-full-title] Neurosurgery
  • [ISO-abbreviation] Neurosurgery
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


56. Dusick JR, Mattozo CA, Esposito F, Kelly DF: BioGlue for prevention of postoperative cerebrospinal fluid leaks in transsphenoidal surgery: A case series. Surg Neurol; 2006 Oct;66(4):371-6; discussion 376
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Pathology included 80 pituitary adenomas, 11 craniopharyngiomas, 7 Rathke's cleft cysts, 6 chordomas, 5 meningiomas, 4 spontaneous CSF leaks, 3 arachnoid cysts, and 8 other parasellar pathologies.
  • [MeSH-minor] Adolescent. Adult. Aged. Aged, 80 and over. Child. Craniopharyngioma / pathology. Craniopharyngioma / surgery. Female. Humans. Male. Materials Testing / standards. Meningioma / pathology. Meningioma / surgery. Middle Aged. Nasal Cavity / anatomy & histology. Nasal Cavity / surgery. Pituitary Neoplasms / pathology. Pituitary Neoplasms / surgery. Reconstructive Surgical Procedures / instrumentation. Reconstructive Surgical Procedures / methods. Retrospective Studies. Skull Base Neoplasms / pathology. Skull Base Neoplasms / surgery. Treatment Outcome

  • MedlinePlus Health Information. consumer health - After Surgery.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17015111.001).
  • [ISSN] 0090-3019
  • [Journal-full-title] Surgical neurology
  • [ISO-abbreviation] Surg Neurol
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Bio-glue; 0 / Proteins
  •  go-up   go-down


57. Kobayashi T, Kida Y, Mori Y, Hasegawa T: Long-term results of gamma knife surgery for the treatment of craniopharyngioma in 98 consecutive cases. J Neurosurg; 2005 Dec;103(6 Suppl):482-8
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Long-term results of gamma knife surgery for the treatment of craniopharyngioma in 98 consecutive cases.
  • OBJECT: The authors analyzed the long-term outcomes of gamma knife surgery (GKS) for residual or recurrent craniopharyngiomas after microsurgery and the effects of dose reduction.
  • METHODS: A total of 107 patients with craniopharyngiomas were treated with GKS at Komaki City Hospital during the past 12 years, and 98 patients were followed up for 6 to 148 months (mean 65.5 months).
  • The mean tumor diameter and volume were 18.8 mm and 3.5 ml, respectively.
  • These tumors were treated with a maximal dose of 21.8 Gy and a tumor margin dose of 11.5 Gy by using a mean of 4.5 isocenters.
  • Final overall response rates were as follows: complete response 19.4%, partial response 67.4%, tumor control 79.6%, and tumor progression 20.4%.
  • Reducing the tumor margin dose resulted in decreased therapeutic response and increased tumor progression, although the rate of visual and pituitary function loss also decreased.
  • Among the factors examined, age (for adults) and the nature of the tumor (cystic or mixed) were statistically significant favorable and unfavorable prognostic factors, respectively.
  • CONCLUSIONS: Stereotactic GKS is safe and effective, in the long term, as an adjuvant or boost therapy for residual or recurrent craniopharyngiomas after surgical removal and has minimal side effects.
  • [MeSH-major] Craniopharyngioma / surgery. Pituitary Neoplasms / surgery. Radiosurgery
  • [MeSH-minor] Adolescent. Adult. Disease Progression. Female. Humans. Longitudinal Studies. Magnetic Resonance Imaging. Male. Neoplasm Recurrence, Local / surgery. Neoplasm, Residual / surgery. Stereotaxic Techniques. Treatment Outcome

  • Genetic Alliance. consumer health - Craniopharyngioma.
  • MedlinePlus Health Information. consumer health - Pituitary Tumors.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [CommentIn] J Neurosurg. 2006 Aug;105(2 Suppl):159-60; author reply 160 [16922083.001]
  • (PMID = 16383245.001).
  • [ISSN] 0022-3085
  • [Journal-full-title] Journal of neurosurgery
  • [ISO-abbreviation] J. Neurosurg.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


58. Spoudeas HA, Saran F, Pizer B: A multimodality approach to the treatment of craniopharyngiomas avoiding hypothalamic morbidity: a UK perspective. J Pediatr Endocrinol Metab; 2006 Apr;19 Suppl 1:447-51
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] A multimodality approach to the treatment of craniopharyngiomas avoiding hypothalamic morbidity: a UK perspective.
  • The management of craniopharyngiomas is complex and controversial.
  • The perception that they are benign tumours cured by radical surgical resection is not borne out by their often difficult excision, propensity to recur and invade, and high late morbidity and mortality from direct brain injury.
  • Their central location makes visual or pituitary dysfunction and/or hydrocephalus common presenting features.
  • The most important consequence of craniopharyngiomas is hypothalamic injury which may result in severe, crippling and life-threatening sequelae, such as adipsia, morbid obesity, sleep, and behavioural and cognitive disorders.
  • Thus concerns regarding the potential late toxicity of radiotherapy to the developing brain need to be balanced against the recognised morbidity and mortality of recurrent tumour and repeated neurosurgical interventions.
  • National registration and management by multidisciplinary teams in specialised centres according to nationally agreed risk adapted treatment strategies are likely to improve outcomes, as has been demonstrated for example in adult pituitary tumours.
  • Because of the rarity of craniopharyngiomas, international collaborative trials are necessary to properly inform future therapies.
  • [MeSH-major] Craniopharyngioma / complications. Craniopharyngioma / therapy. Hypothalamic Diseases / etiology. Hypothalamic Diseases / prevention & control. Pituitary Neoplasms / complications. Pituitary Neoplasms / therapy

  • MedlinePlus Health Information. consumer health - Pituitary Tumors.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16700323.001).
  • [ISSN] 0334-018X
  • [Journal-full-title] Journal of pediatric endocrinology & metabolism : JPEM
  • [ISO-abbreviation] J. Pediatr. Endocrinol. Metab.
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] England
  • [Number-of-references] 38
  •  go-up   go-down


59. Qiu SJ, Guo YL, Zhang XL, Zhang F, Zhang YZ, Wen G, Hu BS: [Imaging findings of craniopharyngioma in relation to its surgical management: a retrospective analysis]. Nan Fang Yi Ke Da Xue Xue Bao; 2007 Jul;27(7):980-2
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Imaging findings of craniopharyngioma in relation to its surgical management: a retrospective analysis].
  • Of the 123 craniopharyngioma patients, 59 were found to have adamantinous craniopharyngiomas, 41 had papillary squamous craniopharyngiomas, and 23 had mixed tumors.
  • Solid tumor was found in 18 cases, cystic tumor in 38 cases, and calcification in 78 cases; in 23 cases, the posterior of the tumor did not exhibit clear boundary from the wall of the three cerebral ventricles, and in 11 cases CT and MRI displayed hypophysial stalk, which was found intraoperatively in 53 cases.
  • CONCLUSIONS: MRI allows clear vision of the range of craniopharyngioma involvement and the anatomical structures surrounding the tumor.
  • Accurate identification of the site, dimension, calcification patterns and relation between the hypophysial stalk and hypothalamus by the imaging modalities significantly benefits the optimization of the surgical plan for the tumor.
  • [MeSH-major] Craniopharyngioma / diagnosis. Craniopharyngioma / surgery. Magnetic Resonance Imaging. Tomography, X-Ray Computed
  • [MeSH-minor] Adolescent. Adult. Aged. Child. Child, Preschool. Cohort Studies. Female. Humans. Infant. Male. Middle Aged. Retrospective Studies. Young Adult

  • Genetic Alliance. consumer health - Craniopharyngioma.
  • MedlinePlus Health Information. consumer health - CT Scans.
  • MedlinePlus Health Information. consumer health - MRI Scans.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17666331.001).
  • [ISSN] 1673-4254
  • [Journal-full-title] Nan fang yi ke da xue xue bao = Journal of Southern Medical University
  • [ISO-abbreviation] Nan Fang Yi Ke Da Xue Xue Bao
  • [Language] chi
  • [Publication-type] English Abstract; Journal Article
  • [Publication-country] China
  •  go-up   go-down


60. Kassam AB, Prevedello DM, Thomas A, Gardner P, Mintz A, Snyderman C, Carrau R: Endoscopic endonasal pituitary transposition for a transdorsum sellae approach to the interpeduncular cistern. Neurosurgery; 2008 Mar;62(3 Suppl 1):57-72; discussion 72-4
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Pathology consisted of four craniopharyngiomas, four chordomas, and two petroclival meningiomas.
  • RESULTS: Five patients (50%) underwent total resection of the tumor, three patients (30%) underwent near total resection ( > 95% removal), and two patients (20%) had partial resection of petroclival meningiomas with the goal of optic apparatus decompression.
  • The remaining patient with a hypothalamic craniopharyngioma underwent complete resection with obligatory panhypopituitarism and diabetes insipidus.
  • [MeSH-major] Brain Neoplasms / surgery. Nasal Septum / surgery. Neuroendoscopy / methods. Pituitary Gland / surgery. Sella Turcica / surgery. Tegmentum Mesencephali / surgery
  • [MeSH-minor] Adolescent. Adult. Aged. Female. Humans. Male. Middle Aged. Retrospective Studies. Treatment Outcome

  • MedlinePlus Health Information. consumer health - Brain Tumors.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18424968.001).
  • [ISSN] 1524-4040
  • [Journal-full-title] Neurosurgery
  • [ISO-abbreviation] Neurosurgery
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


61. Dekkers OM, Biermasz NR, Smit JW, Groot LE, Roelfsema F, Romijn JA, Pereira AM: Quality of life in treated adult craniopharyngioma patients. Eur J Endocrinol; 2006 Mar;154(3):483-9
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Quality of life in treated adult craniopharyngioma patients.
  • A reduced QoL has been reported in childhood-onset craniopharyngioma; however, reports of QoL in adult craniopharyngioma patients are scarce.
  • In the present study, we assessed QoL in adult patients successfully treated for craniopharyngioma in our centre.
  • METHODS: In this study, we assessed QoL in 29 adult patients in remission during long-term follow-up after treatment for craniopharyngioma.
  • CONCLUSION: Adult patients treated for craniopharyngioma show persistent impairment in QoL, especially in the physical subscales.

  • Genetic Alliance. consumer health - Craniopharyngioma.
  • MedlinePlus Health Information. consumer health - Brain Tumors.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16498063.001).
  • [ISSN] 0804-4643
  • [Journal-full-title] European journal of endocrinology
  • [ISO-abbreviation] Eur. J. Endocrinol.
  • [Language] ENG
  • [Publication-type] Journal Article
  • [Publication-country] England
  •  go-up   go-down


62. Cao J, Lin JP, Yang LX, Chen K, Huang ZS: Expression of aberrant beta-catenin and impaired p63 in craniopharyngiomas. Br J Neurosurg; 2010 Jun;24(3):249-56
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Expression of aberrant beta-catenin and impaired p63 in craniopharyngiomas.
  • Craniopharyngiomas are rare, histologically benign, non-neuroepithelial epithelial tumors arising from the sellar region, the molecular pathogenesis of CPs is yet not understood.
  • The aim of the present study was to assess expression of aberrant beta-catenin and impaired p63 in 66 craniopharyngiomas included 51 adamantinomatous craniopharyngiomas and 15 squamous papillary craniopharyngiomas.
  • On immunohistochemistry, 47 out of 51 adamantinomatous craniopharyngiomas, but not squamous papillary craniopharyngiomas, showed strong nuclear/cytoplasmic expression for beta-catenin predominantly in compactly cohesive epithelial cells within the whorl-like arrays where ki-67 was almost absent and rarely in palisaded cells where ki-67 was mainly present.
  • P63 overexpression was observed in 45 out of 51 adamantinomatous craniopharyngiomas and 14 out of 15 squamous papillary craniopharyngiomas.
  • P63 stained not only in the nuclei of basal layer cells but also within the whorl-like arrays in adamantinomatous craniopharyngiomas and uniformly in squamous papillary craniopharyngiomas.
  • [MeSH-major] Craniopharyngioma / metabolism. Membrane Proteins / metabolism. Pituitary Neoplasms / metabolism. beta Catenin / metabolism
  • [MeSH-minor] Adolescent. Adult. Child. Child, Preschool. DNA-Binding Proteins / metabolism. Female. Humans. Immunohistochemistry. Infant. Ki-67 Antigen / metabolism. Male. Middle Aged. RNA, Messenger / metabolism. Trans-Activators / metabolism. Transcription Factors. Tumor Suppressor Proteins / metabolism. Young Adult

  • MedlinePlus Health Information. consumer health - Pituitary Tumors.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20128632.001).
  • [ISSN] 1360-046X
  • [Journal-full-title] British journal of neurosurgery
  • [ISO-abbreviation] Br J Neurosurg
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  • [Chemical-registry-number] 0 / CKAP4 protein, human; 0 / DNA-Binding Proteins; 0 / Ki-67 Antigen; 0 / Membrane Proteins; 0 / RNA, Messenger; 0 / TP63 protein, human; 0 / Trans-Activators; 0 / Transcription Factors; 0 / Tumor Suppressor Proteins; 0 / beta Catenin
  •  go-up   go-down


63. Lujan-Castilla PJ, Durán-Cruz M, Enríquez-Barrera M, García-Muñóz L, Hernández-Oviedo JO, Barragán-Pérez JA: [Stereotactic radiosurgery with linear accelerator (LINAC). Report of the technical experience in 100 cases treated at the Mexico General Hospital]. Gac Med Mex; 2005 Sep-Oct;141(5):367-82
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Transliterated title] Radiocirugía estereotáxica con acelerador lineal (LINAC). Informe de la experiencia técnica en el manejo de 100 casos en el Hospital General de México.
  • METHODS: One hundred patients received treatment with LINAC stereotactic radiosurgery, 34 AVM, 22 meningiomas, 18 astrocytomas, 11 pituitary adenomas, 5 cavernous malformations, 3 acoustic neuromas, 3 craniopharyngiomas, 2 cases of epilepsy, one brain metastasis and one ependymoma.
  • [MeSH-major] Brain Diseases / surgery. Brain Neoplasms / surgery. Radiosurgery
  • [MeSH-minor] Adolescent. Adult. Aged. Aged, 80 and over. Child. Child, Preschool. Female. Hospitals, General. Humans. Male. Mexico. Middle Aged

  • MedlinePlus Health Information. consumer health - Brain Diseases.
  • MedlinePlus Health Information. consumer health - Brain Tumors.
  • MedlinePlus Health Information. consumer health - Childhood Brain Tumors.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16353882.001).
  • [ISSN] 0016-3813
  • [Journal-full-title] Gaceta médica de México
  • [ISO-abbreviation] Gac Med Mex
  • [Language] spa
  • [Publication-type] English Abstract; Journal Article
  • [Publication-country] Mexico
  •  go-up   go-down


64. Buslei R, Nolde M, Hofmann B, Meissner S, Eyupoglu IY, Siebzehnrübl F, Hahnen E, Kreutzer J, Fahlbusch R: Common mutations of beta-catenin in adamantinomatous craniopharyngiomas but not in other tumours originating from the sellar region. Acta Neuropathol; 2005 Jun;109(6):589-97
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Common mutations of beta-catenin in adamantinomatous craniopharyngiomas but not in other tumours originating from the sellar region.
  • Here, we examined beta-catenin and adenomatous polyposis coli (APC) by mutational analysis in pituitary adenomas (n=60) and a large series of craniopharyngiomas (n=41).
  • Furthermore, the expression pattern of beta-catenin was immunohistochemically analysed in a cohort of tumours and cysts of the sellar region including pituitary adenomas (n=58), craniopharyngiomas (n=57), arachnoidal cysts (n=8), Rathke's cleft cysts (n=10) and xanthogranulomas (n=6).
  • Whereas APC mutations were not detectable in any tumour entity, beta-catenin mutations were present in 77% of craniopharyngiomas, exclusively of the adamantinomatous subtype.
  • We conclude that beta-catenin mutations and/or nuclear accumulation serve as diagnostic hallmarks of the adamantinomatous variant, setting it apart from the papillary variant of craniopharyngioma.
  • [MeSH-major] Craniopharyngioma / genetics. Cytoskeletal Proteins / genetics. Genes, APC. Pituitary Neoplasms / genetics. Sella Turcica / pathology. Trans-Activators / genetics
  • [MeSH-minor] Adolescent. Adult. Aged. Base Sequence. Child. Child, Preschool. DNA Mutational Analysis. Female. Humans. Immunohistochemistry. Male. Middle Aged. Mutation. Polymorphism, Single-Stranded Conformational. Reverse Transcriptase Polymerase Chain Reaction. beta Catenin

  • MedlinePlus Health Information. consumer health - Pituitary Tumors.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15891929.001).
  • [ISSN] 0001-6322
  • [Journal-full-title] Acta neuropathologica
  • [ISO-abbreviation] Acta Neuropathol.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] Germany
  • [Chemical-registry-number] 0 / CTNNB1 protein, human; 0 / Cytoskeletal Proteins; 0 / Trans-Activators; 0 / beta Catenin
  •  go-up   go-down


65. Di Rocco C, Caldarelli M, Tamburrini G, Massimi L: Surgical management of craniopharyngiomas--experience with a pediatric series. J Pediatr Endocrinol Metab; 2006 Apr;19 Suppl 1:355-66
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Surgical management of craniopharyngiomas--experience with a pediatric series.
  • Because of their peculiar location and the possible related postoperative sequelae, craniopharyngiomas usually present difficult management, especially in children.
  • The goal of surgery was total tumor removal.
  • Total surgical removal of craniopharyngiomas should be attempted in children whenever possible in order to minimize the risk of recurrence.
  • [MeSH-major] Craniopharyngioma / surgery. Neurosurgical Procedures. Pituitary Neoplasms / surgery
  • [MeSH-minor] Adolescent. Adult. Child. Child, Preschool. Combined Modality Therapy. Female. Humans. Infant. Magnetic Resonance Imaging. Male. Neoplasm Recurrence, Local / epidemiology. Radiosurgery. Retrospective Studies. Survival Analysis. Tomography, X-Ray Computed. Treatment Outcome

  • MedlinePlus Health Information. consumer health - Pituitary Tumors.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16700311.001).
  • [ISSN] 0334-018X
  • [Journal-full-title] Journal of pediatric endocrinology & metabolism : JPEM
  • [ISO-abbreviation] J. Pediatr. Endocrinol. Metab.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  •  go-up   go-down


66. Krysiak R, Okopień B, Szkróbka W: [Etiology, histopathological picture and clinical presentation of craniopharyngioma]. Pol Merkur Lekarski; 2008 Aug;25(146):175-8
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Etiology, histopathological picture and clinical presentation of craniopharyngioma].
  • Craniopharyngioma is a rare, benign, suprasellar brain tumour accounting for about 1 to 3% of all intracranial neoplasms.
  • In this paper, the authors review different aspects of pathology, and clinical presentation of the craniopharyngiomas.
  • [MeSH-major] Craniopharyngioma / diagnosis. Craniopharyngioma / pathology. Pituitary Neoplasms / diagnosis. Pituitary Neoplasms / pathology
  • [MeSH-minor] Adult. Humans

  • Genetic Alliance. consumer health - Craniopharyngioma.
  • MedlinePlus Health Information. consumer health - Pituitary Tumors.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18942342.001).
  • [ISSN] 1426-9686
  • [Journal-full-title] Polski merkuriusz lekarski : organ Polskiego Towarzystwa Lekarskiego
  • [ISO-abbreviation] Pol. Merkur. Lekarski
  • [Language] pol
  • [Publication-type] English Abstract; Journal Article; Review
  • [Publication-country] Poland
  • [Number-of-references] 27
  •  go-up   go-down


67. Kyrgiannis K, Mourgela S, Karamanakos PN, Liaropoulos K, Papadakis N: Optimal treatment of a recurrent giant craniopharyngioma: lessons from a case. J BUON; 2008 Oct-Dec;13(4):593-6
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Optimal treatment of a recurrent giant craniopharyngioma: lessons from a case.
  • A case of a 33-year-old man presented with symptoms of dramatic deterioration of the level of consciousness because of a recurrence of a previously aspirated and irradiated craniopharyngioma is described.
  • The tumor had grown enormously in dimensions and was extending in the region of hypothalamus, third ventricle and brain stem, with signs of local compression and obstructive hydrocephalus.
  • We conclude that in expert hands, microsurgery aiming at total removal should be the therapeutic option for the treatment of recurrent as well as primary craniopharyngiomas.
  • [MeSH-major] Craniopharyngioma / surgery. Pituitary Neoplasms / surgery
  • [MeSH-minor] Adult. Humans. Magnetic Resonance Imaging. Male. Microsurgery. Neoplasm Recurrence, Local. Tomography, X-Ray Computed

  • Genetic Alliance. consumer health - Craniopharyngioma.
  • MedlinePlus Health Information. consumer health - Pituitary Tumors.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19145689.001).
  • [ISSN] 1107-0625
  • [Journal-full-title] Journal of B.U.ON. : official journal of the Balkan Union of Oncology
  • [ISO-abbreviation] J BUON
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Greece
  •  go-up   go-down


68. Tzotzas T, Papazisis K, Perros P, Krassas GE: Use of somatostatin analogues in obesity. Drugs; 2008;68(14):1963-73
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • These children have hypothalamic dysfunction, mainly due to brain tumours such as craniopharyngiomas, which are thought to generate increased vagal output, leading to hyperinsulinaemia and weight gain.
  • [MeSH-minor] Adult. Child. Humans. Hypothalamic Diseases / complications. Prader-Willi Syndrome

  • Genetic Alliance. consumer health - Obesity.
  • MedlinePlus Health Information. consumer health - Obesity.
  • MedlinePlus Health Information. consumer health - Obesity in Children.
  • The Lens. Cited by Patents in .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Drugs. 1997 Apr;53(4):681-99 [9098666.001]
  • [Cites] Recent Prog Horm Res. 1998;53:95-117; discussion 117-8 [9769705.001]
  • [Cites] Metabolism. 1992 Sep;41(9 Suppl 2):76-9 [1518438.001]
  • [Cites] Pediatr Endocrinol Rev. 2004 Aug;1 Suppl 3:448-54 [16444173.001]
  • [Cites] Science. 2005 Mar 25;307(5717):1909-14 [15790843.001]
  • [Cites] Endocr Rev. 2006 Jun;27(4):371-97 [16543382.001]
  • [Cites] J Clin Endocrinol Metab. 2006 May;91(5):1811-8 [16507637.001]
  • [Cites] Nutr Rev. 1998 Apr;56(4 Pt 1):106-14 [9584495.001]
  • [Cites] Clin Endocrinol (Oxf). 2002 Oct;57(4):539-46 [12354137.001]
  • [Cites] N Engl J Med. 1996 Jan 25;334(4):246-54 [8532003.001]
  • [Cites] Horm Metab Res. 2006 Jul;38(7):442-6 [16933179.001]
  • [Cites] Horm Res. 1998;49(1):17-21 [9438780.001]
  • [Cites] Clin Endocrinol (Oxf). 2003 May;58(5):653-61 [12699450.001]
  • [Cites] Eur J Endocrinol. 1994 Jun;130(6):581-6 [8205258.001]
  • [Cites] Curr Med Chem. 2001 Nov;8(13):1605-48 [11562281.001]
  • [Cites] Obes Surg. 1993 May;3(2):197-200 [10757921.001]
  • [Cites] Obes Res. 1995 Nov;3 Suppl 4:591S-603S [8697062.001]
  • [Cites] Obes Res. 2005 Sep;13(9):1572-9 [16222060.001]
  • [Cites] Medicine (Baltimore). 1975 Jul;54(4):301-30 [1152672.001]
  • [Cites] Expert Opin Investig Drugs. 2006 Aug;15(8):897-915 [16859393.001]
  • [Cites] Int J Obes Relat Metab Disord. 2003 Aug;27(8):875-88 [12861227.001]
  • [Cites] Fertil Steril. 2006 Jul;86 Suppl 1:S28-9 [16798283.001]
  • [Cites] J Clin Endocrinol Metab. 2005 May;90(5):2681-90 [15687345.001]
  • [Cites] Int J Obes (Lond). 2006 Feb;30(2):313-21 [16276365.001]
  • [Cites] J Comp Physiol Psychol. 1981 Apr;95(2):278-87 [6112246.001]
  • [Cites] Obesity (Silver Spring). 2006 Jun;14 (6):1028-37 [16861608.001]
  • [Cites] Lancet. 1983 Jun 11;1(8337):1330-1 [6134114.001]
  • [Cites] Diabetes. 1997 Jun;46(6):1025-9 [9166675.001]
  • [Cites] Proc Soc Exp Biol Med. 1988 Dec;189(3):362-6 [2905062.001]
  • [Cites] Neurosci Biobehav Rev. 1982 Summer;6(2):205-14 [7048155.001]
  • [Cites] Intern Med. 1997 May;36(5):319-20 [9213165.001]
  • [Cites] J Clin Endocrinol Metab. 2001 Sep;86(9):4330-8 [11549670.001]
  • [Cites] Int J Obes Relat Metab Disord. 2004 Feb;28(2):330-3 [14708034.001]
  • [Cites] J Pediatr. 2006 Jan;148(1):23-9 [16423593.001]
  • [Cites] Gut. 2003 Nov;52(11):1555-61 [14570722.001]
  • [Cites] Front Neuroendocrinol. 2003 Jan;24(1):1-10 [12609497.001]
  • [Cites] Nat Med. 2002 Jul;8(7):643-4 [12091883.001]
  • [Cites] Acta Endocrinol Suppl (Copenh). 1987;286:19-25 [2892334.001]
  • [Cites] Obes Rev. 2002 Feb;3(1):27-34 [12119657.001]
  • [Cites] C R Biol. 2006 Aug;329(8):608-22; discussion 653-5 [16860279.001]
  • [Cites] Life Sci. 1979 Aug 13;25(7):561-6 [388132.001]
  • [Cites] J Clin Endocrinol Metab. 2005 Jul;90(7):3854-62 [15827099.001]
  • [Cites] J Clin Endocrinol Metab. 2004 Nov;89(11):5435-40 [15531494.001]
  • [Cites] Endocrinology. 2000 Jan;141(1):111-7 [10614629.001]
  • [Cites] Curr Med Chem. 2004 Jun;11(12):1595-615 [15180566.001]
  • [Cites] J Pediatr Endocrinol Metab. 2006 Feb;19(2):121-7 [16562584.001]
  • [Cites] Diabetes. 1994 May;43(5):696-702 [8168647.001]
  • [Cites] J Clin Endocrinol Metab. 1977 Jun;44(6):1038-53 [874043.001]
  • [Cites] Clin Chim Acta. 2007 Jan;375(1-2):20-35 [16956601.001]
  • [Cites] J Pediatr. 1999 Aug;135(2 Pt 1):162-8 [10431109.001]
  • [Cites] Mol Endocrinol. 2003 Jan;17(1):93-106 [12511609.001]
  • [Cites] J Clin Endocrinol Metab. 2003 Jun;88(6):2586-92 [12788859.001]
  • [Cites] J Clin Endocrinol Metab. 2007 Nov;92(11):4101-6 [17726084.001]
  • [Cites] Nutr Metab Cardiovasc Dis. 2008 Feb;18(2):158-68 [18061414.001]
  • [Cites] J Clin Endocrinol Metab. 2003 May;88(5):2180-4 [12727973.001]
  • [Cites] J Clin Endocrinol Metab. 2004 Aug;89(8):4162-5 [15292365.001]
  • [Cites] Best Pract Res Clin Gastroenterol. 2002 Jun;16(3):493-509 [12079271.001]
  • [Cites] Prog Brain Res. 2006;153:57-73 [16876568.001]
  • [Cites] J Clin Endocrinol Metab. 2003 Aug;88(8):3573-6 [12915638.001]
  • [Cites] J Neurosurg. 1998 Oct;89(4):547-51 [9761047.001]
  • [Cites] Endocr Rev. 1995 Aug;16(4):427-42 [8521788.001]
  • [Cites] J Pediatr. 2005 Apr;146(4):474-81 [15812449.001]
  • [Cites] J Clin Endocrinol Metab. 2004 Jul;89(7):3298-305 [15240606.001]
  • [Cites] J Clin Endocrinol Metab. 1984 Mar;58(3):544-8 [6363441.001]
  • [Cites] Clin Ophthalmol. 2007 Sep;1(3):209-15 [19668474.001]
  • [Cites] Int J Obes (Lond). 2006 Feb;30(2):331-41 [16158082.001]
  • [Cites] Clin Endocrinol (Oxf). 2003 Oct;59(4):492-9 [14510913.001]
  • [Cites] Science. 1973 Jan 5;179(4068):77-9 [4682131.001]
  • [Cites] Trends Genet. 1998 May;14 (5):194-200 [9613204.001]
  • [Cites] Int J Obes Relat Metab Disord. 1993 Sep;17(9):527-32 [8220655.001]
  • [Cites] Diabetologia. 1985 Feb;28(2):70-5 [3884419.001]
  • [Cites] Baillieres Best Pract Res Clin Endocrinol Metab. 1999 Oct;13(3):409-18 [10909432.001]
  • [Cites] Int J Obes Relat Metab Disord. 2003 Feb;27(2):219-26 [12587002.001]
  • [Cites] Pharmacol Biochem Behav. 1982 Jun;16(6):897-902 [6125953.001]
  • [Cites] J Med Chem. 2003 Jun 5;46(12):2334-44 [12773038.001]
  • [Cites] Int J Obes (Lond). 2006 Feb;30(2):382-7 [16231029.001]
  • [Cites] Eur J Endocrinol. 2005 Jun;152(6):887-94 [15941929.001]
  • [Cites] J Endocrinol Invest. 1997 Jun;20(6):348-67 [9294784.001]
  • [Cites] Arch Intern Med. 1991 Aug;151(8):1573-8 [1872661.001]
  • [Cites] J Biol Chem. 1991 Jan 15;266(2):837-43 [1702440.001]
  • (PMID = 18778119.001).
  • [ISSN] 0012-6667
  • [Journal-full-title] Drugs
  • [ISO-abbreviation] Drugs
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] New Zealand
  • [Chemical-registry-number] 0 / Anti-Obesity Agents; 0 / Hormone Antagonists; 51110-01-1 / Somatostatin
  • [Number-of-references] 83
  •  go-up   go-down


69. Sanai N, Quiñones-Hinojosa A, Narvid J, Kunwar S: Safety and efficacy of the direct endonasal transsphenoidal approach for challenging sellar tumors. J Neurooncol; 2008 May;87(3):317-25
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • METHODS: About 64 consecutive patients with large (3-4 cm) pituitary adenomas and craniopharyngiomas were treated by the senior author (SK) using the direct endonasal approach from May 2001 to July 2004.
  • Tumor pathologies included 2 craniopharyngiomas, 16 functional, and 46 nonfunctional pituitary adenomas.
  • Suprasellar extension of tumor was evident in all patients and 10 had cavernous sinus invasion.
  • Five patients (7.8%) had tumor residual requiring radiation therapy.
  • [MeSH-minor] Adult. Female. Humans. Male. Recovery of Function. Retrospective Studies. Sphenoid Sinus / surgery. Treatment Outcome

  • MedlinePlus Health Information. consumer health - Pituitary Tumors.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Neurosurg. 2002 Feb;96(2):235-43 [11838796.001]
  • [Cites] Neurosurgery. 2004 Mar;54(3):653-60; discussion 660-1 [15028140.001]
  • [Cites] Neurosurgery. 1990 Jul;27(1):60-8 [2377282.001]
  • [Cites] Surg Neurol. 2004 May;61(5):436-45; discussion 445-6 [15120215.001]
  • [Cites] Neurosurgery. 2007 Apr;60(4 Suppl 2):322-8; discussion 328-9 [17415170.001]
  • [Cites] Surg Neurol. 2002 Jun;57(6):380-90; discussion 390 [12176196.001]
  • [Cites] J Neurosurg. 1986 May;64(5):713-9 [3701419.001]
  • [Cites] Clin Neurol Neurosurg. 2007 Oct;109(8):645-50 [17686573.001]
  • [Cites] Neurosurgery. 1985 Sep;17(3):446-52 [4047355.001]
  • [Cites] Minim Invasive Neurosurg. 2002 Jun;45(2):124-7 [12087514.001]
  • [Cites] J Endocrinol Invest. 1994 Oct;17(9):703-7 [7868814.001]
  • [Cites] J Clin Endocrinol Metab. 1997 Aug;82(8):2381-5 [9253304.001]
  • [Cites] Neurol Med Chir (Tokyo). 2002 Jun;42(6):275-7; discussion 278 [12116536.001]
  • [Cites] Neurosurgery. 2006 Feb;58(1 Suppl):ONS44-51; discussion ONS44-51 [16479628.001]
  • [Cites] J Neurosurg. 1987 Jan;66(1):140-2 [3783248.001]
  • [Cites] Surg Neurol. 1993 Jan;39(1):18-24 [8451714.001]
  • [Cites] J Neurosurg. 2005 May;102(5):832-41 [15926706.001]
  • [Cites] J Neurosurg. 2003 Feb;98(2):350-8 [12593622.001]
  • [Cites] Neurol Res. 2001 Jan;23(1):51-4 [11210430.001]
  • [Cites] Neurosurgery. 2006 Jul;59(1):105-14; discussion 105-14 [16823306.001]
  • [Cites] Neurosurgery. 2002 Aug;51(2):435-42; discussion 442-4 [12182782.001]
  • [Cites] Pituitary. 1999 Aug;2(2):133-8 [11081164.001]
  • [Cites] Chin Med J (Engl). 1998 Nov;111(11):963-7 [11189219.001]
  • [Cites] Mayo Clin Proc. 1999 Jul;74(7):661-70 [10405694.001]
  • [Cites] J Neurosurg. 2001 Dec;95(6):1083-96 [11765830.001]
  • [Cites] Otolaryngol Head Neck Surg. 2000 Mar;122(3):367-9 [10699812.001]
  • (PMID = 18094936.001).
  • [ISSN] 0167-594X
  • [Journal-full-title] Journal of neuro-oncology
  • [ISO-abbreviation] J. Neurooncol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


70. Aquilina K, O'Brien DF, Farrell MA, Bolger C: Primary cerebellopontine angle craniopharyngioma in a patient with gardner syndrome. Case report and review of the literature. J Neurosurg; 2006 Aug;105(2):330-3
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Primary cerebellopontine angle craniopharyngioma in a patient with gardner syndrome. Case report and review of the literature.
  • The authors report on the case of a craniopharyngioma arising in the cerebellopontine angle (CPA) in a patient with Gardner syndrome.
  • Although familial adenomatous polyposis (FAP) is associated with intracranial neoplasms, the current case is only the third reported craniopharyngioma in a patient with Gardner syndrome.
  • Two of these tumors, including that of the current case, originated in the CPA, an unusual location for craniopharyngiomas.
  • The literature concerning FAP and its associations with intracranial neoplasia, as well as the pathogenesis of craniopharyngiomas in the posterior fossa, is discussed.
  • [MeSH-major] Cerebellar Neoplasms / genetics. Cerebellar Neoplasms / surgery. Cerebellopontine Angle / pathology. Cerebellopontine Angle / surgery. Craniopharyngioma / surgery. Gardner Syndrome / surgery
  • [MeSH-minor] Adult. Cerebellum / pathology. Cerebellum / surgery. Diagnosis, Differential. Fibroma / diagnosis. Fibroma / genetics. Fibroma / pathology. Fibroma / surgery. Humans. Magnetic Resonance Imaging. Male. Neoplasms, Multiple Primary / diagnosis. Neoplasms, Multiple Primary / genetics. Neoplasms, Multiple Primary / pathology. Neoplasms, Multiple Primary / surgery. Scalp / pathology. Scalp / surgery. Skin Neoplasms / diagnosis. Skin Neoplasms / genetics. Skin Neoplasms / pathology. Skin Neoplasms / surgery

  • Genetic Alliance. consumer health - Craniopharyngioma.
  • Genetic Alliance. consumer health - Gardner Syndrome.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17219843.001).
  • [ISSN] 0022-3085
  • [Journal-full-title] Journal of neurosurgery
  • [ISO-abbreviation] J. Neurosurg.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article; Review
  • [Publication-country] United States
  • [Number-of-references] 24
  •  go-up   go-down


71. Majchrzak K, Bierzyńska-Macyszyn G, Bobek-Billewicz B, Majchrzak H, Ładziński P: Rare primary tumours of the hypothalamus in adults: clinical course and surgical treatment. Neurol Neurochir Pol; 2010 Nov-Dec;44(6):546-53
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • BACKGROUND AND PURPOSE: The paper presents the operative technique and the results of treatment of adult patients with primary tumours of the hypothalamus, including rare ones.
  • There were 2 patients with craniopharyngiomas located exclusively in the third ventricle, and single patients with gemistocytic astrocytoma, Langerhans cell histiocytosis X and hamartoma of the hypothalamus each.
  • In two cases, the neuronavigation system with the use of tractography (DTI) was used to determine the location of the lamina terminalis, the posterior surface of the optic chiasm and the optic tracts.
  • [MeSH-minor] Adult. Female. Humans. Male. Middle Aged. Neurosurgical Procedures. Poland. Postoperative Period. Rare Diseases

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 21225516.001).
  • [ISSN] 0028-3843
  • [Journal-full-title] Neurologia i neurochirurgia polska
  • [ISO-abbreviation] Neurol. Neurochir. Pol.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Poland
  •  go-up   go-down


72. Yamini B, Narayanan M: Craniopharyngiomas: an update. Expert Rev Anticancer Ther; 2006 Sep;6 Suppl 9:S85-92
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Craniopharyngiomas: an update.
  • Craniopharyngiomas have been challenging practitioners for over 100 years.
  • They are rare tumors found in both the adult and pediatric populations.
  • Patients in general have high long-term survival but can have significant tumor- and treatment-associated morbidity requiring a lifetime of medical and psychological management.
  • [MeSH-major] Craniopharyngioma / pathology. Craniopharyngioma / surgery. Pituitary Neoplasms / pathology. Pituitary Neoplasms / surgery

  • MedlinePlus Health Information. consumer health - Pituitary Tumors.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17004862.001).
  • [ISSN] 1744-8328
  • [Journal-full-title] Expert review of anticancer therapy
  • [ISO-abbreviation] Expert Rev Anticancer Ther
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] England
  • [Number-of-references] 58
  •  go-up   go-down


73. Frank G, Pasquini E, Doglietto F, Mazzatenta D, Sciarretta V, Farneti G, Calbucci F: The endoscopic extended transsphenoidal approach for craniopharyngiomas. Neurosurgery; 2006 Jul;59(1 Suppl 1):ONS75-83; discussion ONS75-83
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] The endoscopic extended transsphenoidal approach for craniopharyngiomas.
  • The authors present their experience with this technique in 10 patients with craniopharyngiomas.
  • From November 1998 through May 2005, four males and six females with a craniopharyngioma, either purely supradiaphragmatic (six patients) or with a significant suprasellar component (four patients), were treated.
  • Further studies are required to better define the exact location of the tumor with respect to the arachnoidal plane, the extra-arachnoidal craniopharyngioma being the most suitable for a radical removal using a transsphenoidal supradiaphragmatic approach.
  • [MeSH-major] Craniopharyngioma / surgery. Endoscopy / methods. Neurosurgical Procedures / instrumentation. Pituitary Neoplasms / surgery. Sella Turcica / surgery. Sphenoid Sinus / surgery
  • [MeSH-minor] Adult. Cerebrospinal Fluid Rhinorrhea / etiology. Cerebrospinal Fluid Rhinorrhea / physiopathology. Child. Diabetes Insipidus, Neurogenic / etiology. Diabetes Insipidus, Neurogenic / physiopathology. Endocrine System Diseases / etiology. Endocrine System Diseases / physiopathology. Female. Follow-Up Studies. Humans. Hypothalamo-Hypophyseal System / physiopathology. Male. Middle Aged. Obesity / etiology. Obesity / physiopathology. Optic Chiasm / anatomy & histology. Optic Chiasm / pathology. Optic Chiasm / surgery. Pituitary Diseases / etiology. Pituitary Diseases / physiopathology. Postoperative Complications / etiology. Postoperative Complications / physiopathology. Subarachnoid Space / anatomy & histology. Subarachnoid Space / surgery. Treatment Outcome. Vision, Low / etiology. Vision, Low / physiopathology

  • MedlinePlus Health Information. consumer health - Endoscopy.
  • MedlinePlus Health Information. consumer health - Pituitary Tumors.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16888556.001).
  • [ISSN] 1524-4040
  • [Journal-full-title] Neurosurgery
  • [ISO-abbreviation] Neurosurgery
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


74. Oikonomou E, Barreto DC, Soares B, De Marco L, Buchfelder M, Adams EF: Beta-catenin mutations in craniopharyngiomas and pituitary adenomas. J Neurooncol; 2005 Jul;73(3):205-9
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Beta-catenin mutations in craniopharyngiomas and pituitary adenomas.
  • Craniopharyngiomas and pituitary adenomas are both tumors of the hypothalamic and pituitary region, respectively that are frequently associated with endocrine defects either because of direct involvement of hormone producing cells (most pituitary tumors) or because of secondary defects due to disturbance of hypothalamic function (some pituitary tumors and craniopharyngiomas).
  • Some studies suggest that mutant beta-catenin gene cells in craniopharyngiomas and pituitary adenomas contribute to their tumorigenesis.
  • Sequenced PCR products for possible beta-catenin gene mutations showed a total of 7/43 alterations in adamantinomatous craniopharyngioma-derived DNA samples.
  • None of the 22 pituitary adenomas and the eight papillary craniopharyngiomas analyzed presented any sequence alterations.
  • These findings demonstrate an association between beta-catenin gene alterations and craniopharyngiomas of the adamantinomatous type.
  • Since this gene product is involved with development, these results suggest that beta-catenin mutations may contribute to the initiation and subsequent growth of congenital craniopharyngiomas.
  • [MeSH-major] Adenoma / genetics. Craniopharyngioma / genetics. Cytoskeletal Proteins / genetics. Pituitary Neoplasms / genetics. Trans-Activators / genetics
  • [MeSH-minor] Adult. Base Sequence. Child. DNA Mutational Analysis. Female. Humans. Male. Middle Aged. Mutation. Polymerase Chain Reaction. beta Catenin

  • MedlinePlus Health Information. consumer health - Pituitary Tumors.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Am J Pathol. 2002 Dec;161(6):1997-2001 [12466115.001]
  • [Cites] Endocrinologie. 1990 Apr-Jun;28(2):67-72 [2293330.001]
  • [Cites] Cancer. 2001 Jan 1;91(1):42-8 [11148558.001]
  • [Cites] Genes Dev. 2000 Aug 1;14 (15):1837-51 [10921899.001]
  • [Cites] Cancer Sci. 2003 Mar;94(3):225-9 [12824913.001]
  • [Cites] Bioessays. 1989 Oct;11(4):88-91 [2695079.001]
  • [Cites] Semin Diagn Pathol. 1986 Feb;3(1):69-82 [3039632.001]
  • [Cites] Science. 1991 Mar 22;251(5000):1451-5 [2006419.001]
  • [Cites] Development. 1998 Nov;125(21):4225-34 [9753677.001]
  • [Cites] J Embryol Exp Morphol. 1975 Oct;34(2):311-25 [1194833.001]
  • [Cites] Bioessays. 1999 Dec;21(12):1021-30 [10580987.001]
  • [Cites] Biochem Biophys Res Commun. 2000 Feb 16;268(2):243-8 [10679188.001]
  • [Cites] Neurosurgery. 1994 Dec;35(6):1001-10; discussion 1010-1 [7885544.001]
  • [Cites] Pathol Int. 2001 Jul;51(7):543-8 [11472567.001]
  • [Cites] Virchows Arch. 2001 Dec;439(6):725-51 [11787845.001]
  • [Cites] J Neurosurg. 1995 Aug;83(2):206-14 [7616262.001]
  • [Cites] Mod Pathol. 2002 Dec;15(12):1357-65 [12481018.001]
  • (PMID = 15980970.001).
  • [ISSN] 0167-594X
  • [Journal-full-title] Journal of neuro-oncology
  • [ISO-abbreviation] J. Neurooncol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / CTNNB1 protein, human; 0 / Cytoskeletal Proteins; 0 / Trans-Activators; 0 / beta Catenin
  •  go-up   go-down


75. Mehrazin M, Rahmat H, Yavari P: Epidemiology of primary intracranial tumors in Iran, 1978-2003. Asian Pac J Cancer Prev; 2006 Apr-Jun;7(2):283-8
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • The pattern of primary brain tumors have not been reported in Iran and the etiology remains largely unknown.
  • The purpose of this study was to review cases of brain tumors treated in Shariatti hospital, a neurosurgical center, over the twenty five years from 1978 to 2003.
  • A descriptive, retrospective study was made of 3,437 cases who were hospitalized with brain tumors.
  • Data abstracted from the patients' clinical records included age at the time of admission , sex, histological diagnosis and tumor location.
  • The frequency distribution of brain tumors by age and sex, and histology was calculated for comparison with the literature.
  • Of recorded series cases, 20.1% brain tumors occurred in children 15 years and younger, with a mean + sd of 8.7 + 3.9 years, and 79.9 % of cases in adults with the mean + sd of 40.2 + 14.4.
  • These accounted for 84 % of all brain tumors.
  • The 10 most frequent brain tumors were ranked separately by sex and age groups.
  • Male predominance was observed for the astrocytoma group, craniopharyngiomas, ependymomas, glioblastomas, medulloblastomas, and pituitary adenomas.
  • In conclusion, the results present an important epidemiological basis for understanding of the brain tumor burden in Iran.
  • [MeSH-major] Brain Neoplasms / epidemiology. Brain Neoplasms / pathology
  • [MeSH-minor] Adolescent. Adult. Age Distribution. Aged. Aged, 80 and over. Child. Child, Preschool. Female. Hospitals, University. Humans. Infant. Iran / epidemiology. Male. Middle Aged. Retrospective Studies. Sex Distribution

  • MedlinePlus Health Information. consumer health - Brain Tumors.
  • MedlinePlus Health Information. consumer health - Childhood Brain Tumors.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16839224.001).
  • [ISSN] 1513-7368
  • [Journal-full-title] Asian Pacific journal of cancer prevention : APJCP
  • [ISO-abbreviation] Asian Pac. J. Cancer Prev.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Thailand
  •  go-up   go-down


76. Oldfield EH: Transnasal endoscopic surgery for craniopharyngiomas. Neurosurg Focus; 2010 Apr;28(4):E8a; discussion E8b
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Transnasal endoscopic surgery for craniopharyngiomas.
  • [MeSH-major] Craniopharyngioma / surgery. Endoscopy / methods. Pituitary Neoplasms / surgery
  • [MeSH-minor] Adult. Age Factors. Child. Hormone Replacement Therapy. Humans. Minimally Invasive Surgical Procedures / methods. Nasal Cavity. Pituitary Gland / surgery. Pituitary Hormones / therapeutic use

  • MedlinePlus Health Information. consumer health - Endoscopy.
  • MedlinePlus Health Information. consumer health - Pituitary Tumors.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [CommentOn] Neurosurg Focus. 2010 Apr;28(4):E8 [20367365.001]
  • (PMID = 20367366.001).
  • [ISSN] 1092-0684
  • [Journal-full-title] Neurosurgical focus
  • [ISO-abbreviation] Neurosurg Focus
  • [Language] eng
  • [Publication-type] Comment; Editorial
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Pituitary Hormones
  •  go-up   go-down


77. Kim SD, Park JY, Park J, Lee JB, Kim SH, Lim DJ: Radiological findings following postsurgical intratumoral bleomycin injection for cystic craniopharyngioma. Clin Neurol Neurosurg; 2007 Apr;109(3):236-41
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Radiological findings following postsurgical intratumoral bleomycin injection for cystic craniopharyngioma.
  • OBJECTIVES: The purpose of this study was to compare the radiological findings before and after intratumoral bleomycin injection in patients with cystic craniopharyngioma so as to define the role of adjuvant intracavitary bleomycin chemotherapy for cystic craniopharyngiomas.
  • PATIENTS AND METHODS: Eleven patients whose craniopharyngioma was confirmed cytologically and/or histologically were retrospectively reviewed.
  • Only the solid portion of the cystic craniopharyngiomas was excised before repeated injections of bleomycin (15-180 mg in total) into the cystic portion through an Ommaya reservoir were given.
  • RESULTS: After the completion of all treatment cycles, the disappearance or shrinkage of the tumor was initially noted in all cases on follow-up CT and/or MR imaging studies.
  • However, tumor recurrence was seen in four cases with a mixed tumor type.
  • CONCLUSION: Postoperative bleomycin injection in cystic craniopharyngioma does not appear to totally eradicate the tumor and does not stop tumor recurrence unless the cyst is the only portion of the craniopharyngioma that is left.
  • Nevertheless, postoperative bleomycin injection decreases and stabilizes tumor size, and thus may be considered as an option of treatment modalities in patients with predominantly cystic craniopharyngiomas.
  • [MeSH-major] Antibiotics, Antineoplastic / therapeutic use. Bleomycin / therapeutic use. Craniopharyngioma. Cysts. Magnetic Resonance Imaging. Pituitary Neoplasms. Tomography, X-Ray Computed
  • [MeSH-minor] Adolescent. Adult. Aged. Brain / pathology. Brain / radiography. Brain / surgery. Child. Combined Modality Therapy. Female. Humans. Injections. Male. Middle Aged. Neurosurgical Procedures. Postoperative Care

  • Genetic Alliance. consumer health - Craniopharyngioma.
  • MedlinePlus Health Information. consumer health - CT Scans.
  • MedlinePlus Health Information. consumer health - MRI Scans.
  • MedlinePlus Health Information. consumer health - Pituitary Tumors.
  • Hazardous Substances Data Bank. BLEOMYCIN .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17046151.001).
  • [ISSN] 0303-8467
  • [Journal-full-title] Clinical neurology and neurosurgery
  • [ISO-abbreviation] Clin Neurol Neurosurg
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Netherlands
  • [Chemical-registry-number] 0 / Antibiotics, Antineoplastic; 11056-06-7 / Bleomycin
  •  go-up   go-down


78. Linnert M, Gehl J: Bleomycin treatment of brain tumors: an evaluation. Anticancer Drugs; 2009 Mar;20(3):157-64
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Bleomycin treatment of brain tumors: an evaluation.
  • Bleomycin has been used in the treatment of brain tumors for over 30 years.
  • Currently, we are evaluating electrochemotherapy (the use of electric pulses to enhance uptake of bleomycin) for patients with secondary brain tumors.
  • Using the keywords 'brain' and 'bleomycin', a database search without date restriction was performed and over 500 articles were found.
  • Twenty-five articles were used for this study based on relevance determined by: (i) clinical studies, (ii) use of bleomycin, and (iii) direct injection into brain tissue or cysts.
  • There were two main indications for the use of bleomycin directly into the brain: (i) cystic tumors in the form of craniopharyngiomas and (ii) solid brain tumors such as glioblastomas and astrocytomas.
  • All cases with severe and moderate adverse effects except one were patients with craniopharyngiomas and probably because of tumor localization in the deep brain.
  • In conclusion, bleomycin injection into the brain has been fairly well tolerated at doses much higher than that used in electrochemotherapy.
  • [MeSH-major] Antimetabolites, Antineoplastic / therapeutic use. Bleomycin / therapeutic use. Brain Neoplasms / drug therapy
  • [MeSH-minor] Adolescent. Adult. Aged. Blindness / chemically induced. Brain Edema / chemically induced. Child. Child, Preschool. Craniopharyngioma / drug therapy. DNA Damage. Deafness / chemically induced. Electroporation. Female. Glioma / drug therapy. Humans. Infant. Injections, Spinal. Male. Middle Aged. Pituitary Neoplasms / drug therapy. Young Adult

  • MedlinePlus Health Information. consumer health - Brain Tumors.
  • MedlinePlus Health Information. consumer health - Childhood Brain Tumors.
  • ClinicalTrials.gov. clinical trials - ClinicalTrials.gov .
  • Hazardous Substances Data Bank. BLEOMYCIN .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19396014.001).
  • [ISSN] 1473-5741
  • [Journal-full-title] Anti-cancer drugs
  • [ISO-abbreviation] Anticancer Drugs
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Antimetabolites, Antineoplastic; 11056-06-7 / Bleomycin
  • [Number-of-references] 43
  •  go-up   go-down


79. Dusick JR, Esposito F, Kelly DF, Cohan P, DeSalles A, Becker DP, Martin NA: The extended direct endonasal transsphenoidal approach for nonadenomatous suprasellar tumors. J Neurosurg; 2005 May;102(5):832-41
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Twenty-six procedures for tumor removal were performed in 24 patients (ages 9-79 years), including two repeated operations for residual tumor.
  • Gross-total removal could be accomplished in only 46% of patients, with near-gross-total removal or better in 74% of 23 patients (five of eight with craniopharyngiomas, six of seven with meningiomas, five of six with Rathke cleft cysts, and one of two with a dermoid or epidermoid cyst); a patient with a lymphoma only underwent biopsy.
  • Of 13 patients with tumor-related visual loss, 85% improved postoperatively.
  • [MeSH-major] Brain Neoplasms / surgery. Minimally Invasive Surgical Procedures / methods. Neurosurgical Procedures / methods
  • [MeSH-minor] Adolescent. Adult. Aged. Brain Diseases / surgery. Central Nervous System Cysts / surgery. Child. Craniopharyngioma / surgery. Epidermal Cyst / surgery. Humans. Meningeal Neoplasms / surgery. Meningioma / surgery. Middle Aged. Pituitary Neoplasms / surgery. Postoperative Complications. Sphenoid Bone. Treatment Outcome

  • MedlinePlus Health Information. consumer health - Brain Tumors.
  • MedlinePlus Health Information. consumer health - Childhood Brain Tumors.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [CommentIn] J Neurosurg. 2005 May;102(5):825-7; discussion 827-8 [15926704.001]
  • (PMID = 15926706.001).
  • [ISSN] 0022-3085
  • [Journal-full-title] Journal of neurosurgery
  • [ISO-abbreviation] J. Neurosurg.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


80. Qi S, Huang G, Pan J, Li J, Zhang X, Fang L, Liu B, Meng W, Zhang Y, Liu X: Involvement of osteopontin as a core protein in craniopharyngioma calcification formation. J Neurooncol; 2010 May;98(1):21-30
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Involvement of osteopontin as a core protein in craniopharyngioma calcification formation.
  • To investigate the role of OPN in craniopharyngioma calcification formation, we studied the involvement of OPN and CD44v6 in craniopharyngiomas.
  • Immunohistochemical staining was used in human craniopharyngiomas to detect the relationship of OPN and degree of calcification, and immunogold localization of OPN was done to identify cell secretory granules.
  • OPN expression was elevated in calcification craniopharyngioma samples.
  • These results suggest that OPN is possibly involved as a core protein in the formation of craniopharyngioma calcification.
  • [MeSH-major] Calcinosis / metabolism. Craniopharyngioma / metabolism. Osteopontin / metabolism. Pituitary Neoplasms / metabolism
  • [MeSH-minor] Adolescent. Adult. Aged. Antigens, CD44 / metabolism. Child. Child, Preschool. Epithelium / pathology. Epithelium / ultrastructure. Humans. Magnetic Resonance Imaging / methods. Male. Microscopy, Immunoelectron / methods. Middle Aged. Retrospective Studies. Tomography, X-Ray Computed / methods. Young Adult

  • Genetic Alliance. consumer health - Craniopharyngioma.
  • MedlinePlus Health Information. consumer health - Pituitary Tumors.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Neurosci. 1996 Jul 15;16(14):4457-67 [8699256.001]
  • [Cites] Circ Res. 1999 Feb 5;84(2):166-78 [9933248.001]
  • [Cites] Curr Mol Med. 2001 Nov;1(5):621-32 [11899236.001]
  • [Cites] Cancer Res. 1996 Mar 1;56(5):1037-42 [8640758.001]
  • [Cites] Trends Cell Biol. 2006 Feb;16(2):79-87 [16406521.001]
  • [Cites] J Neurosci Methods. 2006 Jun 15;153(2):276-82 [16406042.001]
  • [Cites] Osteoporos Int. 1993;3 Suppl 1:132-5 [8461540.001]
  • [Cites] Cancer Res. 1988 Oct 15;48(20):5770-4 [3167835.001]
  • [Cites] Cancer. 1997 Jun 25;81(3):157-62 [9196014.001]
  • [Cites] Cancer Res. 1995 Oct 15;55(20):4594-8 [7553635.001]
  • [Cites] Eur Radiol. 1997;7(4):464-9 [9204320.001]
  • [Cites] AJNR Am J Neuroradiol. 1996 Sep;17 (8):1427-39 [8883637.001]
  • [Cites] Am J Pathol. 2002 Dec;161(6):2035-46 [12466120.001]
  • [Cites] Arch Oral Biol. 1994 Sep;39(9):775-82 [7802613.001]
  • [Cites] J Neurosurg Pediatr. 2008 Feb;1(2):124-5; discussion 125 [18352780.001]
  • [Cites] Acta Neuropathol. 1978 Sep 15;43(3):191-203 [696237.001]
  • [Cites] Biochem J. 1985 Dec 15;232(3):715-24 [4091817.001]
  • [Cites] Pathol Oncol Res. 2008 Sep;14(3):293-8 [18493866.001]
  • [Cites] Orphanet J Rare Dis. 2007 Apr 10;2:18 [17425791.001]
  • [Cites] Pediatr Neurosurg. 1994;21 Suppl 1:11-7 [7841069.001]
  • [Cites] Cancer Res. 2007 Mar 1;67(5):2089-97 [17332338.001]
  • [Cites] Ultrastruct Pathol. 1981 Oct-Dec;2(4):343-56 [7324203.001]
  • [Cites] J Cell Biochem Suppl. 1998;30-31:92-102 [9893260.001]
  • [Cites] Cancer Epidemiol Biomarkers Prev. 2007 Jun;16(6):1087-97 [17548669.001]
  • [Cites] Proc Assoc Am Physicians. 1997 Jan;109(1):1-9 [9010911.001]
  • [Cites] Pathol Int. 2000 Jul;50(7):531-5 [10886734.001]
  • [Cites] Ann N Y Acad Sci. 1995 Apr 21;760:213-22 [7540374.001]
  • [Cites] Immunity. 2004 Oct;21(4):539-50 [15485631.001]
  • [Cites] Int J Exp Pathol. 2000 Dec;81(6):373-90 [11298186.001]
  • [Cites] Childs Nerv Syst. 1998 Oct;14(10):558-63 [9840379.001]
  • [Cites] Nat Immunol. 2006 May;7(5):498-506 [16604075.001]
  • [Cites] Biochem J. 1991 Mar 1;274 ( Pt 2):513-20 [2006915.001]
  • [Cites] Am J Pathol. 1995 Jan;146(1):95-100 [7856741.001]
  • [Cites] J Biol Chem. 1992 Dec 5;267(34):24871-8 [1447223.001]
  • [Cites] Coll Relat Res. 1987 Sep;7(4):305-13 [3478171.001]
  • [Cites] Lab Invest. 1995 Jan;72(1):64-9 [7837792.001]
  • [Cites] Biochim Biophys Acta. 2001 Dec 28;1552(2):61-85 [11825687.001]
  • [Cites] J Neurosurg. 1998 Oct;89(4):547-51 [9761047.001]
  • [Cites] Cancer Res. 2002 Sep 15;62(18):5336-43 [12235004.001]
  • [Cites] Nat Rev Mol Cell Biol. 2003 Jan;4(1):33-45 [12511867.001]
  • [Cites] Ultrastruct Pathol. 1999 Nov-Dec;23(6):395-9 [10626690.001]
  • [Cites] Br J Haematol. 2006 Sep;134(5):467-74 [16848793.001]
  • [Cites] Br J Cancer. 2004 May 17;90(10):1877-81 [15138464.001]
  • [Cites] J Neurosurg. 2005 Oct;103(4 Suppl):297-8; discussion 298 [16270679.001]
  • [Cites] Mol Biol Cell. 1992 Oct;3(10):1169-80 [1421573.001]
  • [Cites] J Neurosurg. 2004 Aug;101(1 Suppl):85-90 [16206977.001]
  • [Cites] Arterioscler Thromb Vasc Biol. 1997 Mar;17(3):547-52 [9102175.001]
  • [Cites] J Neuropathol Exp Neurol. 1986 Jul;45(4):463-70 [3723142.001]
  • [Cites] J Neurosurg. 1995 Aug;83(2):206-14 [7616262.001]
  • [Cites] Am J Pathol. 2006 May;168(5):1676-85 [16651633.001]
  • [Cites] Proc Natl Acad Sci U S A. 2005 Nov 22;102(47):17101-6 [16286640.001]
  • (PMID = 19902145.001).
  • [ISSN] 1573-7373
  • [Journal-full-title] Journal of neuro-oncology
  • [ISO-abbreviation] J. Neurooncol.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Antigens, CD44; 0 / CD44v6 antigen; 106441-73-0 / Osteopontin
  •  go-up   go-down


81. Yamasaki F, Kurisu K, Satoh K, Arita K, Sugiyama K, Ohtaki M, Takaba J, Tominaga A, Hanaya R, Yoshioka H, Hama S, Ito Y, Kajiwara Y, Yahara K, Saito T, Thohar MA: Apparent diffusion coefficient of human brain tumors at MR imaging. Radiology; 2005 Jun;235(3):985-91
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Apparent diffusion coefficient of human brain tumors at MR imaging.
  • PURPOSE: To determine if apparent diffusion coefficient (ADC) can be used to differentiate brain tumors at magnetic resonance (MR) imaging.
  • MR images were reviewed retrospectively in 275 patients with brain tumors: 147 males and 128 females 1-81 years old, treated between September 1997 and July 2003.
  • Regions of interest were placed manually in tumor regions on MR images, and ADC was calculated with a five-point regression method at b values of 0, 250, 500, 750, and 1000 sec/mm2.
  • ADC values were average values in tumor.
  • All brain tumor subgroups were analyzed.
  • Logistic discriminant analysis was performed by using ADC, age, and patient sex as independent variables to discriminate among tumor groups.
  • ADC of craniopharyngiomas was higher than that of pituitary adenomas (accuracy, 85.2%; P < .05).
  • CONCLUSION: ADC is useful for differentiation of some human brain tumors, particularly DNT, malignant lymphomas versus glioblastomas and metastatic tumors, and ependymomas versus PNETs.
  • [MeSH-major] Brain Neoplasms / pathology. Magnetic Resonance Imaging
  • [MeSH-minor] Adolescent. Adult. Aged. Aged, 80 and over. Child. Child, Preschool. Diagnosis, Differential. Female. Humans. Infant. Male. Middle Aged. Retrospective Studies

  • MedlinePlus Health Information. consumer health - Brain Tumors.
  • MedlinePlus Health Information. consumer health - Childhood Brain Tumors.
  • MedlinePlus Health Information. consumer health - MRI Scans.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright RSNA, 2005.
  • (PMID = 15833979.001).
  • [ISSN] 0033-8419
  • [Journal-full-title] Radiology
  • [ISO-abbreviation] Radiology
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


82. Izumoto S, Suzuki T, Kinoshita M, Hashiba T, Kagawa N, Wada K, Fujimoto Y, Hashimoto N, Saitoh Y, Maruno M, Yoshimine T: Immunohistochemical detection of female sex hormone receptors in craniopharyngiomas: correlation with clinical and histologic features. Surg Neurol; 2005 Jun;63(6):520-5; discussion 525
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Immunohistochemical detection of female sex hormone receptors in craniopharyngiomas: correlation with clinical and histologic features.
  • BACKGROUND: Although craniopharyngiomas have a histologically benign nature, their treatment can be difficult.
  • The correlation among clinical, proliferative, and immunohistologic features of female sex hormone receptors was determined in craniopharyngiomas to analyze whether they influence the growth of the tumor.
  • METHODS: The study subjects were 43 patients with previously untreated craniopharyngioma who underwent surgery at our department over the past 15 years.
  • ER and PR were detected in 9 of 30 (30%) craniopharyngiomas, and the incidence of postoperative tumor regrowth was significantly higher in patients negative for ER and PR (29%) than in those positive for both receptors (11%).
  • CONCLUSIONS: A high Ki-67 labeling index suggests a high possibility of tumor regrowth, and the presence of ER and PR is suggestive of a high tissue differentiating potential.
  • ER and PR assay may be useful for determining the indication for additional radiation therapy in craniopharyngioma patients treated by incomplete resection.
  • [MeSH-major] Biomarkers, Tumor / analysis. Craniopharyngioma / diagnosis. Ki-67 Antigen / analysis. Pituitary Neoplasms / diagnosis. Receptors, Estrogen / analysis. Receptors, Progesterone / analysis
  • [MeSH-minor] Adolescent. Adult. Aged. Child. Child, Preschool. Female. Humans. Immunohistochemistry. Male. Middle Aged. Neoplasm Recurrence, Local. Neurosurgical Procedures. Patient Selection. Predictive Value of Tests. Prognosis. Radiotherapy / standards

  • MedlinePlus Health Information. consumer health - Pituitary Tumors.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15936368.001).
  • [ISSN] 0090-3019
  • [Journal-full-title] Surgical neurology
  • [ISO-abbreviation] Surg Neurol
  • [Language] eng
  • [Publication-type] Clinical Trial; Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Biomarkers, Tumor; 0 / Ki-67 Antigen; 0 / Receptors, Estrogen; 0 / Receptors, Progesterone
  •  go-up   go-down


83. de Luis DA, Reina C: [Clinical and biochemical characteristics of patients with pituitary disease]. An Med Interna; 2005 Aug;22(8):364-8
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Transliterated title] Características clínico bioquímicas de pacientes con patología hipofisaria.
  • Pituitary adenoma are unfrequent, however this pathology represent 10-12% of brain tumors.
  • MATERIAL AND METHODS: We study 58 patients with diagnosis of pituitary tumor, with regular follow-up in our Hospital, between 1999-2001.
  • The most frequent tumor was prolactinoma and non-functioning adenomas, amenorrhea was the most frequent symptom with the specialist physician (15%) and the general practice physician was the first step in diagnosis protocol.
  • Invasive lesions (craniopharyngiomas, germinomas and invasive adenomas) representing a 6.9%.
  • [MeSH-minor] Adolescent. Adult. Aged. Aged, 80 and over. Female. Humans. Male. Middle Aged

  • MedlinePlus Health Information. consumer health - Pituitary Tumors.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16351487.001).
  • [ISSN] 0212-7199
  • [Journal-full-title] Anales de medicina interna (Madrid, Spain : 1984)
  • [ISO-abbreviation] An Med Interna
  • [Language] spa
  • [Publication-type] English Abstract; Journal Article
  • [Publication-country] Spain
  • [Chemical-registry-number] 0 / Pituitary Hormones
  •  go-up   go-down


84. Kawamata T, Amano K, Aihara Y, Kubo O, Hori T: Optimal treatment strategy for craniopharyngiomas based on long-term functional outcomes of recent and past treatment modalities. Neurosurg Rev; 2010 Jan;33(1):71-81
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Optimal treatment strategy for craniopharyngiomas based on long-term functional outcomes of recent and past treatment modalities.
  • Although many authors have described treatment strategies for craniopharyngiomas, the optimal treatment of craniopharyngiomas remains controversial.
  • This study aimed to define an adequate surgical strategy for craniopharyngiomas by reviewing the long-term functional performance of patients treated by current and past treatment modalities.
  • There were 28 adult patients (14 males; median age, 44.4 years) and 27 children younger than 16 years of age (15 males; median age, 8.1 years).
  • Adequate primary treatment for craniopharyngiomas is important to avoid subsequent multiple treatments.
  • Craniopharyngiomas should be removed surgically as far as possible but without further deteriorating cognitive and visual functions, either as total resection or subtotal resection with a small remnant that is controllable by radiation therapy.
  • [MeSH-major] Craniopharyngioma / surgery. Pituitary Neoplasms / surgery
  • [MeSH-minor] Adolescent. Adult. Aged. Child. Child, Preschool. Cognition Disorders / psychology. Female. Follow-Up Studies. Humans. Karnofsky Performance Status. Magnetic Resonance Imaging. Male. Middle Aged. Neurologic Examination. Neurosurgical Procedures. Pituitary Function Tests. Postoperative Complications / pathology. Postoperative Complications / psychology. Prognosis. Radiosurgery. Tomography, X-Ray Computed. Treatment Outcome. Vision Tests. Young Adult

  • MedlinePlus Health Information. consumer health - Pituitary Tumors.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Neurosurg. 1986 Jul;65(1):22-7 [3712025.001]
  • [Cites] Neurosurgery. 1997 Feb;40(2):263-9; discussion 269-70 [9007857.001]
  • [Cites] Radiother Oncol. 1993 Apr;27(1):13-21 [8327728.001]
  • [Cites] J Clin Endocrinol Metab. 1996 Jul;81(7):2734-7 [8675604.001]
  • [Cites] J Neurosurg. 2007 Oct;107(4 Suppl):318-23 [17941498.001]
  • [Cites] Neurosurg Rev. 1983;6(2):43-9 [6657077.001]
  • [Cites] J Neurosurg. 1990 Jul;73(1):3-11 [2352020.001]
  • [Cites] Cancer. 2007 May 15;109 (10 ):2124-31 [17407137.001]
  • [Cites] Neurosurgery. 1977 Nov-Dec;1(3):238-41 [615967.001]
  • [Cites] Neurosurgery. 2007 Aug;61(2):288-95; discussion 295-6 [17762741.001]
  • [Cites] Eur J Endocrinol. 2006 Mar;154(3):483-9 [16498063.001]
  • [Cites] J Neurosurg. 1999 Feb;90(2):251-7 [9950495.001]
  • [Cites] Neurosurgery. 1995 Apr;36(4):715-24 [7596502.001]
  • [Cites] Acta Neurochir Suppl (Wien). 1985;35:94-100 [3867266.001]
  • [Cites] Radiother Oncol. 1993 Jan;26(1):1-10 [8438080.001]
  • [Cites] Surg Neurol. 1973 Jan;1(1):5-12 [4544703.001]
  • [Cites] J Neurosurg. 1996 Jul;85(1):73-81 [8683285.001]
  • [Cites] Clin Neurosurg. 1980;27:169-87 [7273552.001]
  • [Cites] J Neurosurg. 2007 May;106(5 Suppl):391-3 [17566208.001]
  • [Cites] J Neurosurg. 1990 Oct;73(4):534-40 [2398383.001]
  • [Cites] Pediatr Neurosurg. 1994;21 Suppl 1:11-7 [7841069.001]
  • [Cites] Neurol Res. 2002 Apr;24(3):259-65 [11958419.001]
  • [Cites] J Neurosurg. 2005 Apr;102(4):650-7 [15871507.001]
  • [Cites] J Clin Endocrinol Metab. 2004 Jan;89(1):81-6 [14715831.001]
  • [Cites] Acta Neurochir (Wien). 1986;81(3-4):85-9 [3489356.001]
  • [Cites] Childs Nerv Syst. 1996 Jul;12(7):385-90; discussion 390-1 [8869774.001]
  • [Cites] J Neurosurg. 1999 Feb;90(2):237-50 [9950494.001]
  • [Cites] Int J Radiat Oncol Biol Phys. 1998 Oct 1;42(3):601-6 [9806520.001]
  • [Cites] J Neurosurg. 1983 Sep;59(3):409-17 [6886754.001]
  • [Cites] J Neurosurg. 1990 Jul;73(1):12-7 [2352012.001]
  • [Cites] Childs Nerv Syst. 1998 Oct;14(10):558-63 [9840379.001]
  • [Cites] Clin Endocrinol (Oxf). 2005 Apr;62(4):397-409 [15807869.001]
  • [Cites] J Neurosurg. 2002 Jul;97(1):3-11 [12134929.001]
  • [Cites] Acta Neurochir (Wien). 2002 Nov;144(11):1221-4 [12434179.001]
  • [Cites] Clin Endocrinol (Oxf). 2005 Feb;62(2):197-204 [15670196.001]
  • [Cites] Brain Tumor Pathol. 2005;22(2):75-8 [18095108.001]
  • [Cites] J Neurosurg. 1998 Oct;89(4):547-51 [9761047.001]
  • [Cites] Neurosurgery. 1994 Dec;35(6):1001-10; discussion 1010-1 [7885544.001]
  • [Cites] J Neurosurg. 1975 Jan;42(1):86-93 [1110394.001]
  • [Cites] Neurosurgery. 2000 Feb;46(2):291-302; discussion 302-5 [10690718.001]
  • [Cites] Minim Invasive Neurosurg. 2002 Dec;45(4):208-10 [12494355.001]
  • [Cites] Eur J Pediatr. 1984 Aug;142(3):179-85 [6381061.001]
  • [Cites] Neurosurgery. 2002 Jun;50(6):1393-7 [12015864.001]
  • [Cites] Int J Radiat Oncol Biol Phys. 1999 May 1;44(2):255-63 [10760417.001]
  • (PMID = 19669813.001).
  • [ISSN] 1437-2320
  • [Journal-full-title] Neurosurgical review
  • [ISO-abbreviation] Neurosurg Rev
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Germany
  •  go-up   go-down


85. Rutka JT: Endonasal resection of craniopharyngiomas. J Neurosurg; 2008 Jul;109(1):1; reply 3-5
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Endonasal resection of craniopharyngiomas.
  • [MeSH-major] Craniopharyngioma / pathology. Craniopharyngioma / surgery. Endoscopy. Pituitary Neoplasms / pathology. Pituitary Neoplasms / surgery
  • [MeSH-minor] Adult. Humans. Nasal Cavity. Treatment Outcome

  • MedlinePlus Health Information. consumer health - Endoscopy.
  • MedlinePlus Health Information. consumer health - Pituitary Tumors.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [CommentOn] J Neurosurg. 2008 Jul;109(1):6-16 [18590427.001]
  • (PMID = 18590425.001).
  • [ISSN] 0022-3085
  • [Journal-full-title] Journal of neurosurgery
  • [ISO-abbreviation] J. Neurosurg.
  • [Language] eng
  • [Publication-type] Comment; Editorial
  • [Publication-country] United States
  •  go-up   go-down


86. Hölsken A, Kreutzer J, Hofmann BM, Hans V, Oppel F, Buchfelder M, Fahlbusch R, Blümcke I, Buslei R: Target gene activation of the Wnt signaling pathway in nuclear beta-catenin accumulating cells of adamantinomatous craniopharyngiomas. Brain Pathol; 2009 Jul;19(3):357-64
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Target gene activation of the Wnt signaling pathway in nuclear beta-catenin accumulating cells of adamantinomatous craniopharyngiomas.
  • Activating beta-catenin (CTNNB1) mutations can be identified in the majority of adamantinomatous craniopharyngiomas (adaCP), suggesting an aberrant Wnt signaling pathway in this histopathologically peculiar tumor entity.
  • We performed a laser-microdissection-based study comparing beta-catenin accumulating vs. non-accumulating tumor cells.
  • Mutational analysis and gene expression profiling using real-time polymerase chain reaction were conducted in adamantinomatous and papillary tumor specimens.
  • Target gene activation, that is, over-expression of Axin2 could be detected in adaCP, especially in tumor cells with nuclear beta-catenin accumulation.
  • Interestingly, accumulating and non-accumulating tumor cell populations carried CTNNB1 mutations within exon 3.
  • [MeSH-major] Craniopharyngioma / genetics. Signal Transduction / physiology. Transcriptional Activation. Wnt Proteins / metabolism. beta Catenin / metabolism
  • [MeSH-minor] Adolescent. Adult. Axin Protein. Bone Morphogenetic Protein 4 / genetics. Cell Nucleus / metabolism. Cell Nucleus / pathology. Child. Child, Preschool. Cytoskeletal Proteins / genetics. DNA Mutational Analysis. Female. Gene Expression. Humans. Immunohistochemistry. Male. Microdissection. Pituitary Neoplasms / genetics. Pituitary Neoplasms / metabolism. Pituitary Neoplasms / pathology. Reverse Transcriptase Polymerase Chain Reaction

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18540944.001).
  • [ISSN] 1750-3639
  • [Journal-full-title] Brain pathology (Zurich, Switzerland)
  • [ISO-abbreviation] Brain Pathol.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] Switzerland
  • [Chemical-registry-number] 0 / AXIN2 protein, human; 0 / Axin Protein; 0 / Bone Morphogenetic Protein 4; 0 / Cytoskeletal Proteins; 0 / Wnt Proteins; 0 / beta Catenin
  •  go-up   go-down


87. Moon SH, Kim IH, Park SW, Kim I, Hong S, Park CI, Wang KC, Cho BK: Early adjuvant radiotherapy toward long-term survival and better quality of life for craniopharyngiomas--a study in single institute. Childs Nerv Syst; 2005 Aug;21(8-9):799-807
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Early adjuvant radiotherapy toward long-term survival and better quality of life for craniopharyngiomas--a study in single institute.
  • OBJECTIVES: The objective of the study is to compare survival and quality of life (QoL) by the delivery time of adjuvant radiotherapy (RT), early or late, for craniopharyngiomas.
  • Initial tumor size was the only prognostic factor (p=0.034) for progression-free survival in univariate analysis.
  • Better visual acuity or field was maintained, and diabetes insipidus was partly improved with early RT, but all were deteriorated as tumor progressed without early RT.
  • Poor QoL with late RT resulted from relapsed tumor and repeated surgery but was not associated with RT itself.
  • [MeSH-major] Craniopharyngioma / radiotherapy. Pituitary Neoplasms / radiotherapy. Quality of Life
  • [MeSH-minor] Adolescent. Adult. Child. Child, Preschool. Disease Progression. Disease-Free Survival. Female. Follow-Up Studies. Humans. Imaging, Three-Dimensional. Infant. Male. Middle Aged. Postoperative Complications. Radiosurgery. Radiotherapy Dosage. Radiotherapy, Adjuvant / methods. Retrospective Studies. Time Factors. Treatment Outcome. Vision Disorders / etiology

  • MedlinePlus Health Information. consumer health - Pituitary Tumors.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Neurosurg. 1986 Jul;65(1):22-7 [3712025.001]
  • [Cites] Pediatr Neurosurg. 1994;21 Suppl 1:50-6 [7841078.001]
  • [Cites] J Neurosurg. 1989 Mar;70(3):469-74 [2536806.001]
  • [Cites] J Neurosurg. 1972 Mar;36(3):299-302 [5059968.001]
  • [Cites] J Neurosurg. 1990 Jul;73(1):3-11 [2352020.001]
  • [Cites] Int J Radiat Oncol Biol Phys. 2004 Mar 1;58(3):714-20 [14967425.001]
  • [Cites] J Neurosurg. 1979 May;50(5):617-23 [430156.001]
  • [Cites] Pediatr Neurosurg. 1994;21 Suppl 1:11-7 [7841069.001]
  • [Cites] Int J Radiat Oncol Biol Phys. 1993 Sep 30;27(2):189-95 [8407391.001]
  • [Cites] J Neurosurg. 1983 Sep;59(3):409-17 [6886754.001]
  • [Cites] J Clin Oncol. 1992 Sep;10(9):1390-6 [1517781.001]
  • [Cites] Pediatr Neurosurg. 1994;21 Suppl 1:44-9 [7530990.001]
  • [Cites] J Neurosurg. 1992 Jan;76(1):47-52 [1727168.001]
  • [Cites] Int J Radiat Oncol Biol Phys. 1989 Dec;17(6):1313-21 [2689398.001]
  • [Cites] J Neurosurg. 1998 Oct;89(4):547-51 [9761047.001]
  • [Cites] Int J Radiat Oncol Biol Phys. 1989 Jan;16(1):17-24 [2912938.001]
  • [Cites] Int J Radiat Oncol Biol Phys. 1999 May 1;44(2):255-63 [10760417.001]
  • (PMID = 15959734.001).
  • [ISSN] 0256-7040
  • [Journal-full-title] Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery
  • [ISO-abbreviation] Childs Nerv Syst
  • [Language] eng
  • [Publication-type] Clinical Trial; Comparative Study; Journal Article
  • [Publication-country] Germany
  •  go-up   go-down


88. Kitano M, Taneda M: Icing and multilayering technique of injectable hydroxyapatite cement paste for cranial base reconstruction after transsphenoidal surgery: technical note. Neurosurgery; 2007 Sep;61(3 Suppl):E53-4; discussion E54
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Bone defects of the sellar floor after transsphenoidal surgery for pituitary adenomas, craniopharyngiomas, meningiomas, or suprasellar arachnoid cysts were reconstructed using the HAC in 55 patients during a 5-year period.
  • [MeSH-minor] Adolescent. Adult. Aged. Child. Female. Humans. Injections / methods. Male. Middle Aged. Skull Neoplasms / surgery. Treatment Outcome

  • MedlinePlus Health Information. consumer health - Plastic and Cosmetic Surgery.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17876222.001).
  • [ISSN] 1524-4040
  • [Journal-full-title] Neurosurgery
  • [ISO-abbreviation] Neurosurgery
  • [Language] eng
  • [Publication-type] Clinical Trial; Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Biopex; 0 / Bone Cements; 0 / Calcium Phosphates; 0 / Hydroxyapatites; 0 / Succinates; 9007-28-7 / Chondroitin Sulfates
  •  go-up   go-down


89. Combs SE, Thilmann C, Huber PE, Hoess A, Debus J, Schulz-Ertner D: Achievement of long-term local control in patients with craniopharyngiomas using high precision stereotactic radiotherapy. Cancer; 2007 Jun 1;109(11):2308-14
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Achievement of long-term local control in patients with craniopharyngiomas using high precision stereotactic radiotherapy.
  • BACKGROUND: The long-term outcome in patients with craniopharyngiomas treated with fractionated stereotactic radiotherapy (FSRT) was evaluated.
  • METHODS: A total of 40 patients with craniopharyngiomas were treated between May 1989 and July 2006 with FSRT.
  • Most patients were treated for tumor progression after surgery.
  • CONCLUSIONS: The long-term outcome of FSRT for craniopharyngiomas is excellent with regard to local control as well as treatment-related side effects.
  • [MeSH-major] Craniopharyngioma / radiotherapy. Pituitary Neoplasms / radiotherapy. Radiotherapy / methods. Stereotaxic Techniques
  • [MeSH-minor] Adolescent. Adult. Aged. Child. Female. Humans. Male. Middle Aged. Retrospective Studies

  • MedlinePlus Health Information. consumer health - Pituitary Tumors.
  • MedlinePlus Health Information. consumer health - Radiation Therapy.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] (c) 2007 American Cancer Society.
  • (PMID = 17469176.001).
  • [ISSN] 0008-543X
  • [Journal-full-title] Cancer
  • [ISO-abbreviation] Cancer
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


90. Gopalan R, Dassoulas K, Rainey J, Sherman JH, Sheehan JP: Evaluation of the role of Gamma Knife surgery in the treatment of craniopharyngiomas. Neurosurg Focus; 2008;24(5):E5
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Evaluation of the role of Gamma Knife surgery in the treatment of craniopharyngiomas.
  • The management of craniopharyngioma involves balancing adequate reduction in tumor volume and prevention of recurrence while minimizing damage to delicate surrounding structures.
  • Gamma Knife surgery (GKS) is now being considered as a viable method of providing tumor control while ensuring minimal side effects.
  • The authors conducted a literature review of 10 studies in which GKS was used to treat craniopharyngioma; some lesions had been previously treated and some had not.
  • Tumor control was achieved in 75% of cases overall and varied with tumor subtype (cystic, solid, mixed).
  • These results suggest that GKS may provide a favorable benefit-to-risk profile for many patients with craniopharyngiomas.
  • [MeSH-major] Craniopharyngioma / radiotherapy. Craniopharyngioma / surgery. Hypophysectomy / methods. Pituitary Neoplasms / radiotherapy. Pituitary Neoplasms / surgery. Radiosurgery
  • [MeSH-minor] Adolescent. Adult. Brachytherapy / methods. Combined Modality Therapy. Cranial Irradiation / methods. Female. Follow-Up Studies. Humans. Male. Neoplasm Recurrence, Local / surgery. Postoperative Complications / etiology. Radiotherapy, Adjuvant. Remission Induction. Retrospective Studies. Salvage Therapy. Treatment Outcome

  • MedlinePlus Health Information. consumer health - Pituitary Tumors.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18447744.001).
  • [ISSN] 1092-0684
  • [Journal-full-title] Neurosurgical focus
  • [ISO-abbreviation] Neurosurg Focus
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] United States
  • [Number-of-references] 38
  •  go-up   go-down


91. Le BH, Towfighi J, Kapadia SB, Lopes MB: Comparative immunohistochemical assessment of craniopharyngioma and related lesions. Endocr Pathol; 2007;18(1):23-30
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Comparative immunohistochemical assessment of craniopharyngioma and related lesions.
  • Craniopharyngiomas (CP), Rathke's cleft cysts (RCC), and sellar xanthogranulomas (XG) are closely related lesions.
  • [MeSH-major] Biomarkers, Tumor / metabolism. Craniopharyngioma / pathology. Keratin-20 / metabolism. Keratin-8 / metabolism. Pituitary Neoplasms / pathology
  • [MeSH-minor] Adolescent. Adult. Aged. Aged, 80 and over. Central Nervous System Cysts / metabolism. Central Nervous System Cysts / pathology. Child. Child, Preschool. Diagnosis, Differential. Female. Humans. Male. Middle Aged. Reproducibility of Results. Xanthogranuloma, Juvenile / metabolism. Xanthogranuloma, Juvenile / pathology

  • Genetic Alliance. consumer health - Craniopharyngioma.
  • MedlinePlus Health Information. consumer health - Pituitary Tumors.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Front Horm Res. 2006;34:105-26 [16474218.001]
  • [Cites] Pathol Res Pract. 2001;197(11):735-42 [11770017.001]
  • [Cites] Diagn Cytopathol. 1999 Mar;20(3):137-47 [10086237.001]
  • [Cites] J Clin Endocrinol Metab. 1999 Nov;84(11):3972-82 [10566636.001]
  • [Cites] J Neurosurg. 2004 Oct;101(4):577-84 [15481709.001]
  • [Cites] J Neurosurg. 1991 Apr;74(4):535-44 [2002366.001]
  • [Cites] Acta Neuropathol. 1999 Apr;97(4):377-82 [10208277.001]
  • [Cites] Acta Neurochir (Wien). 2001;143(2):147-51 [11459086.001]
  • [Cites] Acta Neurochir (Wien). 1990;107(3-4):93-101 [1706558.001]
  • [Cites] Oral Surg Oral Med Oral Pathol. 1983 Nov;56(5):502-11 [6196702.001]
  • [Cites] Brain Tumor Pathol. 1997;14(1):41-5 [9384801.001]
  • [Cites] J Neurosurg. 1999 Feb;90(2):237-50 [9950494.001]
  • [Cites] Arch Pathol Lab Med. 2002 Oct;126(10):1174-8 [12296753.001]
  • [Cites] J Neurosurg. 2005 Feb;102(2):189-93 [15739543.001]
  • [Cites] J Neurosurg. 1998 Oct;89(4):547-51 [9761047.001]
  • [Cites] J Oral Pathol Med. 1997 Sep;26(8):349-55 [9379423.001]
  • [Cites] Neurosurgery. 2000 Feb;46(2):291-302; discussion 302-5 [10690718.001]
  • [Cites] Surg Neurol. 1992 Aug;38(2):106-9 [1509341.001]
  • [Cites] Acta Neurochir (Wien). 1993;124(2-4):139-43 [7508161.001]
  • [Cites] J Neurosurg. 1995 Aug;83(2):206-14 [7616262.001]
  • [Cites] Noshuyo Byori. 1993;10(1):43-52 [7693227.001]
  • (PMID = 17652797.001).
  • [ISSN] 1046-3976
  • [Journal-full-title] Endocrine pathology
  • [ISO-abbreviation] Endocr. Pathol.
  • [Language] eng
  • [Publication-type] Comparative Study; Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Biomarkers, Tumor; 0 / Keratin-20; 0 / Keratin-8
  •  go-up   go-down


92. Arbolay OL, González JG, González RH, Gálvez YH: Extended endoscopic endonasal approach to the skull base. Minim Invasive Neurosurg; 2009 Jun;52(3):114-8
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • RESULTS: The extended endoscopic endonasal approach was used in 12 patients with the following lesions: 4 invasive adenomas to the cavernous sinus, 2 clival chordomas, 2 craniopharyngiomas, 1 hypothalamic astrocytoma and 3 pituitary adenomas extended upon the tuberculum.
  • [MeSH-major] Brain Neoplasms / surgery. Endoscopy / methods. Minimally Invasive Surgical Procedures / methods. Neurosurgical Procedures / methods. Skull Base / surgery
  • [MeSH-minor] Adenoma / surgery. Adult. Chordoma / surgery. Craniopharyngioma / surgery. Female. Humans. Male. Middle Aged. Pituitary Neoplasms / surgery. Retrospective Studies. Treatment Outcome

  • MedlinePlus Health Information. consumer health - Brain Tumors.
  • MedlinePlus Health Information. consumer health - Endoscopy.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright Georg Thieme Verlag KG Stuttgart. New York.
  • (PMID = 19650013.001).
  • [ISSN] 1439-2291
  • [Journal-full-title] Minimally invasive neurosurgery : MIN
  • [ISO-abbreviation] Minim Invasive Neurosurg
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Germany
  •  go-up   go-down


93. Yano S, Tsuiki H, Kudo M, Kai Y, Morioka M, Takeshima H, Yumoto E, Kuratsu J: Sellar repair with resorbable polyglactin acid sheet and fibrin glue in endoscopic endonasal transsphenoidal surgery. Surg Neurol; 2007 Jan;67(1):59-64; discussion 64
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • METHODS: The sellar repair using absorbable PGA sheet and fibrin glue was applied to 18 consecutive patients with sellar tumors that include 13 pituitary adenomas, 2 craniopharyngiomas, 2 Rathke's cleft cysts, and 1 meningioma within 135 patients who were treated with endoscopic endonasal transsphenoidal approach.
  • [MeSH-minor] Adenoma / surgery. Adult. Aged. Craniopharyngioma / surgery. Endoscopy. Female. Follow-Up Studies. Humans. Male. Meningioma / surgery. Middle Aged. Sphenoid Sinus / surgery

  • MedlinePlus Health Information. consumer health - Pituitary Tumors.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17210302.001).
  • [ISSN] 0090-3019
  • [Journal-full-title] Surgical neurology
  • [ISO-abbreviation] Surg Neurol
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Fibrin Tissue Adhesive; 0 / Tissue Adhesives; 34346-01-5 / Polyglactin 910
  •  go-up   go-down


94. Jiang ZL, Ren XH, Chu JS, Lin S, Zhang MZ: [Microsurgical treatment of adult craniopharyngiomas in 156 cases]. Zhonghua Yi Xue Za Zhi; 2010 Feb 2;90(5):291-4
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Microsurgical treatment of adult craniopharyngiomas in 156 cases].
  • OBJECTIVE: To explore the clinical features, surgical approaches and outcomes of craniopharyngioma in adults.
  • METHODS: A total of 156 cases of adult craniopharyngioma underwent microsurgery at our hospital were retrospectively reviewed and classified into four types according to the location of tumor relative to sellar diaphragm and the third ventricle.
  • 75.3% of the cases were capable of normal work and life and tumor recurred in 26 cases.
  • CONCLUSION: Selection of appropriate approach is the key to successful microsurgery for craniopharyngioma according to the site and growth pattern of tumor.
  • [MeSH-major] Craniopharyngioma / surgery. Microsurgery. Pituitary Neoplasms / surgery
  • [MeSH-minor] Adolescent. Adult. Aged. Female. Humans. Male. Middle Aged. Retrospective Studies. Young Adult

  • MedlinePlus Health Information. consumer health - Pituitary Tumors.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20368046.001).
  • [ISSN] 0376-2491
  • [Journal-full-title] Zhonghua yi xue za zhi
  • [ISO-abbreviation] Zhonghua Yi Xue Za Zhi
  • [Language] chi
  • [Publication-type] English Abstract; Journal Article
  • [Publication-country] China
  •  go-up   go-down


95. Campanini ML, Colli LM, Paixao BM, Cabral TP, Amaral FC, Machado HR, Neder LS, Saggioro F, Moreira AC, Antonini SR, de Castro M: CTNNB1 gene mutations, pituitary transcription factors, and MicroRNA expression involvement in the pathogenesis of adamantinomatous craniopharyngiomas. Horm Cancer; 2010 Aug;1(4):187-96
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] CTNNB1 gene mutations, pituitary transcription factors, and MicroRNA expression involvement in the pathogenesis of adamantinomatous craniopharyngiomas.
  • Genes involved in formation/development of the adenohypophysis, CTNNB1 gene, and microRNAs might be implicated in the craniopharyngioma pathogenesis.
  • The objective of this study is to perform the molecular analysis of HESX1, PROP1, POU1F1, and CTNNB1 genes and evaluate a panel of miRNA expression in craniopharyngioma.
  • The study included 16 patients with adamantinomatous craniopharyngioma (nine children and seven adults; eight females and eight males; 6-55 years, median 15.5 years).
  • DNA, RNA, and cDNA were obtained from craniopharyngioma and normal pituitaries.
  • We found no mutations in HESX1, PROP1, and POU1F1 genes and four polymorphisms in PROP1 gene which were in Hardy-Weinberg equilibrium and had similar allelic frequencies in craniopharyngioma and controls.
  • We observed hyperexpression of miR-150 (1.7-fold); no different expression of miR-16-1, miR-21, and miR23a; and an underexpression of miR-141, let-7a, miR-16, miR-449, miR-145, miR-143, miR-23b, miR-15a, and miR-24-2 (ranging from -7.5 to -2.5-fold; p = 0.02) in craniopharyngioma.
  • There was no association between tumor size or the recurrence and the presence of CTNNB1mutations. miR-16 and miR-141 were underexpressed in craniopharyngioma presenting CTNNB1 mutations. miR-23a and miR24-2 were hyperexpressed in patients who underwent only one surgery.
  • Mutations or polymorphisms in pituitary transcription factors are unlikely to contribute to the adamantinomatous craniopharyngioma pathogenesis, differently of CTNNB1 mutations.
  • Our data suggest the potential involvement of the deregulation of miRNA expression in the craniopharyngioma pathogenesis and outcome and also that the miRNA could modulate the Wnt signaling pathway in craniopharyngioma tumorigenesis.
  • [MeSH-major] Craniopharyngioma / genetics. MicroRNAs / genetics. Pituitary Neoplasms / genetics. Transcription Factors / genetics. beta Catenin / genetics
  • [MeSH-minor] Adolescent. Adult. Aged. Child. Female. Gene Expression Profiling. Gene Expression Regulation, Neoplastic. Gene Frequency. Genetic Predisposition to Disease. Genotype. Homeodomain Proteins / genetics. Humans. Male. Middle Aged. Mutation. Pituitary Gland / metabolism. Pituitary Gland / pathology. Polymorphism, Single Nucleotide. Transcription Factor Pit-1 / genetics. Young Adult

  • MedlinePlus Health Information. consumer health - Pituitary Tumors.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Cell Physiol. 2005 Jul;204(1):280-5 [15648093.001]
  • [Cites] J Clin Endocrinol Metab. 2009 Jan;94(1):320-3 [18840638.001]
  • [Cites] Am J Surg Pathol. 2006 Dec;30(12):1595-603 [17122517.001]
  • [Cites] Am J Clin Pathol. 2003 Nov;120(5):732-6 [14608900.001]
  • [Cites] Am J Pathol. 2002 Dec;161(6):1997-2001 [12466115.001]
  • [Cites] Childs Nerv Syst. 2005 Aug;21(8-9):622-7 [15965669.001]
  • [Cites] Arq Bras Endocrinol Metabol. 2009 Feb;53(1):31-9 [19347183.001]
  • [Cites] Endocr Rev. 2006 Jun;27(4):371-97 [16543382.001]
  • [Cites] J Pathol. 2004 Jul;203(3):814-21 [15221941.001]
  • [Cites] J Cell Physiol. 2007 Feb;210(2):370-7 [17111382.001]
  • [Cites] Cell. 2006 May 5;125(3):593-605 [16678101.001]
  • [Cites] Genes Dev. 2001 Dec 1;15(23 ):3193-207 [11731482.001]
  • [Cites] Acta Neuropathol. 2005 Jun;109(6):589-97 [15891929.001]
  • [Cites] Development. 1998 Dec;125(23):4835-40 [9806931.001]
  • [Cites] Brain Pathol. 2009 Jul;19(3):357-64 [18540944.001]
  • [Cites] Mol Endocrinol. 1996 Dec;10(12):1570-81 [8961267.001]
  • [Cites] Science. 1997 Mar 21;275(5307):1787-90 [9065402.001]
  • [Cites] Annu Rev Cell Dev Biol. 2004;20:781-810 [15473860.001]
  • [Cites] Obesity (Silver Spring). 2011 Jan;19(1):36-42 [20379145.001]
  • [Cites] Acta Neuropathol. 2010 May;119(5):631-9 [20131060.001]
  • [Cites] Nucleic Acids Res. 2005 Mar 01;33(4):1290-7 [15741182.001]
  • [Cites] Cancer Res. 2009 Apr 15;69(8):3278-82 [19351815.001]
  • [Cites] Acta Neuropathol. 1998 Mar;95(3):291-6 [9542595.001]
  • [Cites] J Neurosurg. 1999 Feb;90(2):237-50 [9950494.001]
  • [Cites] Development. 1996 Jan;122(1):41-52 [8565852.001]
  • [Cites] J Neurosurg. 2003 Jan;98(1):162-4 [12546365.001]
  • [Cites] J Neurosurg. 1990 Jul;73(1):12-7 [2352012.001]
  • [Cites] Clin Endocrinol (Oxf). 2005 Apr;62(4):397-409 [15807869.001]
  • [Cites] Nat Genet. 1998 Jun;19(2):125-33 [9620767.001]
  • [Cites] Biochem Biophys Res Commun. 1992 Dec 15;189(2):851-5 [1472057.001]
  • [Cites] J Pediatr. 2001 Nov;139(5):754 [11713462.001]
  • [Cites] Curr Opin Pediatr. 2007 Aug;19(4):471-9 [17630614.001]
  • [Cites] J Clin Endocrinol Metab. 2004 May;89(5):2200-6 [15126542.001]
  • [Cites] Dev Biol. 2007 Feb 1;302(1):1-12 [16989803.001]
  • [Cites] Clin Endocrinol (Oxf). 1995 May;42(5):467-73 [7621564.001]
  • [Cites] Neurosurgery. 1994 Dec;35(6):1001-10; discussion 1010-1 [7885544.001]
  • [Cites] J Clin Endocrinol Metab. 1999 Mar;84(3):942-5 [10084575.001]
  • [Cites] Arch Pathol. 1960 Sep;70:293-9 [13850582.001]
  • [Cites] Nature. 1996 Nov 28;384(6607):327-33 [8934515.001]
  • [Cites] J Neurol Neurosurg Psychiatry. 2003 Feb;74(2):260-1 [12531965.001]
  • [Cites] Annu Rev Pathol. 2009;4:199-227 [18817506.001]
  • [Cites] Neurosci Lett. 2001 Sep 7;310(1):5-8 [11524144.001]
  • [Cites] Nature. 1990 Oct 11;347(6293):528-33 [1977085.001]
  • (PMID = 21761366.001).
  • [ISSN] 1868-8500
  • [Journal-full-title] Hormones & cancer
  • [ISO-abbreviation] Horm Cancer
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / CTNNB1 protein, human; 0 / HESX1 protein, human; 0 / Homeodomain Proteins; 0 / MicroRNAs; 0 / POU1F1 protein, human; 0 / Prophet of Pit-1 protein; 0 / Transcription Factor Pit-1; 0 / Transcription Factors; 0 / beta Catenin
  •  go-up   go-down


96. Müller HL, Gebhardt U, Etavard-Gorris N, Kolb R, Warmuth-Metz M, Sörensen N: Current strategies in diagnostics and endocrine treatment of patients with childhood craniopharyngioma during follow-up--recommendations in KRANIOPHARYNGEOM 2000. Onkologie; 2005 Mar;28(3):150-6
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Current strategies in diagnostics and endocrine treatment of patients with childhood craniopharyngioma during follow-up--recommendations in KRANIOPHARYNGEOM 2000.
  • Craniopharyngiomas are rare dysontogenetic malformations.
  • As the survival rate after craniopharyngioma diagnosed during childhood and adolescence is high, prognosis and quality of life (QoL) in survivors mainly depend on adverse late effects such as hypopituitarism and obesity.
  • In order to evaluate and standardize diagnostic and therapeutical strategies in childhood craniopharyngioma the prospective multicenter surveillance study KRANIOPHARYNGEOM 2000 was initiated for patients diagnosed with craniopharyngioma during childhood and adolescence.
  • We are reporting on current strategies for laboratory diagnostics and endocrine substitution in patients with childhood craniopharyngioma recruited in KRANIOPHARYNGEOM 2000.
  • [MeSH-major] Craniopharyngioma / diagnosis. Craniopharyngioma / therapy. Diabetes Insipidus, Neurogenic / diagnosis. Diabetes Insipidus, Neurogenic / therapy. Pituitary Neoplasms / diagnosis. Pituitary Neoplasms / therapy
  • [MeSH-minor] Adolescent. Adult. Child. Female. Germany. Humans. Infant. Infant, Newborn. Male. Obesity / diagnosis. Obesity / etiology. Obesity / therapy. Practice Guidelines as Topic. Practice Patterns, Physicians'. Treatment Outcome

  • Genetic Alliance. consumer health - Craniopharyngioma.
  • MedlinePlus Health Information. consumer health - Pituitary Tumors.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15772466.001).
  • [ISSN] 0378-584X
  • [Journal-full-title] Onkologie
  • [ISO-abbreviation] Onkologie
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't; Review
  • [Publication-country] Switzerland
  • [Number-of-references] 24
  •  go-up   go-down


97. Minamida Y, Mikami T, Hashi K, Houkin K: Surgical management of the recurrence and regrowth of craniopharyngiomas. J Neurosurg; 2005 Aug;103(2):224-32
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Surgical management of the recurrence and regrowth of craniopharyngiomas.
  • OBJECT: The authors performed a retrospective analysis of a consecutive series of craniopharyngiomas and their recurrences, which were managed with surgery alone.
  • METHODS: In the past 20 years, 37 consecutive patients with craniopharyngiomas underwent surgery without adjuvant radiotherapy.
  • Of these 37 patients, 11 experienced tumor recurrence (29.7%) during the mean follow-up period of 11.1 years.
  • Using a proper surgical approach (mainly a basal interhemispheric approach) and meticulous microsurgical techniques, total removal of the recurrent tumor was achieved in nine surgeries (52.9).
  • CONCLUSIONS: Recurrence of craniopharyngioma can be safely managed by using meticulous contemporary microsurgical techniques without additional radiotherapy.
  • The role of surgery and adjuvant radiotherapy for craniopharyngiomas may vary in the future, depending on innovations in treatment and technology.
  • Nevertheless, surgery can be still a major therapeutic option in the management of recurrent craniopharyngiomas.
  • [MeSH-major] Craniopharyngioma / pathology. Craniopharyngioma / surgery. Neoplasm Recurrence, Local / surgery. Pituitary Neoplasms / pathology. Pituitary Neoplasms / surgery
  • [MeSH-minor] Adolescent. Adult. Aged. Child. Child, Preschool. Cognition. Disease Progression. Humans. Infant. Male. Middle Aged. Morbidity. Radiotherapy, Adjuvant. Retrospective Studies. Survival Analysis

  • MedlinePlus Health Information. consumer health - Pituitary Tumors.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16175850.001).
  • [ISSN] 0022-3085
  • [Journal-full-title] Journal of neurosurgery
  • [ISO-abbreviation] J. Neurosurg.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


98. Choi SH, Kwon BJ, Na DG, Kim JH, Han MH, Chang KH: Pituitary adenoma, craniopharyngioma, and Rathke cleft cyst involving both intrasellar and suprasellar regions: differentiation using MRI. Clin Radiol; 2007 May;62(5):453-62
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Pituitary adenoma, craniopharyngioma, and Rathke cleft cyst involving both intrasellar and suprasellar regions: differentiation using MRI.
  • AIMS: To determine the differential magnetic resonance imaging (MRI) features of pituitary adenoma, craniopharyngioma, and Rathke cleft cyst involving both intrasellar and suprasellar regions.
  • MATERIALS AND METHODS: The MRI images of 64 patients with pituitary adenoma (n=38), craniopharyngioma (n=13), or Rathke cleft cyst (n=13) were retrospectively reviewed by three neuroradiologists.
  • A superiorly lobulated shape, third ventricle compression by superior tumour extension, mixed solid and cystic characteristics, and reticular enhancement of the solid portion were more common in craniopharyngiomas (p<0.017).
  • Finally, an ovoid shape, a small tumour volume, cystic characteristics, and no or thin cyst wall enhancement were more common in Rathke cleft cysts (p<0.017).
  • The flowchart yielded diagnostic accuracies as follows: 92.1% in pituitary adenoma; 92.3% in craniopharyngioma; 92.3% in Rathke cleft cyst; and 92.2% overall.
  • [MeSH-major] Adenoma / pathology. Central Nervous System Cysts / pathology. Craniopharyngioma / pathology. Magnetic Resonance Imaging / methods. Pituitary Neoplasms / pathology
  • [MeSH-minor] Adult. Aged. Aged, 80 and over. Diagnosis, Differential. Female. Humans. Male. Middle Aged. Radiology Information Systems. Retrospective Studies


99. Karavitaki N, Brufani C, Warner JT, Adams CB, Richards P, Ansorge O, Shine B, Turner HE, Wass JA: Craniopharyngiomas in children and adults: systematic analysis of 121 cases with long-term follow-up. Clin Endocrinol (Oxf); 2005 Apr;62(4):397-409
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Craniopharyngiomas in children and adults: systematic analysis of 121 cases with long-term follow-up.
  • BACKGROUND: Craniopharyngiomas account for 2-5% of all primary intracranial tumours.
  • AIM: To analyse the natural history and treatment outcome of children and adults presenting to the Departments of Paediatrics and Endocrinology with craniopharyngioma between 1964 and 2003.
  • In this large series no substantial differences in the outcome of tumours diagnosed during childhood or adult life were found.
  • CONCLUSIONS: Craniopharyngiomas remain tumours associated with significant morbidity.
  • Childhood- and adult-onset lesions generally behave similarly.
  • [MeSH-major] Craniopharyngioma. Neoplasm Recurrence, Local. Pituitary Neoplasms
  • [MeSH-minor] Adolescent. Adult. Aged. Aged, 80 and over. Chi-Square Distribution. Child. Child, Preschool. Disease-Free Survival. Female. Follow-Up Studies. Humans. Male. Middle Aged. Statistics, Nonparametric. Survival Rate

  • MedlinePlus Health Information. consumer health - Pituitary Tumors.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15807869.001).
  • [ISSN] 0300-0664
  • [Journal-full-title] Clinical endocrinology
  • [ISO-abbreviation] Clin. Endocrinol. (Oxf)
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] England
  • [Number-of-references] 65
  •  go-up   go-down


100. Tena-Suck ML, Ortiz-Plata A, Galán F, Sánchez A: Expression of epithelial cell adhesion molecule and pituitary tumor transforming gene in adamantinomatous craniopharyngioma and its correlation with recurrence of the tumor. Ann Diagn Pathol; 2009 Apr;13(2):82-8
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Expression of epithelial cell adhesion molecule and pituitary tumor transforming gene in adamantinomatous craniopharyngioma and its correlation with recurrence of the tumor.
  • Craniopharyngiomas are benign tumors of the sellar region generally associated with endocrine disorders and often locally aggressive.
  • The reliable criteria for predicting the tumor behavior are still lacking.
  • It has been suggested that proliferative potential of the tumor cells is necessary for recurrence.
  • The aim of this study was to evaluate the activity and correlation of epithelial cell adhesion molecule (Ep-CAM) and pituitary tumor transforming gene (PTTG-1) immunoexpression that is possibly related to relapse in 40 patients with adamantinomatous craniopharyngioma.
  • The PTGG-1 expression in craniopharyngioma may suggest hypophyseal metaplasia.
  • The Ep-CAM and PTTG-1 expression in craniopharyngioma could be used as prediction markers of relapsing tumor.
  • It has been suggested that proliferative potential of the tumor cells is necessary for recurrence.
  • [MeSH-major] Antigens, Neoplasm / biosynthesis. Cell Adhesion Molecules / biosynthesis. Craniopharyngioma / metabolism. Neoplasm Proteins / biosynthesis. Neoplasm Recurrence, Local / metabolism. Pituitary Neoplasms / metabolism
  • [MeSH-minor] Adult. Biomarkers, Tumor / analysis. Female. Gene Expression. Humans. Immunohistochemistry. Male. Securin

  • Genetic Alliance. consumer health - Craniopharyngioma.
  • MedlinePlus Health Information. consumer health - Pituitary Tumors.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [CommentIn] Ann Diagn Pathol. 2009 Dec;13(6):428-9 [19917481.001]
  • (PMID = 19302955.001).
  • [ISSN] 1532-8198
  • [Journal-full-title] Annals of diagnostic pathology
  • [ISO-abbreviation] Ann Diagn Pathol
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Antigens, Neoplasm; 0 / Biomarkers, Tumor; 0 / Cell Adhesion Molecules; 0 / EPCAM protein, human; 0 / Neoplasm Proteins; 0 / Securin; 0 / pituitary tumor-transforming protein 1, human
  •  go-up   go-down






Advertisement